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ABSTRACT 
Molecular Characterization of Vibrio cholerae Isolates from 
Pakistan 
Cholera, a severe acute watery diarrhoeal disease, is caused by a motile, Gram-negative, 
bacillus named Vibrio cholerae. Millions of people around the globe died of cholera in 
the past. Cholera has remained endemic in South Asia and the first six pandemics have 
been considered to have originated from the Bay of Bengal. The favorable climatic 
conditions and contaminated water and food have maintained the disease in this region 
including Pakistan. In the last few years, WHO reported a significant increase in cholera 
cases around the world particularly in Haiti, Zimbabwe and Pakistan. The present study 
was carried out to characterize Vibrio cholerae isolates from Pakistan which involved 
determining the prevalence of different serogroups, phenotypic and genotypic 
characterization of associated antibiotic resistance, analysis of the cholera toxin (CTX) 
prophage, clonal relationship study, whole genome sequence analysis and single 
nucleotide polymorphisms (SNPs) based phylogeny. During this study (2009-2011), 113 
V. cholerae O1 El Tor isolates were collected from cholera patients in different cities of 
Pakistan. Among these 113 isolates, 108 (96%) have O1 serogroup and El Tor biotype 
whereas the serotype was Ogawa. Serogroup O139 which used to exist in Pakistan and 
elsewhere in the past was replaced by O1 serogroup. All the isolates were resistant to 
sulfamethoxazole, trimethoprim, streptomycin and nalidixic acid. However, resistance to 
tetracycline, ampicillin, ceftazidime, erythromycin, cefotaxime, chloramphenicol and 
ciprofloxacin was seen in 63%, 19.5%, 7.2%, 2%, 01%, 06% and 01% isolates 
respectively, whereas all isolates were sensitive to ofloxacin. At the genotypic level SXT 
integrative and conjugative element (ICE), was present in all the isolates whereas 
integrons (class 1, 2 and 3) and qnrA, qnrB and qnrS for encoding quinolone resistance 
were absent in all the O1 El Tor isolates studied. Genetic basis of resistance to 
sulfamethoxazole, trimethoprim, streptomycin and tetracycline was analyzed by detecting 
sul2, dfrA1, strAB, tetA and tetA which were present in all the isolates showing resistance 
to the respective antibiotic respectively. florR was detected in about 37 isolates, however 
only six of them showed resistance phenotype for chloramphenicol. gyrA and parC were 
also studied for mutations responsible for quinolones resistance; all the isolates had 
xi 
 
transversions of AGT (underlined) and TCG (underlined) in codons 83 (substituting 
isoleucine for serine) and 85 (substituting leucine for serine) in case of gyrA and parC 
respectively, these mutations render bacteria resistant to quinolones. Year wise (2009-
2011) antibiotic analysis showed an increasing trend of antibiotic resistance which should 
be properly addressed by focusing on the standard treatment of cholera, rehydration 
therapy, whereas antibiotics should be prescribed only in case of severe dehydration.  
 
CTX prophage was analyzed by different PCRs and sequencing approaches. Cholera 
toxin which is the major virulence factor of V. cholerae was present in all O1 El Tor 
isolates except one isolate, CS15 from Charsada. All the isolates have ctxB of classical 
biotype. CTX prophage analysis revealed that all isolates have only one copy of CTXф 
located on the large chromosome, no tandem repeats of CTX prophage and RS1 were 
found and the order of RS1 and CTX prophage in the genome of V. cholerae O1 El Tor 
was: 5’-RSI-CTX prophage-3’. The frequency of heptanucleotide repeat (TTTTGAT) 
between ctxA and zot for ToxR binding in these isolates varied from 5 to 6 which is 
high in the region and frequently related to the toxin productivity of the isolates.  
 
Multi-locus variable number of tandem repeat analysis (MLVA) of V. cholerae O1 El Tor 
isolates based on five loci divided the 98 El Tor isolates into 47 sequence types belonging 
to six clonal complexes (CCs) and three singletons. Epidemiological data revealed that 
CC1 was associated with cholera cases all over the country in 2011 and Rawalpindi in 
2009 whereas as V. cholerae O1 El Tor causing cholera in 2010 were associated with 
CC2, CC4 and CC3. Based on characteristic antibiotic resistance patterns and 
presence/absence of tagA and aldA, all V. cholerae O1 El Tor isolates were categorized in 
two groups, however MLVA generated clonal complexes did not reflected such 
relationship. The whole genome sequence analysis of the isolates and comparative 
genomics divided the V. cholerae O1 El Tor isolates from Pakistan in two categories. 
Genome wide SNPs analysis was carried out using the whole genome sequence data and 
a global phylogenetic tree was constructed comparing Pakistan Vibrio cholerae O1 El 
Tor isolates with 146 global and temporal representative V. cholerae isolates. All the O1 
El Tor isolates from Pakistan were classified in two unique sub-clades named as Pakistan 
sub-clade 1 (PSC-1) and Pakistan sub-clade 2 (PSC-2) respectively. Both PSCs belonged 
xii 
 
to the third transmission wave of the current seventh pandemic. Both sub-clades 
possessed distinct antibiotic resistance patterns and were distinguished by signature 
deletions in Vibrio pathogenicity island -1 (VPI-1) and Vibrio seventh pandemic 2 (VSP-
2). All the PSC-1 isolates had a unique three gene (VC0819-VC0821) deletion in VPI-1 
whereas in PSC-2 VPI-1 was intact. In PSC-1 a four gene (VC0495-VC0498) deletion 
was present in VSP-2 whereas a large 18 gene (VC0495-VC0512) deletion was present in 
VSP-2 of PSC-2. PSC-2 representing (4/4) and (31/38) isolates in 2009 and 2010 
respectively was dominant in Pakistan whereas PSC-1 was only seen in Karachi 
representing (6/7) isolates. However in 2011, PSC-1 has apparently replaced PSC-2 
representing 54/56 (96.5%) isolates and only 2/56 (3.5%) belonged to PSC-2. In nutshell, 
the study showed that two sub-clades with distinct antibiotic resistance patterns and 
genomic signatures circulating in Pakistan caused cholera during 2009-2011. 
Furthermore, SNPs based genetic markers can be used to track and identify the 
distribution of existing V. cholerae sub-clades or even any new type in future.  
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1 Introduction 
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Vibrio cholerae, a Gram-negative, motile, filamentous bacillus of genus Vibrio, is the 
causative agent of cholera (Matz et al., 2005). Cholera, a severe acute watery diarrhoeal 
disease, is caused after ingestion of water and food contaminated with V. cholerae. As a 
result of climatic conditions, ecological and political disturbances, the supply of safe 
drinking water has become difficult in various parts of the world which leads to increased 
cholera cases (Mathers and Loncar, 2006; Weiss and McMichael, 2004). In 2012, an 
estimated two to three million cholera cases with approx. 100,000 deaths were reported 
(Ali et al., 2012). However, the reported cases are much less than the actual because of 
the lack of surveillance particularly in the under developed countries. For the last few 
years, WHO has been reporting an increase in cholera cases around the world suggesting 
the need of preparedness by the health care authorities to control the disease, otherwise 
the fear of future outbreaks is quite possible (WHO, 2013) (Figure 1.1). In the first 
decade of 21
st
 century, massive cholera outbreaks affected people in South Asia 
(Pakistan, Bangladesh), Africa (Zimbabwe, Mozambique, Somalia, Sudan) and South 
America (Haiti, etc.), causing hundreds of thousands of cases and thousands of deaths 
(Harris et al., 2010a; Shah et al., 2014). 
 
1.1  Classification 
According to Bergey's Manual of Systematic Bacteriology, the genus Vibrio belongs to 
phylum Proteobacteria, class Gammaproteobacteria, order Vibrionales and family 
Vibrionaceae. Other close relatives of V. cholerae at the order level include 
Aeromondales and Enterobacteriales. Based on 16S rRNA, it is extremely difficult to 
distinguish closely related species of genus Vibrio. To date more than 60 species are 
included in the genus Vibrio (Thompson et al., 2004). Pathogenic members of the genus 
include V. cholerae, V. vulnificus and V. parahaemolyticus, all these inhabit aquatic 
especially the marine environment.  
1.2 Reservoirs of Vibrio cholerae 
Vibrio spp. are inhabitant of both aquatic environment and gut of human or other animals. 
Vibrio cholerae are often found in brackish and sea water as well as associated with other 
marine organisms such as planktonic copepods, fish, corals or in the form of biofilms
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Figure 1.1 Cholera cases in the countries from 2000 to 2012 (WHO, 2013) 
The figure shows that there is an increasing trend of cholera infections in different 
countries as well as more countries are reporting cholera during the last few years.  
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(Huq et al., 1983; Sochard et al., 1979). Generally the species flourishes in the temperate 
water having temperature >17˚C, salt content of 5 to 30 PSU, and high planktonic density 
(Bauer et al., 2006; Collin and Rehnstam-Holm, 2011; Kaneko and Colwell, 1973). 
However, sometimes this relationship between vibrios and their hosts matters more than 
the water temperature (Chowdhury et al., 1990).  
1.2.1 Serogroups, biotypes and serotypes of V. cholerae 
Based on variations in the somatic O antigen structure, responsible for cell wall 
composition, to date above 200 serogroups of V. cholerae have been recognized 
(Shimada et al., 1994; Yamai et al., 1997). These serogroups differ in their pathogenic 
and epidemic potential because mostly serogroup O1 and O139 are responsible for 
cholera epidemics while the other serogroups collectively named as non-O1/non-O139 
cause mild diarrhoea (Ramamurthy et al., 1993a).  
The serogroup O1 isolates have been divided into two distinct biotypes, classical and El 
Tor, on the basis of phenotypic tests such as Voges-Proskauer (VP) reaction, 
agglutination of chicken erythrocytes, hemolysis and sheep erythrocytes, sensitivity to 
specific phages and polymyxin B (Wachsmuth et al., 1994; WHO, 1987). Both biotypes 
also have sequence variation at specific genes such as toxin co-regulated pilin A (tcpA), 
repeat sequence transcriptional regulator (rstR), cholera toxin subunit B (ctxB) and 
absence of rtxC in classical biotype which are used to distinguish classical and El Tor 
isolates (Faast et al., 1989; Kimsey and Waldor, 1998; Lin et al., 1999; Olsvik et al., 
1993).  
Based on the antigenic forms (A, B and C) of the O1 antigen, O1 classical and El Tor 
isolates are further subdivided into three serotypes: Ogawa, Inaba and Hikojima. Ogawa 
serotype express A, B and small amount of C, Inaba serotype expresses only A and C 
antigens, whereas Hikojima (rare and unstable) strains express all three antigens (Kaper 
et al., 1995).   
Since, 1817 seven cholera pandemics occurred, classical biotype of serogroup O1 caused 
fifth and sixth cholera pandemics whereas the El Tor biotype caused seventh pandemic 
(Barua and Greenough, 1992; Faruque et al., 1998).  A new serogroup named as O139 
first time appeared in India and Bangladesh during 1992-93 and caused cholera 
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epidemics replacing O1 serogroup (Ramamurthy et al., 1993b; Albet et al., 1993).  
However, serogroup O1 reemerged in 1994 and reemergences and disappearances of the 
two serogroups were observed in the later years (Faruque et al., 2003). However, in the 
last decade, serogroup O1 has once again became the major causative agent of cholera 
throughout the world (Ang et al., 2010; Chin et al., 2011; Nguyen et al., 2009; 
Roychowdhury et al., 2008; Shah et al., 2014).  
1.3 Virulence factors 
The pathogenic potential of V. cholerae O1 and O139 strains is dependent on presence of 
a variety of virulence factors. The two major virulence factors include cholera toxin 
which is responsible for loss of electrolytes and toxin co-regulated pilus (TCP) to 
colonize it to the intestine and to dock the cholera phage on V. cholerae (De, 1959; 
Waldor and Mekalanos, 1996; Sun et al., 1990). Other accessory virulence factors 
include zonula occludens toxin (Zot), accessory cholera enterotoxin (Ace), Vibrio 
cholerae cytolysin (VCC), and repeats in toxin (Rtx) (Baudry et al., 1992; Trucksis et al., 
1997; Olson and Gouaux, 2005; Lin et al., 1999). These virulence factors have 
documented evidence of potential virulence even in the absence of cholera toxin. Other 
virulence factors include genes encoded by Vibrio pathogenicity islands 1 and 2 (VPI-1 
and VPI-2), Vibrio seventh pandemic 1 and 2 (VSP1 and VSP2) and integrative and 
conjugative element SXT which aid the pathogen in survival, virulence and drug 
resistance, will be discussed in the next sections (Karaolis et al., 1998; Jermyn and Boyd, 
2002; Dziejman et al., 2002; O'Shea et al., 2004; Hochhut and Waldor, 1999). A brief 
description of cholera toxin and other virulence factors is described below:  
1.3.1 Cholera toxin (CT) 
The major virulence factor of V. cholerae O1 and O139 and other toxigenic isolates is 
cholera toxin (CT) which is encoded by the filamentous phage named as CTXΦ (Waldor 
and Mekalanos, 1996). The cholera toxin was discovered by De in 1959 (De, 1959). Later 
studies showed the effect of cell free lysate containing cholera toxin inducing severe 
diarrhoea in rabbits (Dutta et al., 1959). In the following years, cholera toxin was purified 
and its effects in causing cholera were confirmed in human volunteers (Finkelstein and 
LoSpalluto, 1969; Levine et al., 1983). CT is an AB5 enterotoxin, 82 kDa (Ohtomo et al., 
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1976). The B subunit is a lectin which binds to GM1 ganglioside (King and Van 
Heyningen, 1973). The expression of cholera toxin and toxin co-regulated pilus is 
regulated by the ToxR regulator located on Vibrio pathogenicity island-1, VPI-1 
(Skorupski and Taylor, 1997).  
1.3.2 Accessory cholera enterotoxin (Ace) 
Accessory cholera enterotoxin (Ace) is encoded in the core region of CTX prophage 
(Waldor and Mekalanos, 1996). Earlier Ace was proposed as putative V. cholerae toxin 
(Trucksis et al., 1993). In animal models, crude Ace exracts induced increased 
intercellular ion transport in the gut cells, which is an important factor in causing cholera. 
Besides ion secretion, Ace has showed pore formation in rabbit ileal loops (Trucksis et 
al., 1997). This secretory role of Ace was further confirmed in in-vitro studies on 
intestinal epithelial cells T84 Ace showed Ca
2+
 dependent stimulation of ion secretion 
(Trucksis et al., 2000). 
1.3.3 Zonula occludens toxin (Zot): 
 
Zonula occludens toxin (44.8 kDa) is encoded by CTX prophage in V. cholerae (Baudry 
et al., 1992; Waldor and Mekalanos, 1996). In-vivo and in-vitro studies on epithelial cells 
showed that Zot binds to specific receptor and alters epithelial tight junctions by 
rearranging cytoskeleton by action of protein kinase C alpha-dependent F-actin 
polymerization to increase the permeability of the small intestine (Fasano et al., 1991; 
Fasano et al., 1995; Uzzau et al., 2001). Zonulin, a mammalian analog of Zot, located on 
the intestinal epithelia in response to induced stimuli such as intestinal injury or bacterial 
loading binds to its receptors and regulates the tight junctions (Fasano, 2001; Wang et al., 
2000). Both Zot and zonulin share identical binding motif at the N termini, thus Zot 
mimicks the zonulin role in regulating epithelial junction (DiRita, 1992; Wang et al., 
2000). 
1.3.4 Toxin-coregulated Pili (TCP) 
Toxin-coregulated pilus (TCP), is one of the major virulence factors because it not only 
helps in colonization of the V. cholerae to the small intestine during infection but also 
serves as receptor of CTX prophage on V. cholerae (Herrington et al., 1988; Sun et al., 
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1990; Taylor et al., 1987; Waldor and Mekalanos, 1996). The biogenesis and regulation 
of TCP is regulated by a cluster of 15 genes named as tcp gene cluster located on the 
VPI-1 and other genes (Everiss et al., 1994; Manning, 1997).   
TcpA, a homopolymer of 15 kDa pilin, is the major pilin protein. Both classical and El 
Tor biotypes of O1 and O139 isolates produce TcpA, however TcpA of El Tor shows 
80% and 100% amino acid identity with classical and O139 serogroup respectively 
(Iredell and Manning, 1994; Jonson et al., 1991; Rhine and Taylor, 1994). ToxR, a 
transmembrane binding protein, also located on VPI-1 regulates the expression of both 
CT and Tcp (Skorupski and Taylor, 1997). 
1.3.5 Vibrio cholerae cytolysin (VCC)/haemolysin 
VCC (85 kDA), a pore-forming toxin is produced by majority of O1, O139 and non-
O1/non-O139 V. cholerae isolates (Kaper et al., 1995; Tilley and Saibil, 2006). VCC is 
encoded by hlyA, its active 65 kDa form kills many eukaryotic cell types including rabbit 
and human erythrocytes, enterocytes and lymphocytes by implanting itself in the lipid 
bilayer in the form of heptameric B-barrel diffusion channels (Olson and Gouaux, 2005; 
Zitzer et al., 1995). VCC also causes lethal infection and delayed development in 
nematode Caenorhabditis elegans, a commonly used invertebrate infection model 
organism, (Cinar et al., 2010). 
1.3.6 Repeats in toxin (RTX)  
RTX family of toxins are produced by many Gram-negative pathogens (Welch, 2001). In 
V. cholerae RTX were discovered by Lin and colleages in 1999 (Lin et al., 1999). The 
RTX toxins can be divided into two categories: leukotoxins and haemolysins (Lally et al., 
1999). The RTX gene cluster consists of four genes named as rtxA, rtxB, rtxC and rtxD.  
RtxA, cytotoxin is responsible for rounding and detachment of laryngeal carcinoma cells 
mediated by actin crosslinking or inactivation of Rho GTPases (Fullner and Mekalanos, 
2000; Lin et al., 1999; Sheahan and Satchell, 2007). RtxC is the acytransfrase, RtxB and 
RtxE are transport proteins and RtxD is a transmembrane linker. RtxA toxin (454 kDa) at 
the time of discovery was the mega toxin in the genome (Lin et al., 1999). RTX toxin is 
secreted by type three secretion system, TTSS (Boardman and Satchell, 2004). 
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1.4 Cholera Background 
Little can be said with certainty about cholera in ancient times due to a combination of 
clinical characteristics and resemblance with diarrhoea and vomiting. 
 Etymology 
Hippocrates was the first one to use the term cholera, derived from the Greek word chole 
means bile and rein means to flow, describing the disease resulting in the massive flow of 
bile (Macpherson, 1872; Pollitzer et al., 1959). However, Alexander Trallianus in 1622, 
related the term cholera with cholades meaning intestine because the discharge is often 
serous (Macleod, 1910).  
In India/Sub-continent, Sanskrit word, visuchika, which meant abnormal bowel 
movement or gut disturbance, represented cholera in old Sanskrit surgery text/book, 
Sushruta Samhita written in 500-400 BC . In Urdu, the word heidja is used for cholera. 
Al Rhazes in 900 AC used the word Haida to describe cholera. Chinese called Fok lun to 
describe cholera disease over 02 millennia resulting in vomiting and motions due to some 
huddled in the inner body. But the recent word for cholera is huo luon written in ancient 
Chinese chronicles described characteristic problems of gastrointestinal tract. 
1.4.1  Cholera before 1817 
Historians in Asia and Europe noticed cholera like disease, but there is confusion about 
presence of V. cholerae O1 which is responsible for present day cholera disease in 
Europe before the first pandemic in 1817, when it was introduced from India. But in 
history by finding cholera like disease, it is possible to trace history of cholera. 
Sushruta Samhita descriptions and the texts of a Portuguese settler in 16th AC in India 
describe cholera like disease in the early days. Ancient Indian history does not mention 
about cholera epidemics, although translations of Sushruta Samhita describe about 
sporadic nature of a cholera like disease. 
De SN work strengthen the belief that cholera existed in Europe before the pandemics as 
well as by MacPherson in 1872 and 1884 (De, 1961; Macpherson, 1872). However, 
Howard-Jones and MacNamara disagreed (Howard-Jones, 1974; Macnamara, 1876).  
MacPherson mentioned the descriptions of cholera like disease from Greek authors 
(Hippocrates and Aretaeus), Indian (Suhsruta and Samhita) and Chinese texts citing 
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disease with characteristic cholera symptoms. Although the disease description (proper 
word) of Romans and Greeks were more exact. Rhazes gave the description of heyda in 
900 AC. All of these above descriptions of cholera were almost the same 
(Macpherson,1884). 
1.4.2 Cholera Pandemics 
Since 1817, seven cholera pandemics have been reported which are briefly discussed 
below.  
 
1.4.2.1 First cholera pandemic (1817- 1823) 
First pandemic of cholera spread from India in two waves/routes.  In one route cholera 
invaded South Asia (Nepal, 1818; Sri Lanka and Burma, 1819) and South East Asian 
(Thailand/Siam, Malaca, Penang, and Singapore, Philippines and Indonesian islands in 
the same period/time, 1820) countries (Hirsch, 1883). China and Japan were affected in 
1817 and 1822 by land and water routes respectively (Takano et al., 1926).  
The other route was via Oman which was affected by large outbreak in 1821 carried by 
Indian troops. From Oman it spread to Bahrain, the Persian Gulf, Iraq, Turkey, parts of 
Russia and Syrian cities neighbouring Egypt (Macnamara, 1876). 
African cities, Mauritius and Reunion were caught by cholera through shipping by Sri 
Lanka (Ceylon) and Zanzibar by Arabian ships in 1820-1821 (Macnamara, 1876).  
1.4.2.2 Second cholera pandemic (1829-1851) 
Second pandemic spread either from Astrakhan (Russia) in 1830 which was affected by 
recrudescence of the first pandemic infection or from Orenburg (Chaklov) which caught 
the disease transmitted via Afghanistan and Iran (Persia) from India to Orenburg 
(Chaklov) in the South Eastern European Russia in 1829. Despite strict quarantine 
measures, cholera reached Moscow in 1830 (Pollitzer et al., 1959). 
From Russia, cholera spread in European countries including England, Scotland, Ireland, 
France, Belgium, Finland, Netherland and Norway within a year (Haeser, 1882). Arabia 
suffered a devastating epidemic during Hajj in 1831 and due to huge life loss it was said, 
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the "living ceased to bury the dead singly". The pilgrims transmitted the disease to 
countries in Asia, Europe and Africa.  
In 1832, cholera reached in United States by Irish immigrants and during 1833-34 severe 
epidemics were caused in Mexico, Cuba and Guatemala. From Morocco, cholera spread 
to other European countries in few years. In 1840s, severe cholera epidemic affected and 
resulted in huge life loss in China, different parts of India, Philippines and Afghanistan.  
In 1848, cholera again affected Europe and Egypt, Philistine and Syria. United States was 
again affected despite quarantine measures and epidemics ravaged in New York, Texas, 
and other parts (Duffy, 1971). Cholera epidemics spread in Europe in 1849’s Spring 
where in England it caused 53,293 deaths (Snow, 1849). During this period John Snow 
made one of the major discoveries in epidemiology by showing the role of contaminated 
water in cholera transmission. In 1849, due to immense ravages cholera was declared as 
"America's greatest scourge" (Chambers, 1938). 
1.4.2.3 Third cholera pandemic (1852-1859) 
In 1853-4, cholera epidemics raged and affected North America, Northern Europe, Persia 
and Mesopotamia and South American countries, Columbia, Venezuela and Brazil. In 
this period it was also prevailing in the Near East. Cholera also reached lands not familiar 
with the disease in the past like Cape Verde.  
When cholerae affected Italy, Filippo Pacini discovered V. cholerae by examining the 
stools of the cholera patients and observed numerous curved bacteria. He published his 
findings in a local journal in 1854 (Barua, 1988). 
In Asia, cholera affected China and Japan in 1854, but more seriously when Philippine 
and Korea were also involved. In Africa, cholera outbreaks affected Mauritius and spread 
to Mozambique in 1859. Frequent epidemics affected Ethiopia during this period. Central 
America was affected in 1856 and Guyana in 1857.  
Cholera incidences increased in 1859 in Scandinavian region, Russia, Arabia, Morocco, 
Spain and Algeria.  Europe remained cholera free from the end of 1859.  
1.4.2.4 Fourth cholera pandemic (1859-1880) 
This pandemic in 1865 took lives of thirty thousand Mecca pilgrims and many of them 
transmitted the disease to Europe and Africa (Macnamara, 1876). During the war 
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between Germany and Austria, in 1866 thousands of deaths were caused in Germany, 
Austria, Italy and Russia (Barua and Greenough, 1992). In 1867-68, the epidemic 
subsided in Europe and Africa.  
The poor sanitary conditions in New York favoured the epidemic (Rosenberg, 1962). In 
1872, the pandemic caused 190,000 deaths in Hungary and from Mecca  the pandemic 
was carried to Russia, Turkey, Arabia and Southeast Asia and the surrounding islands 
(Hirsch, 1883). 
1.4.2.5 Fifth cholera pandemic (1881-96)  
In 1881-82, 5
th
 cholera pandemic started in mecca and spread to Egypt where Koch 
showed that cholera morbus was caused by the bacterium Komma bazillen (Pollitzer et 
al., 1959). Koch got fame in this period by his contributions of identify a comma shaped 
bacillus as the causative agent of cholera and that the patient intestine was not harmed 
despite enormous bacillus population in the intestine which suggested the role of 
extracellular toxin in the disease.  
50% fatality rate during this pandemic in Europe forced the governments to introduce 
changes in sanitary system which was spearheaded by Great Britain (Longmate, 1966). 
This almost eliminated cholera as last indigenous case of cholera was experienced in 
1893. By improvement of sanitary system only few cholera cases were reported in United 
States during this pandemic (Chambers, 1938; Lacey, 1993). However, the pandemic 
stormed South America and Europe, especially Moscow where it caused 80,000 deaths in 
1893-94. Africa, Philippines and Japan were also affected during this pandemic 
(Pollitzer, 1959). 
1.4.2.6 Sixth cholera pandemic (1899-1923) 
This pandemic was initiated in Mecca, and in 1902 infected pilgrims spread cholera to 
Egypt despite quarantine measures. From Egypt cholera spread to other countries 
(Hussein, 1949). 1907’s epidemic in Mecca spread the disease to whole Arabia. The 
epidemic affected eastern Asia throughout this pandemic (Barua and Greenough, 1992). 
Cholera before the seventh pandemic 
Many countries became cholera free during this period and it was thought that in future 
cholera would not be pandemic due to improvements in the water supply system. The last 
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indigenously acquired case of cholera was noticed in Europe (in 1925, Malaysia and 
Philippines (in 1937) and Egypt (in1947). D.N. De discovered cholera toxin in 1953 (De 
and Chatterje, 1953). As well as, this transient phase was characterized by improvements 
in cholera treatment by introduction of intravenous fluids therapy and antibiotics 
(Carpenter, 1976). 
.  
1.4.2.7  Seventh cholera pandemic (1961-present) 
The seventh pandemic started in 1961 from Java (Indonesia) and is affecting the whole 
world. The recent pandemic was caused by El Tor biotype of V. cholerae while the 
classical biotype caused the previous pandemics. In 1937, the El Tor biotype appeared for 
the first time in Indonesia and was named by enteritis choleriformus El Tor after a 
quarantine station El Tor in Sinai, Egypt (de Moor, 1949; Van Loghem, 1938).  
This pandemic spread in three phases: first phase (1961-66), second phase (1970-71), and 
the third phase (1991-present). In the first phase, the cholera epidemic spread to other 
neighbouring countries, Philippines, Sabah and Taiwan (Kamal, 1974). In 1963, the 
pandemic reached Malaysia, Burma, Thailand, Vietnam, Cambodia, Pakistan, India and, 
Bangladesh. Then from Afghanistan, Iran and Iraq to the states of Soviet Union (Kamal, 
1974). Until 1970, the pandemic evaded Saudi Arabia, Syria and Israel in middle East 
(Cohen et al., 1971). Africa was invaded by cholera epidemics in the second phase, 
especially West Africa where it causes thousands of cholera infections with high fatality 
rate where cholera epidemics could not establish in the past hundred years (Barua, 1972; 
Goodgame and Greenough, 1975). The Pandemic spread rapidly in Africa by two routes, 
one along the coast and the other route through interior infecting the Ghana, Niger, 
Cameron and Morocco. As in 1970, majority of cholera epidemics were reported in 
Africa (Kaper et al., 1995).  
 In Bangladesh El Tor biotype dominated over the classical during 1973-82 (Samadi et 
al., 1983). In 1974, small epidemic hit Mecca but in contrast to previous, it was 
eradicated. Portugal was affected by cholera epidemic caused by consumption of shell 
fish contaminated with El Tor. Then in late 1970s, it affected other African countries 
including the Congo, Rwanda, Zaire, Burundi and Zambia.  
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In the third phase, cholera spread from Peru in 1991 to other South American countries 
which had not been affected by cholera since 1895. Over 18 countries in South America 
reported cholera in just one year, 1992 (Hall et al., 1991; Ries et al., 1992).  
From Peru the epidemic reached neighbouring countries of Ecuador and Columbia where 
the epidemic raged because of lack of safe drinking water and compromised sanitary 
conditions due to poor socio-economic conditions (Levine, 1991). Then cholera 
penetrated in South and Central American countries and in one year, 1991-92, caused 
750,000 cases and 6,500 deaths. 
In Zaire one of the most fatal cholera outbreaks took 12,000 lives of Rwandan refugees 
who migrated to Zaire because of civil war in Rwanda in 1994 (Siddique et al., 1995). 
All these outbreaks were caused by V. cholerae O1 El Tor, however a non-O1 serogroup 
named as O139 caused epidemics in Bangladesh and India. Later on the O139 serogroup 
was also reported from Pakistan where it caused epidemics (Garg et al., 1993; Jabeen and 
Hasan, 2003). 
1.5  Infectious dose 
Before infection to proceed in human, an adequate ingestion of V. cholerae is required to 
overcome the gut defences and colonize the small intestine for multiplication and further 
spread through exit in faeces. Animal infection models for cholera have shown that two 
different ID50 of 100 and 500 cells for V. cholerae from human source and in-vitro 
respectively depending on the source of the infecting V. cholerae (Nelson et al., 2008; 
Zahid et al., 2008). 
Microarray based global transcriptional profile revealed that V. cholerae from rice watery 
stool have different profile that those grown in-vitro or vomited (Larocque et al., 2005). 
These hyperinfectious strains are highly motile but chemotaxis is down-regulated (Butler 
et al., 2006). The infectious dose was determined mainly from planktonic V. cholerae 
whereas human excrete vibrios in aggregates or biofilm-like arrangement, therefore, to 
determine the infectious dose of this aggregate form may be useful to check transmission 
and disease control (Faruque et al., 2006a; Nelson et al., 2007).  
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1.5.1  Infectious dose in humans 
The infectious dose to cause cholera mainly depends on the V. cholerae strain and its 
host. In a study of healthy volunteers in North America, the infectious dose to cause 
intestinal colonization was 10
8
-10
11 
(Cash et al., 1974; Kaper et al., 1995).  However, a 
lower infectious dose of 10
4
-10
8
 with 90% success is required in achlorhydria because 
bicarbonate buffer neutralizes the gastric acid. In case of household, volunteers ingesting 
V. cholerae with food such as fish, rice and milk have shown the infectious dose similar 
to when the bacterium was inoculated in buffered stomach. This has important 
implications when the achlorhydric condition is prevalent due to some other infections 
such as Helicobacter pylori (Wachsmuth et al., 1994). In endemic cases, the infectious 
dose has not been determined due to requirement of rapid response and fluorescence 
microscope to count both viable and viable but non-culturable  (VBNC) V. cholerae 
(Brayton et al., 1987).  
1.6 Transmission 
The infectious state of V. cholerae plays an important role in the transmission of cholera. 
The hyperinfectious state of the excreted V. cholerae persists for 5 hours which is 
particularly important in densely populated areas where there is a possibility of further 
infections in relatively short time. One of the models of cholera suggest that a new 
epidemic begins either from the migration of a carrier or from the introduction of cholera 
pathogen from environment.  
V. cholerae may also be transmitted from their aquatic reservoirs where they exist free-
living or associated with phytoplankton, coral, shrimp, fish, molluscs and other living or 
non-living forms (Halpern et al., 2004; Huq et al., 1983; Islam et al., 2007; Senderovich 
et al., 2010; Tamplin et al., 1990).  
Cholera is transmitted mainly by two routes, one is from the natural aquatic reservoirs in 
environment and the other is from already infected persons which has role in the spread 
of epidemic (Ruiz-Moreno et al., 2010). The transmission cycle is represented in the 
figure 1.2. 
In endemic regions, since main source is water, although food is also a source whereas in 
non-endemic regions the raw food including fish, seafood, shrimps, is responsible for the  
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Figure 1.2 Transmission cycle of V. cholerae 
Toxigenic and non-toxigenic V. cholerae persist in the aquatic reservoir and their maintenance is 
aided by survival on biofilms and utilizing chitin as carbon and nitrogen source. Upon ingestion 
of contaminated seafood or water from the environment, the pathogenic strains establish infection 
in the host gut and hyperinfectious strains are excreted with stool and released in the environment 
due to compromised sewage. The excreted hyperinfectious pathogens serve as transient state 
which results in amplification of outbreak through transmission to other hosts (Nelson et al., 
2009).
16 
 
initiation of infection. The infection starts by the ingestion of contaminated food where 
infected people excrete V. cholerae in the rice water stool which contaminates the   water 
supplies because of compromised sewage infrastructure. As a result more people are 
infected by ingesting the contaminated water. Person-to-person transmission is relatively 
uncommon and in such studies an infectious dose of 10
2
 -10
3
 cells was determined 
(Hartley et al., 2006). Infectious dose is low for transmission through faeces and it also 
has short incubation period (Pascual et al., 2006).  
1.7 Signs and symptoms 
Cholera patients have characteristic signs such as severe acute watery diarrhoea (fluids 
loss of upto 1 L per hr)   which may result in hypotensive shock and sometimes death in 
few hours after the start of first symptom (called cholera-gravis). In severely dehydrated 
patients, without treatment the fatality rate may rise to 70% (Lindenbaum et al., 1967). 
Stool resemblance to rice water develops after unstopped purging, initially the stool 
contains faeces and bile content. At the onset of symptoms, vomiting is common but later 
on it disappears.  
Cholera is usually painless, however in some cases abdominal pain or cramps may appear 
due to fluid loss in the bowel.  Fever is not common, however when it occurs secondary 
infection may be suspected.  
Most complications of cholera are due to dehydration and imbalance of the electrolytes 
which include lethargy, dry mouth, sunken eyes, decreased skin turgor, wrinkles on hands 
and feet. In children severe hypoglycaemia results in shaky consciousness, fits and even 
coma (Lindenbaum et al., 1966). Another rare complication is cholera sicca characterized 
by accumulation of fluids in the intestines and results in circulatory failure or death after 
the stool (Guerrant et al., 2003). 
1.8  Host susceptibility 
Susceptibility of host to cholera is affected by many factors including intestinal immunity 
by previous exposure, retinol deficiency, blood group and concomitant infections of 
enteric pathogens (Chowdhury et al., 2010; Harris et al., 2009).  Individuals with retinol 
deficiency have higher risk of cholera. Similarly, individuals with blood group O suffer 
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severe cholera because H antigen of blood O individuals has weaker bonding with 
cholera toxin subunit B (CTB) complex to reduce its toxicity as compared blood group A 
and B antigens (Holmner et al., 2010). Low prevalence of blood group O in South Asia 
as compared to other regions suggests that due to endemic cholera in South Asia, O blood 
group was not favoured (Glass et al., 1985).  At the gene level variants in different 
component of immune system such as BPI fold containing family B, member 1 (BPIFB1) 
have higher expression level in cholera patients (Shin et al., 2011).  
1.9 Treatment 
For treatment of cholera rehydration and antibiotic therapies are implied which result in 
rapid cure of cholera and the case fatality has been reduced to < 2% and the epidemics 
are negotiated successfully in the recent years (Mintz and Guerrant, 2009). 
The recommended treatment of cholera is rehydration therapy to compensate the loss of 
fluids and electrolytes. The therapy includes oral or intravenous rehydration depending 
on dehydration state of the patient. Severely dehydrated patients are treated with 
intravenous Ringer's solution (isotonic fluid) until the pulse is stable because the severe 
cases cannot tolerate the oral dose. The dose of Ringer's solution also depends on 
patient’s condition. Mild dehydrated patients are treated with oral rehydration, however 
moderately dehydrated patients can also be treated intravenously. Rehydration therapy 
has played a vital role to reduce the case fatality in cholera and saved millions of lives 
since its anticipation (Ryan et al., 2000; Sack et al., 2006).  
Since the main therapy for cholera is rehydration therapy. However, antibiotics are used 
as an adjunct to rehydration therapy because they help in reducing the disease duration 
and vibrio excretion as well as are also helpful in prophylaxis situation to control 
outbreaks.  
Tetracyclines are used for cholera treatment for the past 5 decades. Doxycycline's single 
dose is effective however, it is not recommended to children and pregnant women. 
Furazolidone, trimethoprim, erythromycin, chloramphenicol are effective (Kabir et al., 
1996). Despite emergence of resistance against other antibiotics, most of cholera 
pathogens are sensitive to ciprofloxacin and azithromycin, and their single dose is 
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effective instead of multiple doses of erythromycin (Hossain et al., 2002; Saha et al., 
2006; Saha et al., 2005) 
1.10  Genome of Vibrio cholerae 
The genome of Vibrio cholerae consists of two heterogeneous circular chromosomes 
(Trucksis et al., 1998). The complete genome of a seventh pandemic representative V. 
cholerae O1 El Tor Inaba N16961 from Bangladesh was sequenced by Heidelberg and 
colleagues in 2000 for the first time (Heidelberg et al., 2000). Since then a large number 
of genomes of V. cholerae isolates have been sequenced to understand the evolutionary 
mechanisms and spread of different cholera outbreaks (Hendriksen et al., 2011; Mutreja 
et al., 2011; Shah et al., 2014). The large chromosome of V. cholerae was named as 
chromosome 1 (ch1) whereas the small one as chromosome 2 (ch2). The sizes of the ch1 
and ch2 are 2,961,146 and 1,072,314 bp, respectively. The total number of ORFs 
encoded by V. cholerae genome is 3885, 2775 and 1110 on large and small chromosome, 
respectively. The ch1 consists of many functional genes having role in DNA replication, 
transcription, translation and cell-wall synthesis. Virulence associated genes such as 
adhesins, toxins and antigens are also encoded by ch1. Integrons and other gene catch 
systems are located on the small chromosome. Both chromosomes have the same G+C 
content which suggests that they have been coexisting for a long time in evolutionary 
scale. The small chromosome may have been originated either from the excision of a 
solitary large chromosome or a mega plasmid which had been captured by an ancestor of 
Vibrio spp. The hypothetical genes account for 42% in ch1 whereas in ch2 their share is 
59%. 
1.11 Cholera phage (CTXΦ) 
The CTX phage converts non-pathogenic V. cholerae to pathogenic V. cholerae by phage 
conversion process.  In toxigenic V. cholerae, cholera toxin is encoded by CTX prophage 
integrated in the host genome (Waldor and Mekalanos, 1996). The CTXΦ has similarities 
with other filamentous phages (M13 and f1) of E. coli (Faruque and Nair, 2008). CTXΦ 
is a 6.9 kb filamentous phage, its genome is organized into two structurally and 
functionally distinct regions (Waldor and Mekalanos, 1996) (Figure 1.3). These regions 
include RS2 (repeat sequence 2) and the core region. The RS2 region consists of three  
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Figure 1.3 Organization of RS1,CTX prophage and TLC element  in V. cholerae O1 El Tor 
[Figure from (Faruque and Mekalanos, 2012)] 
The arrows represent the ORFs whereas the rectangle represents the dif site. RS1 is a satellite 
phage encoding four polypeptides whereas CTX consisting of core region and RS2 encoding 
cholera toxin and other important genes included zot, ace and cep. A satellite phage genome TLC 
comprising different ORFs is shown.  
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genes, rstR, rstA and rstB while the core region encodes cholera toxin AB (ctxAB) and 
others including psh, cep, orfU (gIII), ace and zot.  The rstA is responsible for 
replication of CTXΦ genome, rstA has similar role to that of the pII in Ff filamentous 
coliophage of E. coli. The rstR is a repressor and functions in site-specific 
recombination whereas rstB gene product functions in integration of the CTXΦ 
genome into the bacterial host (Waldor et al., 1997). In core region, Psh, Cep, OrfU 
and Ace are structural components of the phage whereas Zot mediates phage 
assembly. However, ctxAB genes are not required for phage survival. CTXΦ has no 
integrase gene, but it uses host encoded XerC and XerD for integration into the 
bacterial host. The  XerCD are conserved proteins in eubacteria and cholera toxin is 
secreted from the cell by type two secretion system  (TTSC), which is also used for 
export of other bacterial products such as chitinase and hemagglutinin-protease of V. 
cholerae (Davis et al., 2000a; Johnson et al., 2006).  Like other filamentous phages, 
CTXΦ is secreted without lysis of the host. 
1.11.1 Origin of CTXΦ 
From various characteristics of CTXΦ genome, it is believed that a CTX phage 
progenitor has acquired ctxAB from some unknown source (Boyd et al., 2000a; 
Waldor and Mekalanos, 1996).  This was also supported by G+C composition of 
ctxAB (38%) and CTXΦ genome (40%). In addition, two promoters promote cholera 
toxin production, one is rstA (5 kb upstream of ctxAB) which promotes both CTXΦ 
virion synthesis as well as ctxAB, and the other is pctxAB located immediately 
upstream. CTX prophages which lack ctxAB have also been reported (Boyd et al., 
2000a). The replicative forms of both, the precursor CTX (preCTX) and CTXΦ, is 
identical. These similarities suggest that ctxAB and their promoters have been 
acquired by preCTX simultaneously and prior to this event, the ctxAB has been 
acquired by some unknown donor by imprecise replication of phage (Faruque and 
Nair, 2008).  
This acquisition of phage and ctxAB has increased the survival of V. cholerae, 
because the action of cholera toxin results in severe diarrhoea through which V. 
cholerae is disseminated. This CTXΦ is a quite stable lysogen and it is replicated 
without host lysis. CTXΦ can be transferred by vertical as well as horizontal mode 
(Faruque and Nair, 2008; Waldor and Mekalanos, 1996).  
21 
 
1.11.2 Diversity of CTX phage 
The rstR sequence is variable among classical, El Tor and O139 isolates, however 
rstA and rstB are highly conserved among different V. cholerae strains (Kimsey et al., 
1998; Nandi et al., 2003). Usually, CTX phages have been classified based on 
variations in rstR sequence. The CTXΦ having rstR type of classical, El Tor and 
O139 are named as CTX
Classical
, CTX
ET
 and CTX
Calc
 respectively. Serogroup O139 
isolates may contain rstR
ET
 or rstR
Calc
 (Davis et al., 1999; Kimsey et al., 1998). Both 
rstR
ET
 and rstR
Calc
 may be present simultaneously in O139 isolates. Other rstR types 
have been identified in V. cholerae non-O1/non-O139 serogroups from environmental 
strains. ctxB is also variable among V. cholerae. Sequence similarities of rstR and 
OrfU of CTX phages, showed that CTXΦs have been acquired by different V. 
cholerae isolates independently as well as novel CTXΦ integration into classical, El 
Tor and O139 isolates (Bhattacharya et al., 2006; Boyd et al., 2000a). 
1.12  Organization of CTX prophage in V. cholerae genome 
The position of CTX prophage in V. cholerae genome varies and depends upon copy 
number of the CTX prophage as well as the biotype and serogroup of the V. cholerae 
isolates. In El Tor biotype, CTX prophage is located on the large chromosome, and 
downstream of TLC (toxin linked cryptic) which was recognised as a satellite phage 
(Hassan et al., 2010; Mekalanos, 1983). Another satellite phage, RS1Φ, 2.7 kb 
repetitive sequence) also flanks the CTX prophage of the El Tor biotype (Davis et al., 
2002). CTX and RS1 arrangements varied over the years. For example, RS1-CTX
ET
-
RS1-CTX
ET
-RS1 and CTX
ET
-RS1 arrays were observed in V. cholerae O1 El Tor 
from Bahrain (in 1978) and Peru (in 1991) respectively (Mekalanos, 1983; Waldor 
and Mekalanos, 1994). The CTXΦ infectious particles are produced only in V. 
cholerae isolates having either CTX-CTX array or CTX-RS1 array, as well as when 
the CTXΦ genome is hybrid of the CTX and RS1 or comes from these elements 
(Davis and Waldor, 2000). In classical biotype, CTXΦ lacks RS1 while it has two 
copies of CTXΦ, one on each chromosome (Davis et al., 2000b). In large 
chromosome, the location of CTXΦ is same as it has in El Tor biotype, between TLC 
and repeat in toxin (RTX) gene clusters. However, in the small chromosome it is 
located between the loci, VCA0569 and VCA0570 (Davis et al., 2000b). Sometimes 
in classical isolates, CTX is truncated on the large chromosome whereas a complete 
copy is present on the small chromosome or vice versa. Various CTX arrangements 
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have been reported in the last two decades from different countries (Das et al., 2007; 
Faruque et al., 2007b; Safa et al., 2008; Shah et al., 2014). All these highlight the 
dynamic nature of CTXΦ which is continually giving new variant strains.  
1.12.1  Distribution of CTX prophage 
Most V. cholerae isolates of toxigenic serogroups of O1 and O139 carry CTX 
prophage whereas in non-O1/non-O139 serogroups it is present sporadically (Faruque 
et al., 1998a; Faruque et al., 1998b). This sporadic distribution of CTXΦ may be 
because of the limited existence of TCP in the non-toxigenic V. cholerae because TCP 
acts as a receptor on V. cholerae for attachment of CTXΦ (Waldor and Mekalanos, 
1996). For example, many Vibrio mimicus isolates positive for TCP also carry the 
CTXΦ. The presence of homologs of TCP island and CTX phage in other members of 
genus Vibrio may serve as reservoirs to enhance their virulence (Boyd et al., 2000b). 
1.13  Pathogenicity islands in V. cholerae  
The pathogenicity islands (PIs) are 10-200 kb genomic regions and have different 
G+C content from the core genome. The PIs encode virulence genes and are 
associated with repeats, integrases and transposases. Generally PIs are present in the 
pathogenic members of a species while absent in the non-pathogenic ones (Dobrindt 
et al., 2004). Genomic islands differ from PIs in the role of the genes they encode 
which are often associated with the nutrient uptake system, which enhance the fitness 
and survival of both pathogenic and environmental organisms (Dobrindt et al., 2004). 
Following is a brief description of the important PIs and GIs identified in V. cholerae: 
1.13.1   Vibrio pathogenicity island-1 (VPI-1) 
This 39.5kb island encodes 28 open reading frames (ORFS) on chromosome one, 
which include TCP, colonization factor to the epithelial cells and receptor of CTXΦ 
on the V. cholerae cell surface (Karaolis et al., 1998; Taylor et al., 1987). VPI-1 is 
distributed sporadically among V. cholerae isolates. The exact mechanism of 
transmission of VPI-1 is unclear. According to one of the hypothesis, VPI-1 was a 
filamentous bacteriophage (Karaolis et al., 1999), but there are serious concerns to 
accept this due to lack of sequence similarity between VPI-1 and filamentous 
bacteriophages and failure to identify independently existing VPIΦ. However, Boyd 
and O’Shea have shown the transfer of VPI-1 to a recipient strain by using 
transducing bacteriophage CP-T1 (O'Shea and Boyd, 2002). This finding supported 
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the hypothesis of VPI-1 as a satellite element, which requires helper bacteriophage for 
packing, but by themselves VPI-1 are not viable bacteriophages (Faruque et al., 2003; 
O'Shea and Boyd, 2002; Waldor and Mekalanos, 1996). Recombinases, int and vpiT, 
encoded on VPI-1 mediate the formation of extra-chromosomal circular product 
(pVPI) which excises VPI from the chromosome. This phenomenon suggests a 
possible transfer route for VPI-1 (Boyd and Brussow, 2002). 
1.13.2  Vibrio pathogenicity island -2 (VPI-2) 
The Vibrio pathogenicity island -2 (VPI-2) consists of a 57.3 kb region located on 
chromosome one encompassing 52 ORFs (Jermyn and Boyd, 2002). It is 
integrated/inserted at a tRNA -serine locus and encodes an integrase of the tyrosine 
recombinase family (Jermyn and Boyd, 2002). G+C content of VPI-2 is 42% and like 
VPI-1, it is quite stable. VPI-2 has several functionally distinct regions; restriction 
modification system, consisting of six ORFs, and many chemotaxis proteins. nag 
region consisting of 12 ORFs is involved in sialic acid utilization which may serve as 
secondary nutrition, neuraminidase (nanH), an insertion (IS) elements, two 
recombination directionality factors or excisionases and Mu-phage-like genes 
(Almagro-Moreno et al., 2010; Jermyn and Boyd, 2002). 
1.13.3   Vibrio seventh pandemic-1 (VSP-1) 
The Vibrio seventh pandemic island-1 (16 kb region on large chromosome, spanning 
11 ORFs) is present only in El Tor strains of the seventh pandemic as well as in O139 
isolates. The G+C content of VSP-1 is 40% in contrast to 47% of V. cholerae core 
genome. Majority of the genes encoded by VSP-1 are hypothetical proteins (Dziejman 
et al., 2002). VC0175 and VC0176 encode deoxycytidylate deaminase-related 
protein, and homologue of transcriptional regulator is encoded by VSP-1.It excises by 
forming a circular intermediate (Murphy and Boyd, 2008). 
1.13.4  Vibrio seventh pandemic-2 (VSP-2) 
The Vibrio seventh pandemic island -2 (VSP-2) was discovered by Dziejman and 
colleagues in 2002 while doing a comparative microarray of the seventh pandemic V. 
cholerae strains (Dziejman et al., 2002). Initially, it was assessed to be a 7.5 kb region 
consisting of only eight ORFs (VC0490-VC0497), but  later on O'Shea and colleagues 
showed that VSP-2 is 27 kb in size and consisted of 27 ORFs (O'Shea et al., 2004) 
Majority of ORFs in VSP-2 have not been assigned a role while 13 of 24 genes 
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encode for conserved hypothetical proteins. The important ones include tyrosine 
recombinase family and an excisionase, methyl -accepting chemotaxis proteins and a 
type IV pilus (O'Shea et al., 2004). The role of VSP-2 in pathogenesis or survival has 
not been explored in detail. 
1.14 1. Antibiotics for cholera treatment 
Fluid replacement or oral dehydration therapy is the cornerstone in treatment of 
cholera. However, antibiotics are an adjunct therapy for cholera as they reduce the 
illness period by 50%, vibrio shedding in the stool and episodes of watery diarrhoea 
(Greenough et al., 1964; Lindenbaum et al., 1967; Pierce et al., 1968) The antibiotics 
are particularly very useful in epidemics when hundreds of cholera cases are to be 
treated with limited hospital infrastructure and to control the spread of the outbreaks.  
WHO recommends oral rehydration therapy containing glucose, potassium chloride, 
sodium chloride and tri-sodium citrate to treat cholera (WHO, 2002). Tetracycline 
have been in use to treat cholera since 1960's, thereafter tetracycline resistant V. 
cholerae strains emerged and the antibiotics were prescribed only to patients with 
severe dehydration (Garg et al., 2001). Single-dose of doxycycline and ciprofloxacin 
or multi-doses of tetracycline while continuing oral rehydration therapy are very 
useful (Alam et al., 1990; Saha et al., 2005). Erythromycin is prescribed to children 
and pregnant women for cholera treatment (Roy et al., 1998). 
WHO does not encourage the use of antibiotics for cholera treatment but for severe 
cases only. However, the indiscriminate use of the antibiotics leads to emergence of 
antibiotic resistance which is a major problem these days. 
1.14.1  Mechanisms of antibiotic resistance  
V. cholerae strains offer resistance to antibiotics by a variety of ways. These include 
export of drugs through efflux pumps, mutations in the genome, exchange of 
conjugative plasmids, integron, transposon and integrative and conjugative element 
(ICE) such as SXT.  
1.14.1.1  Efflux pumps  
The efflux pumps are multipurpose which are used to export antibiotics, detergents, 
dyes and other foreign substances (Paulsen et al., 1996). Two main categories of 
efflux pumps on the basis of energy requirement are: ATP dependent and proton-
motive force (PMP) of transmembrane H+ or Sodium ion gradients (Putman et al., 
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2000). An ATP-driven pump such as VcaM, V. cholerae ABC (ATP binding cassette) 
confers multidrug resistance including tetracycline, ciprofloxacin, norfloxacin and 
doxorubicin. PMP related categories encoding resistance in V. cholerae include 
MATE (multidrug and toxic compound extrusion), MFS (major facilitator 
superfamily) conferring resistance to deoxycholate and antibiotics, RND (resistance-
nodulation-cell division) facilitating colonization and efflux of antibiotics, SDS, 
Triton X-100 and SMR (Small multidrug resistance) (Begum et al., 2005; Bina et al., 
2008; Colmer et al., 1998; Paulsen et al., 1996; Woolley et al., 2005).  
1.14.1.2 Spontaneous mutations 
Bacteria offer resistance to antibiotics due to spontaneous mutations in particular 
regions of their genome. In V. cholerae resistance to cell wall biosynthesis inhibitor 
alafosfalin and DNA replication inhibitors such as quinolones is offered by 
spontaneous mutations (Allen et al., 1979; Gellert et al., 1977; Sugino et al., 1977). 
Studies showed that V. cholerae has more tendency towards spontaneous mutations 
than E. coli to survive the action of alafosfalin (Atherton et al., 1979). Baranwal and 
group found that mutations in DNA gyrase A (gyrA) and topoisomerase IV (parC) 
reduce their affinity for quinolones (Baranwal et al., 2002).  Acquisition of gyrA and 
parC mutations over the time has been related to increased quinolones resistance in V. 
cholerae (Kim et al., 2010).  Different studies in the last decade identified V. cholerae 
resistant to tetracycline, erythromycin, quinolones and chloramphenicol (Abera et al., 
2010; Bhattacharya et al., 2011; Roy et al., 1998; Shah et al., 2014).  
1.14.1.3  Integrative and conjugative element (ICE) SXT 
Horizontal gene transfer resulting in acquisition of integrative and conjugative 
element (ICE), integrons and mobile genetic elements has played an important role 
for evolution of drug resistance in V. cholerae strains (Hochhut and Waldor, 1999). 
The ICE, SXT was discovered in 1996 from a V. cholerae O139 isolate MO10 from 
Madras and carried SXT designation because of characteristic resistance pattern to 
sulfamethoxazole, streptomycin, trimethoprim and furazolidone (Waldor et al., 1996). 
Those serogroup O139 strains differed from the El Tor strains by a distinctive 
antibiotic resistance pattern. These strains showed resistance to SXT, 
chloramphenicol, trimethoprim and streptomycin. The resistance genes were found on 
a mobile element, called SXT after that named SXT
MO10
, and classified as conjugative 
transposon (Hochhut et al., 2001). However, SXT
MO10
 was not detected in any O1 
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strain (Amita et al., 2003). When V. cholerae O1 El Tor remerged in South Asia 
following the decline of O139 as the principle cause of cholera, the El Tor had the 
same antibiotic resistance pattern as O139 serogroup (Yamamoto et al., 1995), 
encoded on a mobile element similar to SXT
MO10
, named SXT
ET
 (Hochhut and 
Waldor, 1999).  SXT elements had undergone many variations since discovery and 
many variants have been reported from Sub-continent, Vietnam, South Africa and 
other countries (Amita et al., 2003; Ceccarelli et al., 2006; Dalsgaard et al., 2001; 
Ehara et al., 2004; Iwanaga et al., 2004). The SXT elements have similar core 
organization while differ by specific insertions. 
Like R391 ICEs, the common composition of SXT-like elements consists of plasmids, 
phages, transposons, and several unknown genetic sources. The major feature of 
R391-like ICEs is their transfer between Gram-negative bacteria by conjugation. The 
SXT-like elements have integration site at peptide chain release factor 3 (prfC) locus 
like R-391, by site-specific recombination. Due to similarity, both elements, SXT and 
R391, are classified as subgroups of ICE family (Beaber et al., 2002). According to 
the recent nomenclature, mobile elements having integrase similar to SXT (intSXT)  
and having integration at the prfC locus are included in the SXT/R391 family of ICEs 
(Burrus et al., 2006).  
The SXT elements move between different bacteria by conjugation like plasmids, 
however they are integrated into the host’s genome instead of independent existence 
(Hochhut and Waldor, 1999). For integration into the host genome, SXT has an extra-
chromosomal intermediate which integrates via site specific recombination between 
attP (SXT) and attB (host) facilitated by tyrosine recombinase (Hochhut and Waldor, 
1999). Once integrated then SXT can also be transferred to other bacterial species 
(Burrus et al., 2006). Since, 1996 after their discovery, the SXT elements have been 
reported in many other species, probably moved through horizontal gene transfer 
(Beaber et al., 2002). The SXT elements undergo changes rapidly such as an SXT in 
Laos acquired gene of a putative helicase by losing trimethoprim resistance (Iwanaga 
et al., 2004). The SXT also mobilize conjugative elements and genomic islands in 
trans to provide alternate ways of drug resistance transfer (Daccord et al., 2010; 
Hochhut et al., 2000).  
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1.14.1.4  Integrons 
Integrons of large sizes are present in V. cholerae to mediate transfer of large 
cassettes carrying antibiotic resistance genes (Mazel, 2006). Besides large integrons 
V. cholerae may contain small integrons embedded as conjugative plasmids or 
transposons (Mazel, 2006). Class 1 integrons are the most frequent type having close 
association with a Tn402 transposon, whereas class 2 integrons are associated with 
transposon Tn21. The integrons transfer resistance to trimethoprim (dfrA1) (Dalsgaard 
et al., 2001; Opintan et al., 2008). The integrons are integrated via stimulation of SOS 
triggered by the antibiotic stress (Beaber et al., 2002; Guerin et al., 2009).  
1.14.1.5  Conjugative plasmids 
Since tetracycline was one of the initial antibiotics used with rehydration therapy to 
treat cholera, as a result resistance to tetracycline emerged in V. cholerae from 
Astrakhan (USSR) in 1970 (Greenough et al., 1964). Besides tetracycline these V. 
cholerae isolates were also resistant to streptomycin and chloramphenicol. This 
antibiotic resistance was transferrable as well as a solitary plasmid was also detected 
in these V. cholerae strains (Hedges and Jacob, 1975). Later on in 1979, such 
conjugative plasmid mediated resistance to tetracycline, ampicillin, streptomycin, 
kanamycin, trimethoprim and gentamycin was observed in Bangladesh (Glass et al., 
1983). However, surprisingly in short period, such antibiotic resistant strains 
disappeared from Bangladesh (Faruque et al., 1998a). 
1.15 Methods of genotyping 
To analyse the bacterial populations for clonal relatedness for epidemiological 
purposes, sensitive, robust, reproducible, economic and high throughput methods are 
required. Available methods for this purpose are described below: 
1.15.1  Phenotypic methods 
One of the earliest methods for determining the clonal relatedness comprised of 
approaches based on phenotypic traits such as serogroup determination based on 
surface antigens. O1 and O139 serogroups of V. cholerae showed strong correlation 
with epidemic cholera in the past two centuries, however different variants within 
these serogroups have emerged which caused cholera in past in various countries. But 
this method lacks the resolution because it is based on only one characteristic and 
does not include overall chromosomal diversity for complete analysis. Furthermore, 
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the serogroup gene has been shown to be transferred horizontally among unrelated 
organisms and as well as to maintain more than 200 antisera for V. cholerae for 
determining clonal relatedness makes it very difficult (Yamai et al., 1997).  
Measuring certain phenotypic traits offers another way to genotype the isolates. For 
this purpose different kits based on biochemical tests are available which include 
Biolog microplate (Biolog, Inc. Hayward, CA), API identification system 
(bioMerieux, Inc., Hazelwood, MO) and Phenoplate system (PhPlatAB, Stockholm, 
Sweden), utilizing 23-95 tests. Despite being costly, labour intensive and time 
consuming, they also have discriminatory limitations when analysing isolates of the 
same species. In additions, these have less reproducibility and culture conditions 
sensitivity.  
Multilocus enzyme electrophoresis (MLEE) based on the electrophoresis profile of 
different housekeeping enzymes has been utilized for long-term epidemiological 
studies (Selander et al., 1986). Although better than other phenotype specific 
methods, however due to its cumbersome nature this has not been in use for routine 
epidemiological studies. 
1.15.2   Molecular methods  
The molecular approaches to detect variations at the DNA level are very actively 
utilized which are robust and generate reproducible results. The methods are briefly 
described below:  
1.15.2.1  Ribotyping 
It detects the variations in rRNA gene loci by restriction analysis of genomic DNA 
separated by gel electrophoresis and hybridized with labelled ribosomal DNA probes 
(Grimont and Grimont, 1986). 
1.15.2.2  PFGE 
Pulse field gel electrophoresis (PFGE) is a variant of (Restriction fragment length 
polymorphism (RFLP) which involves the digestion of genomic DNA with rare 
cutting enzyme, and the resulting  DNA fragments are separated by a specialized 
electrophoresis technique. PFGE has been used for clonal analysis of bacterial 
populations such as V. cholerae, E. coli, Campylobacter, Yersinia, etc. (Cooper et al., 
2006; Olive and Bean, 1999). PulseNet program uses this data to identify outbreaks of 
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bacterial infections. In PFGE, for each organism a standard protocol was established 
to get the results which are accepted and compared worldwide for genotypic analysis. 
1.15.3  PCR based methods 
These approaches are extensively used these days because of robustness, simplicity 
and furthermore no sophisticated instruments are required. By using appropriate 
primers, the whole genome can be analysed random and even ways, and the 
fingerprint patterns are generated without any bias. Several PCR based methods 
applied are briefly described below: 
1.15.3.1  Random amplified polymorphic DNA PCR (RAPD-PCR) 
This method uses generic primers, usually 6-10 base pair long, under low stringency 
conditions to generate randomly amplified PCR fragments (Barrett et al., 1995; 
Williams et al., 1990). At the beginning the annealing temperature is kept low for 
less-stringent conditions, to bind the primers to regions with incomplete homology, 
and at the completion multiple amplicons are generated for bacterial fingerprinting 
(Busch and Nitschko, 1999). After gel electrophoresis, the respective banding patterns 
are used to relate the bacterial isolates (Franciosa et al., 2001). The major drawback is 
the reproducibility of the genotyping pattern, sensitive to minor changes in different 
parameters including reagents and amplification conditions (Meunier and Grimont, 
1993) (Micheli et al., 1994). The method has advantage as it is rapid and the prior 
knowledge of genome of the test organisms is not needed (Franklin et al., 1999). 
RAPD-PCR has less resolution as compared to AFLP and PFGE.  
1.15.3.2  Amplified fragment length polymorphism (AFLP) 
Amplified fragment length polymorphism was developed by KeyGene International 
in 1995, and since then it has been applied for genomic fingerprinting in various fields 
(Vos et al., 1995). It has advantage to analyse DNA from any source without 
requiring prior sequence information, robustness, sensitivity and reliability (Janssen et 
al., 1996; Vos et al., 1995). AFLP workflow has three steps: 1- Restriction digestion 
of DNA using one or more enzymes and ligation of adapters specific to restriction 
half sites of all fragments. 2- Amplification of particular fragments with primers and 
3- Generation of band patterns by gel electrophoresis of the fragments. AFLP since its 
inception has been applied to analyse V. cholerae isolates from patients and other 
sources (Mishra et al., 2011; Rivera et al., 2001). AFLP has successfully 
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discriminated the V. cholerae strains prevalent at different times in the past (Jiang et 
al., 2000a; Jiang et al., 2000b). Seventh pandemic V. cholerae isolates in the 
beginning and middle of the pandemic were clearly differentiated by AFLP than 
ribotyping during last two decades of 20
th
 century (Lan and Reeves, 2002).  
1.15.3.3  Multiple locus variable number of tandem repeats (VNTRs) analysis 
(MLVA) 
This genotyping approach is based on short DNA sequence tandem repeats at 
different genic and intergenic loci and the number of repeats in different loci varies 
between different organisms of a species, this variation is used to relate the bacterial 
isolates (Jansen et al., 2002). The number, sequence and position of the repeats is 
variable in different species (Bachellier et al., 1997; van Belkum et al., 1998). In the 
recent past, MLVA has been extensively applied to genotype various pathogens such 
as Bacillus anthracis (Keim et al., 2000), Salmonella enterica (Lindstedt et al., 2004), 
Enterococcus faecium (Somer and Kashi, 2003) and V. cholerae (Danin-Poleg et al., 
2007; Ghosh et al., 2008; Lam et al., 2012; Stine et al., 2008).  
1.15.3.4  Repetitive element PCR (Rep-PCR) 
Rep-PCR is based on amplification of the sequences flanking the repeats by using 
repeat specific primers (Versalovic et al., 1991). The separated amplicons by gel 
electrophoresis are used to relate the bacterial strains. The repeat sequences for this 
purpose include enterobacterial repetitive intergenic consensus (ERIC), repetitive 
extragenic palindromic (REP) and BOX sequences. ERIC-PCR has been effective for 
genotyping Vibrio cholerae, Y. enterocolitica and Salmonella serotypes but the 
discriminatory ability is less than PFGE (Falcao et al., 2006; Olive and Bean, 1999; 
Singh et al., 2001; Waturangi et al., 2012).  
1.15.3.5  Sequence based methods 
In Multilocus sequence typing (MLST), sequence variations within particular 
housekeeping genes by comparing nucleotide changes are used to determine the 
clonal relationship among bacterial populations (Maiden et al., 1998; Spratt, 1999). 
For best MLST results, it is preferred to use good reagents and sequencing at both 
ends. MLST has advantage of reproducibility and ease in sharing data between 
research communities. The housekeeping genes are present in all isolates, sequenced 
data is available and generally not subjected to selection pressure. However, sufficient 
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variations in these genes lead to new alleles (Kotetishvili et al., 2002). MLST 
database (www.mlst.net) for many bacteria has been established which allows quick 
MLST data sharing (Enright and Spratt, 1999).   
1.15.4  Whole genome sequencing 
In 1995, when Hemophilus influenzae genome was sequenced it opened a new era of 
whole genome sequencing (Fleischmann et al., 1995). In the past, the sequencing 
projects needed extensive budget and efforts of many peoples for years. Since then 
hundreds of bacterial genomes have been sequenced and deposited in the database 
(Pagani et al., 2012). The cost of DNA sequencing has reduced from $1000/Mb to as 
low as 10 cents/Mb (Margulies et al., 2005; Shendure et al., 2005). Due to feasibility 
of sequencing in terms of cost and time, DNA sequencing has increased and more 
studies are making use of it (Shendure and Ji, 2008). Now the DNA sequencing has 
fundamental role in the epidemiological and surveillance studies as well as 
evolutionary studies (Chin et al., 2011; Mutreja et al., 2011). DNA sequencing has 
influenced the scope and design of the research. In the last decade, the advancements 
in the sequencing technologies (Liu et al., 2012) have made the bacterial genome 
sequencing for surveillance and population genetics feasible. The advances by 
developing massively parallel sequencing platforms also reduced the required time 
and cost thousands of folds as compared to Sanger sequencing to sequence genomes. 
All the sequencing platforms are subject to technical improvements due to 
competition between the manufacturers. The different approaches used for sequencing 
will be discussed later after Sanger sequencing: 
1.15.4.1 Sanger sequencing 
 
Sanger Sequencing based on chain termination approach being one of the major 
milestones in biological research was introduced in 1977 by Fredrick Sanger (Sanger 
et al., 1977). This approach involves cycle sequencing reaction including template 
denaturation, primer annealing and elongation. The sequencing reaction in microliters 
volume consists of unique fluorescently labelled terminating dideoxynucleotide 
triphosphates (ddNTPs) along with regular non-labelled deoxynucleotide 
triphosphates (dNTPs). In each cycle, the primer extension is stopped by fluorescently 
labelled ddNTPs on its incorporation. In the resulting reaction mixture of end labelled 
products, terminally labelled ddNTP of any fragment corresponds to that nucleotide. 
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 Now a days along with regular, non-terminating dNTPs, fluorescently labelled 
ddNTPs are mixed in a sequencing reaction as a result elongation is stopped at all 
positions of labelled ddNTPs. After sequencing cycle, the sequences are separated by 
high resolution polymer gels by length and the base specific signal are read by laser 
excitation of the fragments of varying lengths coupled by four-colour detection 
(Ewing and Green, 1998; Ewing et al., 1998).  After years of improvements, it has 
read length up to 1000 bp and a very high accuracy of 99.99%.  
 
1.15.4.2 Next-generation DNA sequencing platforms 
The three commonly used platforms for massively parallel DNA sequencing include: 
Roche/454 FLX, Illumina/Solexa Genome Analyzer and Solid 
TM
 system of Applied 
Biosystems and Ion-torrent PGM. 
1.15.4.2.1  Roche/454 FLX 
This pyrosequencing (sequencing by synthesis) based next-generation sequencer was 
commercialized for the first time in 2004 (Ronaghi et al., 1996) 
(http://my454.com/products/technology.asp). The 454 sequencing resolved the 
problems faced in Sanger sequencing to sequence large genomes in quick time and at 
affordable cost. In this approach, the cloning requirement in bacterial hosts for 
sequencing was addressed by an efficient in-vitro method, emulsion PCR of DNA 
fragments obtained by shearing of the DNA. Each bead containing templates into a 
plate containing thousands of picoliter wells by which thousands of sequencing 
reactions are performed simultaneously (Margulies et al., 2005). In this approach, 
when a nucleotide is incorporated by polymerase, pyrophosphate is produced which at 
the end of a cascade of reactions produces light which is directly proportional to the 
number of nucleotides incorporated depending on the sensor limit. The average read 
length is 250 nucleotides and in an 8 hr cycle each nucleotide is flown 100 times. 
1.15.4.2.2  Illumina HiSeq system 
It is based on sequencing by synthesis approach in which initially a library of adaptors 
anchored to the flow cell is denatured to get single strands by utilizing a linearizing 
enzyme (Bentley, 2006). Then the all four types of nucleotides and DNA polymerase 
are introduced in the flow cell channel simultaneously to add the nucleotides in the 
oligo-primed cluster fragments. Each nucleotide is fluorescently labelled and 3'-OH is 
33 
 
chemically blocked so that only one nucleotide is added at a time. Image is taken after 
each base incorporation (http://www.illumina.com/pages.ilmn?ID=203). After image, 
the 3'-OH blocking is removed to start the next base incorporation into the strands by 
DNA polymerase (Figure 1.4 and 1.5). These base incorporation cycle is repeated by 
specified number of times resulting in base lengths ranging from 25-35 bases. Each 
read is given quality values by a base-calling algorithm and quality check pipelines 
remove the low-quality sequences. 
1.15.4.2.3  Applied Biosystem SolidTm sequencer 
 This DNA sequencing platform is based on adapter-ligated fragments library, and 
involves emulsion PCR by using magnetic beads to produce the fragments for 
sequencing (Valouev et al., 2008). The amplified fragments are sequenced by a 
unique di-base approach utilizing DNA ligase 
(http://marketing.appliedbiosystems.com/images/Product/SolidKnowledge/flash/1022
07/solid.html). An instrument has two flow cells which are analysed per run, each 
flow cell comprises different libraries in upto four quadrants. The sequencing is done 
by 8 base-probe ligation which contains ligation site, cleavage site and fluorescently 
labelled all four nucleotides.  
1.15.4.2.4 Ion-torrent personal genome machine (PGM) 
This platform was introduced in 2010 by Ion Torrent. Based on semiconductor DNA 
sequencing technology, pH change is detected after incorporation of a nucleotide as a 
result of proton release. After each nucleotide addition, the chip is flooded with 
another nucleotide. pH change signals the addition of a nucleotide or vice versa. After 
duplicate addition of a nucleotide, the signal is proportional and so on.  
This platform does not need camera and fluorescent labelling which increases the 
robustness, economy and portability of the machine. Present read length is 200 bases 
and accommodates eight samples in a single run. A milestone in its application was 
quick characterization the E. coli strain responsible for 2011 E. coli outbreak in 
Germany (Mellmann et al., 2011; Rohde et al., 2011). 
Two major factors influence the utility/effectiveness of the next-generation 
sequencing data are (a) short read length as compared to the traditional capillary 
sequencing and (b) each sequencing platform has an error pattern which is different 
from the established methods for capillary sequencing reads. To address these issues, 
the proper bioinformatics analysis of the data is necessary. The short read length of  
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Figure 1.4 Generation of cluster stands in sequencing-by-synthesis approach in Illumina sequencing. 
Various stages of Illumina work flow for generation of cluster strands form DNA samples is shown. The stages include DNA fragmentation and 
adapter ligation, attachment of the library to illumina flow cell for bridge amplification and generation of cluster stands (Mardis, 2008). 
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Figure 1.5 Nucleotide incorpoation to the generated clusters in illumina sequencing. 
Chemistry of Illumina sequencing cycle and signal processing is shown. In the sequencing cycle, sequencing primers anneal to the 
denatured cluster stands and use 3’ blocked labelled nucleotide in this sequencing by synthesis approach (Mardis, 2008). 
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the next-generation sequencing platforms requires the higher read coverage for 
reliable results especially in case of repeats.  
1.15.4.3 Third generation sequencing 
The advances in the next-generation sequencing led to the introduction of the third 
generation sequencers. The hallmark features of these third generation sequencers are 
short sample preparation time without any need of PCR and in realtime processing of 
the signals whether fluorescence (Pacbio) or electric current (Nanopore).  
1.15.4.3.1 Single-molecule real-time (SMRT) sequencing 
This sequencer was developed by Pacific Bio, based on modified enzyme and 
realtime monitoring of the reaction (Eid et al., 2009). SMRT cell consisting of 
millions of zero-mode waveguides (ZMWs), accomodates only one enzyme and a 
DNA template (Levene et al., 2003). In the sequencing process, new nucleotides are 
added in the complementary stand by the enzyme after removing the fluorescent label 
from the already attached nucleotide and the signal is captured in realtime. In 
comparison to the next-generation sequencing SMRT has many advantage of fastness, 
no need of PCR and an increased read length of 1300 bases (Shin et al., 2013). 
1.15.4.3.2 Nanopore sequencing  
This method involves a nanopore with diameter equal to the protein channels in the 
plasma membrane which mediate ion exchange (Song et al., 1996). The principle of 
nanopore involves the movement of single-stranded DNA across a nanopore formed 
by alpha-haemolysin pore (a 33 kD protein from S. aureus) which results in voltage 
disruption across the channel (Deamer and Akeson, 2000). The ion channel can 
tolerate high voltage (100 mV) and current (100 pa). During sequencing, the current 
flow is maintained and any disruption is measured by electrophysiological techniques. 
For each of the four nucleotides, characteristic modulation occurs and the ion current 
resumes after the trapped nucleotide moves out.  
Nanopore has many useful features which include long read length upto >5 kb and 
speed of 1 bp/ƞs (Timp et al., 2010). In addition fluorescent labels are not required, 
lower effect of temperature on sequencing and significantly short sample preparation 
time.  
The above mentioned genotyping methods and whole genome sequencing helped in 
better understanding of the epidemiology, ecology and relatedness of the pathogens 
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involved in different outbreaks. For instance, recent cholera epidemics in 
Mozambique, Haiti, and Pakistan (Ansaruzzaman et al., 2004; Chin et al., 2011; Shah 
et al., 2014) while E. coli 2011 outbreak in Europe  (Mellmann et al., 2011) were 
caused by particular clones of V. cholerae and E. coli respectively. Similarly, 
Staphylococcus aureus ET4 caused toxic shock syndrome in United States, Canada, 
Denmark and Sweden (Musser et al., 1990). With reference to cholera, the serogroup 
O1 was the causative agent of first six pandemics while the El Tor biotype emerged to 
cause the current seventh pandemic (Faruque et al., 1998a). In the 1990's serogroup 
O139 appeared in Bangladesh and caused epidemics but then it was replaced by El 
Tor biotype. However, in the last decade different forms of El Tor biotype named as 
altered El Tor strains were responsible for cholera in different countries. The above 
changes in the epidemic clones highlight the importance to monitor the pathogen 
population to identify the pathogenic clones and their close relatives to control the 
future infections.  
Despite extensive studies on V. cholerae in South Asia mostly by International Centre 
for Diarrhoeal Diseases Research – Bangladesh (ICDDRB) and National Institute of 
Cholera and Enteric Diseases (NICED) – Kolkata, India, there is strong need to 
analyse the genome structure of V. cholerae isolates from Pakistan. This is important 
to know their place in the global map of V. cholerae which will be helpful in future 
for understanding evolutionary dynamics of this pathogen both local as well as at 
global level.  
1.16 Aims and objectives 
The current PhD study was conducted to: 
1. Assess the prevalence of V. cholerae in the clinical samples. 
2. Find the prevalent serogroups and biotypes of V. cholerae in Pakistan in the 
regional and global context of the disease. 
3. Characterize V. cholerae isolates, gathered from geographically distinct 
locations during different time intervals, for their antimicrobial resistance 
pattern. 
4. Determine the toxin type and characterization of the CTX prophage array in V. 
cholerae toxigenic isolates. 
5. Assess the clonal relationship among clinical isolates across Pakistan by 
techniques such as MLVA. 
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6. Get an insight of the genome of V. cholerae isolates in Pakistan by whole 
genome sequencing technology. 
7. Assess the phylogenetic position of V. cholerae Pakistan isolates by 
comparing them with the global collection of V. cholerae.  
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2 Methods 
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This PhD study to characterize Vibrio cholerae isolates prevalent in Pakistan was 
conducted from 2009 to 2011. The study was approved by Ethics Committee of the 
Biosciences Department of COMSATS Institute of Information Technology (CIIT), 
Islamabad. In this period, clinical and environmental samples were collected for isolation 
of V. cholerae across Pakistan. Following is the detail of the clinical and environmental 
samples collected: 
2.1  Sample Collection 
2.1.1 Clinical samples  
969 rectal swabs of diarrhoea patients were collected in Cary-Blair (Oxoid, Hampshire –
UK) transport medium during 2009 to 2011 from different cities of Pakistan (Figure 2.1). 
Biogeographic data of the patients were taken at the time of sample collection. Samples 
were obtained after the written informed consent of the patients or their guardians for V. 
cholerae isolation. The detail of clinical samples collection in the three years period is as 
below: 
2.1.1.1 First year (2009) 
During the first year of the study, 150 stool samples of acute diarrhoea patients were 
collected from Benazir Bhutto Hospital, Rawalpindi (130 samples) and Pakistan Institute 
of Medical Sciences (PIMS), Islamabad (20 samples) for isolation and characterization of 
V. cholerae. 
2.1.1.2 Second year (2010) 
In July-August 2010, unprecedented rainfall and glacier melt in the North of Pakistan 
resulted in one of the worst ever floods in the history of Pakistan since 1947. 319 rectal 
swabs from diarrhoea patients in the flood affected and non-flood affected parts of 
Khyber Pakhtunkhwa (KPK), Sindh and Punjab were collected to isolate and characterize 
V. cholerae (Figure 2.1). 
2.1.1.3 Third year (2011) 
In 2011, 500 stool samples/rectal swabs of cholera patients were collected from sporadic 
cases in different cities of Punjab, Sindh, Khyber Pakhtunkhwa (KPK), Baluchistan, 
Gilgit Baltistan and Azad Jammu and Kashmir (AJK) (Figure 2.1). During this period the 
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local outbreaks of Murree and Nowshera were also analysed to isolate and characterize V. 
cholerae in these regions.  
2.1.2 Environmental samples collection 
During this study, 145 environmental samples were collected to isolate V. cholerae from 
different environments (Table 2.1). These included: 
2.1.2.1 Water samples 
75 drinking water samples were collected from different cities of Punjab and Khyber-
Pakhtunkhwa during this period. In this case, 1 litre of water was collected in the sterile 
bottles.  
2.1.2.2 Waste water samples collection 
To study the type of V. cholerae prevalent in the waste water, 20 samples were collected 
from the drains of residential areas, hospitals and slaughter houses of Rawalpindi and 
Islamabad to characterize the V. cholerae isolates in these environments.  
2.1.2.3 Fish samples collection 
Vibrio cholerae is a ubiquitously aquatic organism and is often associated with different 
animals in the oceanic and river ecosystems. Therefore, 50 fish samples were collected in 
sterile bags from Rawalpindi, Islamabad and Karachi to characterize V. cholerae in them.  
All the clinical and environmental samples were kept at 4˚C during this procedure and 
transferred to Microbiology laboratory at Biosciences Department, CIIT - Islamabad for 
isolation of V. cholerae. 
2.2 Safety measures  
Vibrio cholerae is an infectious organism, but transmission of V. cholerae is low through 
man to man contact. However, since the disease is waterborne/foodborne so, all the 
samples processing and work was done in biological safety level 2 (BSL2) cabinet. All 
the cultures, gloves, masks and microscope slides were autoclaved before disposal and 
working bench was regularly wiped with 70% ethanol.  
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Figure 2.1 Collection of rectal swabs of diaarhea patient during 2009 to 2011 in Pakistan.  
The circles are representing different cities from where clinical samples were collected. 
The circle size varies depending on the number of samples collected from a particular 
city/location whereas the colour of circle represents the time of sample collection.  
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Table 2.1: Sampling from different sources during 2009-2011 for isolation of V. 
cholerae  
 
Sampling 
source 
City Year (2010) Year (2011) Total 
 
Drinking Water     
 Rawalpindi 19 18 37 
 Islamabad 15 7 22 
 Peshawar 12 0 12 
 Attock 4  4 
  Total: 50 Total: 25 Total: 75 
Sewage/waste 
samples 
    
 Rawalpindi  5 5 
 Islamabad  5 5 
 Jhelum  5 5 
 Peshawar 5  5 
  Total: 5 Total: 15 Total: 20 
Fish     
 Rawalpindi 4 10 14 
 Islamabad 12 7 19 
 Bahawalpur 0 10 10 
 Peshawar 7  7 
  Total: 23 Total: 27 Total: 50 
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2.3 Sample Processing 
2.3.1  Clinical samples  
For isolation of V. cholerae from stool samples/rectal swabs, first the samples were 
enriched in alkaline peptone water (APW) and incubated at 35˚C for 6-8 hours (hrs). 
After incubation, a loop from the surface of the enrichment medium is streaked on 
thiosulfate citrate bile salts (TCBS) medium (Oxoid-Hampshire, UK) and incubated at 
35˚C for 16-20 hrs (Winn et al., 2005).  
2.3.2  Environmental samples 
2.3.2.1 Water samples  
The water samples were filtered by passing through 0.2 µm filters using water filtration 
assembly. Then the filter was enriched in alkaline peptone water (APW) (Oxoid- 
Hampshire, UK) for 6-8 hrs at 30˚C. After incubation, an inoculum of about 10 µl was 
taken from the enrichment medium just below the surface and streaked on thiosulfate 
citrate bile salts (TCBS) plates and incubated at 35˚C for 16 to 20 hrs.  
2.3.2.2 Waste water samples  
The water samples were processed for isolation of V. cholerae according to the method 
described earlier with few modifications (Faruque et al., 2006b). Briefly, 5 ml of aliquots 
of waste water samples were enriched in 3X 2.5 ml bile peptone water (1% peptone, 
0.5% taurocholic acid, 1% NaCl; pH 9.0) for 6 hrs at 37˚C. After enrichment an inoculum 
of 10 µl from this culture was streaked on TCBS plates and incubated for 16-20 hrs at 
35˚C for isolation of V. cholerae.  
2.3.2.3 Fish samples  
For isolation of V. cholerae, the middle or lower intestine of fish was either enriched in 
alkaline peptone water (APW) or intestinal epithelia were streaked on TCBS directly. For 
enrichment the samples inoculated in APW were incubated at 35˚C for 6-8 hours and 
then streaked on TCBS plates and incubated for 16-20 hrs at 35˚C for isolation of V. 
cholerae (Senderovich et al., 2010). 
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2.4 Identification of V. cholerae  
After 16-20 hours incubation of samples on TCBS medium, the characteristic yellow, flat 
colonies of about 2-3 mm in diameter were selected and further sub-cultured on non-
selective medium such as Luria-Bertani (LB) agar or Nutrient Agar (Oxoid, Hampshire -
UK) overnight and different biochemical tests were performed for identification of V. 
cholerae (Winn et al., 2005). These included: Oxidase (+), catalase (+), ONPG (+), 
esculin hydrolysis (-), Indole production (+), sucrose fermentation (+), lactose 
fermentation (-), mannitol fermentation (+), growth in 0% NaCl (+) and Kligler iron agar 
(K/A/-, Slant alkaline/base acidic/no H2S production). 
2.5 Serotyping 
 The isolates identified as V. cholerae were serogrouped as O1 by slide agglutination  test 
using polyvalent Ogawa and Inaba antibodies (Denka Seiken, Tokyo, Japan) and 
serotyped as Ogawa or Inaba by observing agglutination with either monovalent Ogawa 
or Inaba antibodies (Denka Seiken, Tokyo, Japan). In this process, the suspensions of V. 
cholerae isolates were prepared in normal saline (0.85% NaCl) by taking overnight 
growth of V. cholerae on non-selective medium such as Nutrient Agar. Then a drop of 
suspension was placed on glass slide and mixed with polyvalent Ogawa and Inaba 
antibodies and monovalent Inaba and Ogawa antibodies separately to observe 
agglutination for serogroup and serotype determination respectively.  
2.6  Biotyping  
To determine whether the isolated V. cholerae O1 are of classical or El Tor biotype, 
different biochemical tests were performed which included: sheep blood haemolysis, 
chicken cells agglutination test and Voges-Proskauer (VP) reaction. Isolates giving 
positive results of the above mentioned tests were categorized as V. cholerae O1 El Tor 
whereas classical isolates showed negative results for these tests. 
2.7  DNA extraction 
The genomic DNA was extracted either by boiling the cells or by using Archive Pure
TM
 
DNA Purification Kit (5 Prime, Hamburg - Germany). These protocols were as follow: 
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2.7.1  Boiling method  
To extract DNA by boiling, the method described by Yang et al., 2008 was followed with 
few modifications. In this method, V. cholerae was grown overnight on non-selective 
medium, then few colonies were dissolved in tris EDTA (TE) buffer and boiled for 10 
minutes. After this the microcentrifuge tubes were kept on ice for 2 minutes, then 
centrifuged the microcentrifuge tubes at 13,000 rpm for 10 minutes at 4˚C. The 
supernatant was transferred in clean 1.5 ml tubes and stored at -20˚C. It was also used as 
template for PCR in future.  
2.7.2  DNA extraction by Archive PureTM Genomic DNA kit  
For DNA extraction, V. cholerae isolates were grown overnight in 45 ml white capped 
bottles containing 20 ml LB broth and incubated at 37˚C in shaking incubator. The 
protocol followed had following stages:  
2.7.2.1 Cell lysis 
2 ml of cell suspension was taken in a microcentrifuge tube on ice and centrifuged at 
13000 rpm for 30 s (seconds) to pellet the cells in centrifuge (Eppendorf 5810, Hamburg-
Germany). Then 600 µl cell lysis solution was added to the pellet and pipetted up and 
down to suspend the cells and  incubated the samples at 80˚C for 5 min in thermoblock to 
lyse the cells. 
2.7.2.2 RNase treatment 
3 µl RNase A solution was added to each cell lysate and microcentrifuge tubes were 
inverted about 25 times and kept on 37˚C for 30-60 min for incubation. After incubation 
the samples are cooled to room temperature by placing them on ice for 1 min.  
2.7.2.3  Protein precipitation 
200 µl of protein precipitation solution was added to the cell lysate and vortexed the 
samples at high speed for 30 s to mix the protein precipitation solution uniformly in the 
lysate. To pellet the precipitated proteins, the samples were centrifuged at 13000 rpm for 
4 min. If the protein pellet was not tight then the tubes were centrifuged again after 5 
minutes incubation on ice. 
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2.7.2.4  DNA precipitation 
The supernatant containing DNA was poured into a clean 1.5 ml microcentrifuge tube 
containing 600 µl 100% isopropanol (2-propanol) and mixed the samples by gently 
inverting them 50 times. Then the samples were centrifuged at 13000 rpm for 1 min. 
Supernatant was discarded and drained the tubes onto a clean, absorbent paper.  
To wash the DNA, 300 µl 70% ethanol was added to the pellet and inverted the tubes 
several times. After wash the samples were centrifuged at 13000 rpm for 1 min. Ethanol 
was poured off carefully and the tubes were drained by inverting on clean absorbent 
paper and air dried for 10 min.  
2.7.2.5 DNA hydration 
50 µl DNA hydration solution was added to each microcentrifuge tube to dissolve the 
DNA, and incubated the samples for 1 h at 65˚C and taped the tubes periodically to aid in 
dispersing the DNA. 
DNA was kept at 4˚C for routine use. For long term storage it was kept at -20˚C. 
2.8  DNA Quantification  
The isolated DNA was quantified by spectrophotometric technique such as nanodrop as 
well as by fluorometric Qubit (Invitrogen Life technologies, California - USA). The 
protocols were as below: 
2.8.1 Nanodrop 
The genomic DNA was quantified by using the NanoDrop ND-1000 Spectrophotometer 
(ND-1000 Thermo Scientific-C) which could read absorbance between 220-750 nm. For 
quantification, 1.5 µl of DNA sample was taken and the DNA solvent was used as blank 
in the process. 
2.8.2 Qubit Fluorometer  
The DNA was quantified by Qubit 2.0 (Invitrogen) which has high sensitivity and 0.2 ng 
to 100 ng range of quantification. The protocol followed was as under:  
1. For each sample, a quantification solution was prepared by mixing 199 µl Quant-iT ds 
DNA and 1 µl of 200 X dye, depending on the number of samples.  
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2. Standard solutions 1 and 2 were prepared by adding 190 µl of quantification solution 
with 10 µl of ladder 1 and ladder 2. Both ladders were prepared in separate tubes. After 
mixing by vortex, both ladders were kept for 10 s before being quantified. 
3. After successful measure of ladders, 190 µl of quantification solution containing buffer 
and dye was added in a new Quant-iT tube, then 10 µl of sample DNA was added and 
vortexed. The samples were quantified after 10 sec at room temperature. 
4. The sample concentration (ng/µl) was noted.  
2.9  Polymerase chain Reaction (PCR)  
PCR was performed on a clean bench as well as autoclaved tips and PCR tubes of 0.2 ml 
or 0.5 ml were used. The reaction volume was 25 µl. The general PCR conditions to set 
up PCR reactions were described below: 
 
Reagent (conc.) Volume used  Conc. in PCR reaction 
DNA (10 ng/µl) 1 µl 10 ng 
PCR buffer (10X) 2.5 µl 1X 
MgCl2 (25 mM) 2.5 µl 2.5 mM 
dNTPs (10 mM) 0.5 µl
*
 200 µM 
Primer Forward (10 nmol) 1.5 µl 0.6 nmol 
Primer Reverse (10 nmol) 1.5 µl 0.6 nmol 
Taq Polymerase (5U/µl) 0.3 µl 1.5 U 
MilliQ H2O  added to make 25 µl 
*
The amount of dNTPs added was increased by 0.5 µl for each 1 kb increase in size of 
amplification product.  
 All PCR reactions were initiated after an initial denaturation at 95˚C for 5 min. The 30 
cycles included denaturation at 95˚C for 30 s, annealing at variable temperature for 30 s 
and extension at 72˚C @ 1 kb/min, followed by final extension at 72˚C for 10 min. 
Extension time was increased by 1 min for each 1 kb increase in amplification product 
after 1 kb.  
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PCR product was immediately run on gel for results or incase stored at -20˚C until further 
use. 
2.10  Electrophoresis  
For genomic DNA 0.7% (w/v) agarose gel was prepared while for PCR products the 
composition of agarose gel varied from 1.5% to 2.0% depending on the size of the 
amplified fragments.  For gel preparation, agarose (Fermentas, USA) was dissolved in the 
appropriate amount of TBE buffer (Tris, Boric acid and EDTA). After dissolving agarose 
5 µl ethidium bromide was added.  
Loading dye was prepared by mixing 0.25% (w/v) bromophenol blue and 50% (w/v) 
sucrose in water. The size of PCR product was determined by comparing with 100 bp 
DNA marker (Fermentas, USA).  Electrophoresis was performed at 120 volts for 40 
minutes. The gels were visualized by using ABI gel doc.  
2.11  Identification of V. cholerae by PCR  
PCR has been used extensively to identify various pathogens in samples due to its 
sensitivity, rapidness and cost effectiveness. Identification of V. cholerae was confirmed 
by species-specific PCR which was based on detection of the gene (ompW) encoding the 
22 kDa outer membrane protein W (Jalajakumari and Manning, 1990) which has 
conserved sequence and was characteristic to V. cholerae  (Nandi et al., 2000) as well as 
by detecting repeats in toxin, rtxA.  In this process, the repeat in toxins (rtx) and the outer 
membrane protein (ompW) were detected as described earlier (Gubala, 2006; Nandi et al., 
2000). The oligonucleotides were purchased from Alpha DNA, Canada.   
2.12  Serogroup and biotype determination by PCR  
Of more than 200 serogroups, only serogroup O1 and O139 were responsible for 
devastating cholera pandemics and epidemics in the history. To determine the serogroup 
of V. cholerae either O1 or O139, a multiplex PCR (m-PCR) was performed based on the 
amplification O antigen encoding regions (rbf) which were specific to both serogroups. 
The PCR was done as described earlier (Hoshino et al., 1998).  
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2.13  Biotype determination 
Serogroup O1 has been the cause of the seven cholera pandemics until now. Classical 
biotype was the cause first six cholera pandemics while El Tor biotype caused the current 
seventh pandemic. For biotype determination, besides the traditional biochemical 
methods, multiplex PCR (m-PCR) based approach to detect the classical and El Tor 
biotype specific toxin co-regulated pilin A (tcpA) was adopted (Keasler and Hall, 1993).  
2.14  Detection of other virulence genes 
Besides cholera toxin which is the major virulence factor of V. cholerae, other virulence 
genes of the Vibrio pathogenicity island-1 (VPI-1) which included aldehyde 
dehydrogenase (aldA), ToxR regulated gene A (tagA), a regulator (ToxT), and an 
integrase (int) at which the VPI-1 is inserted in the V. cholerae genome were detected. In 
addition, haemolysin (hlyA) was also detected by PCR. HlyA causes the infection and 
cell damage even when it was present in V. cholerae that lack cholera toxin. The 
oligonucleotides and PCR conditions used to detect the above genes are listed in the table 
2.2 and section 2.9 respectively. 
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Table 2.2 Oligonucleotides used for identification, serogroup and biotypes determination and virulence genes detection. 
Gene Oligonucleotides (5’ to 3’) Annealing 
Temperature (˚C) 
PCR amplicon 
(bp) 
Reference 
rtxA Forward AGCAAGAGCATTGTTGTTCCTACC 
Reverse  ACTTCCCTGTACCGCACTTAGAC 
60 120 (Gubala, 2006) 
ompW Forward CACCAAGAAGGTGACTTTATTGTG 
Reverse GAACTTATAACCACCCGCG 
61 588 (Nandi et al., 2000) 
O1 rfb Forward  GTTTCACTGAACAGATGGG 
Reverse GGTCATCTGTAAGTACAAC 
 
55 192 (Hoshino et al., 1998) 
O139 rfb Forward AGCCTCTTTATTACGGGTGG 
Reverse GTCAAACCCGATCGTAAAGG 
 
55 449 
tcpA
Cl
 Forward CACGATAAGAAAACCGGTCAAGAG 
Reverse ACCAAATGCAACGCCGAATGGAGC 
 
60 617 (Keasler and Hall, 
1993) 
tcpA
ET
 Forward GAAGAAGTTTGTAAAAGAAGAACAC 
Reverse GAAAGGACCTTCTTTCACGTTG 
 
60 472 
hlyA Forward AGATCAACTACGATCAAGCC 
Reverse AGAGGTTGCTATGCTTTCTAC 
 
60 1677 (O'Shea et al., 2004) 
tagA Forward GGTGGTAAGATATTCACTC 
Reverse GTCACAACAGGTACACC 
 
52 1707 (Karaolis et al., 1998) 
aldA Forward CTAATAGCGAAACTTCGACTG 
Reverse AGGTGCAGTGCTTCAATTTC 
 
52 1249 (Karaolis et al., 1998) 
Int Forward GATAAAGAGATCAAAGCC 
Reverse ATCTGCTTCCATGTGGG 
 
55 1238 (Karaolis et al., 1998) 
toxT Forward ATAACTTTACGTGGATGGC 
Reverse AAAATCAGTGATACAATCG 
 
52 934 (Karaolis et al., 1998) 
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2.15 Characterization of CTX prophage   
Cholera toxin which is the most important virulence factor responsible for the secretory 
diarrhoea is part of a lysogenic phage genome inserted in the V. cholerae (Waldor and 
Mekalanos, 1996). CTXΦ has genome size of 6.9 kb. Its genome has two components, 
RSI and CTX. The RSI has role in the phage integration, replication etc. whereas the 
CTX encodes for cholera toxin (AB subunit type toxin), and other virulence genes such 
heat stable toxin, and other toxins like called zonula occludens (Zot) and accessory 
cholera enterotoxin (Ace). The CTX typing or analysis was carried out in order to 
determine the phage type in the V. cholerae in isolates from Pakistan during the current 
study.  The genomic structure of RS1 and CTX elements were analysed as described 
previously (Nguyen et al., 2009). Briefly this analysis included determination of the 
location of the CTX prophage on the chromosomes of V. cholerae, its number in the V. 
cholerae, type of the rstR gene, presence/absence of the rstC as well as the detection of 
the cholera toxins A and B, typing of cholera toxin B and other components of CTX 
element like zonula-occludens toxin (zot), accessory cholera enterotoxin (ace), core-
encoded pilin (cep) and heat stable toxin (stn). 
ctxB typing:  
The El Tor biotype would be having the ctxB of El Tor type, but in the past decades, 
ctxB of classical biotype has been found in El Tor isolates. Both classical and El Tor 
ctxB differ only by few subtle point mutations. To type the ctxB, the sequences of ctxB 
were aligned to find their type in Pakistan. 
The primers used for RS1 and CTXΦ analysis are listed in table 2.3 and PCR conditions 
mentioned in the section 2.9 were followed. 
2.15.1  Cholera toxin detection 
Cholera toxin A (ctxA) and B (ctxB) were detected by PCR with primer pairs 
ctxAF/ctxAR and ctxBF/Ch1R respectively. In addition, zonula occludens toxin gene 
(zot) and core encoded pilin gene (cep) were also detected by PCR using primer pairs 
zotF/zotR and rstCF/cepR respectively. 
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2.15.2   rstR type determination 
To determine the rstR type four primer sets were used. These included rstRETF/rstAR, 
rstRClF/rstAR, rstCalF/rstCalR and rstREnvF/restREnvF for detection of rstR of El 
Tor, classical, Calcuta and environmental type respectively. 
2.15.3  RS1 detection and locus determination 
The RS1 consists of various components and in order to detect and find their 
arrangement different PCRs were performed. The rstC (often present in RS1 of El Tor 
biotype) was detected with primer pair rstCF/rstCR. There were two possibilities of RSI 
arrangement which included CTX prophage-RS1 and RS1-CTX prophage, to determine 
these arrays PCR was performed by using primer pairs ctxBF/rstCR and rstCF/cepR 
respectively. 
2.15.4  Tandem repeats of CTX prophage and RS1 
Tandem repeats of CTX prophage and RS1 are present in classical isolates as well as 
the El Tor isolates from different countries also contained the repeats of either one or 
both elements. To determine the tandem repeats of RS1, a PCR was performed by using 
primer set rstCF4/rstCR4. Tandem repeats of CTX prophage were determined by PCR 
using primer set ctxBF/cepR. 
2.15.5  Locus determination of RS1-CTX prophage array on chromosomes 
Location of RS1-CTX prophage array on two chromosomes was determined by PCR 
using different primer sets. On large chromosome, location is determined by two primer 
pairs, Ch1F/rstAR and ctxBF/Ch1R. For presence/absence of the array on small 
chromosome, primer set Ch2F/Ch2R was used.  
2.15.6   ctxB type determination 
The ctxB type was determined by obtaining the sequence of ctxB from the whole 
genome sequences of the isolates. Then ctxB sequences were aligned and compared for 
similarity with those of V. cholerae O1 Inaba N16961 (El Tor) and V. cholerae O1 
O395 (Classical) isolates by using MEGA6 (Tamura et al., 2013).  
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Table 2.3 Oligonucleotides used for CTX prophage analysis. 
Amplification Oligonucleotides (5’-3’) Annealing 
Temp. (˚C)  
Reference 
ctxA  ctxAF CTCAGACGGGATTTGTTAGGCACG 60 (Keasler and Hall, 1993) 
ctxAR TCTATCTCTGTAGCCCCTATTACG 
ctxB ctxBF AGATATTTTCGTATACAGAATCTCTAG 55 (Heidelberg et al., 2000) 
Ch1R CCGCGCTCAAGTGGTTATCGG 
zot zotF TCGCTTAACGATGGCGCGTTTT 60 (Rivera et al., 2001) 
zotR AACCCCGTTTCACTTCTACCCA 
rstR
El Tor
 rstRETF TGAGCATAAGCTCTTGATTT 52 (Nusrin et al., 2004; 
(Heidelberg et al., 2000) rstAR CCGTGAAAGTCATCAACG 
rstR
Classical
 rstRClF TTTGCTACTTCTTCTTGGTT 52 (Nusrin et al., 2004; 
(Heidelberg et al., 2000) rstAR CCGTGAAAGTCATCAACG 
rstR
Calcutta
 rstRCaF TCAAGCTTTTTTTTGCTTTATCTTA 52 (Davis et al., 1999) 
rstRCaR TGGCAACAAAGCACATTAAAGA 
rstR
Environmental
 rstREnF GCTTCATTTGTGTATTGGTCTATTAGGTAGTTA 52 (Nusrin et al., 2004) 
rstREnR TCGAGTTGTAATTCATCAAGAGTGAAAA 
rstC rstCF GATGTTTACGATAGCCTAGAAGACTT 55 (Heidelberg et al., 2000) 
rstCR TACAGTGATGGCTCAGTCAATGC 
RS1-CTX array rstCF GATGTTTACGATAGCCTAGAAGACTT 52 (Heidelberg et al., 2000) 
cepR AAACAGCAAGAAAACCCCGAGT 
CTX-RS1 array ctxBF AGATATTTTCGTATACAGAATCTCTAG 52 (Heidelberg et al., 2000) 
rstCR TACAGTGATGGCTCAGTCAATGC 
Tandem repeats of 
CTX 
Ch1F GACCACTCAGGCCGCTGAAAT 52 (Heidelberg et al., 2000) 
rstAR CCGTGAAAGTCATCAACG 
Tandem repeats of 
RS1 
rstCF4 AAATCCGCAACTCAAGGCATTGA 51 (Heidelberg et al., 2000) 
rstCR4 TAAGCGCCTGAACGCAGATATAAAG 
CTX presence in 
small chromosome 
Ch2F AACAACAGGTTGCAAGAGAGCATT 52 (Heidelberg et al., 2000) 
Ch2R TATTGCTTTTTTAATGGCCGTT 
F, forward; R, reverse.
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2.16 Antimicrobial susceptibility testing 
To determine the antimicrobial susceptibility pattern of V. cholerae in Pakistan, we used 
97 V. cholerae isolates retrieved from different provinces of Pakistan during 2009 to 
2011. The Figure 2.1 as well as the tables 3.2 and 3.3 give the information about their 
origin in different provinces and year wise collection of the isolates.  
2.16.1  Procedure 
The antimicrobial susceptibility of V. cholerae isolates to different classes of antibiotics 
was determined by Kirby-Bauer disc diffusion method (Bauer et al., 1966). The antibiotic 
classes included:  penicillins (ampicillin, 30 µg), sulphonamides (sulfamethoxazole-
trimethoprim, 23.5ug/1.5µg), tetracyclines (tetracycline 30 µg), folate pathway inhibitors 
(nalidixic acid, 30 µg; ciprofloxacin; 5 µg: ofloxacin, 5 µg), phenicols (chloramphenicol, 
30 µg), erythromycin, 15 µg; streptomycin, 10 µg; cefotaxime, 30 µg and ceftazidime, 30 
µg. All the antibiotic discs were purchased form Oxoid (Hampshire, UK). E. coli ATCC 
25992 was used as control in this experiment.  
2.16.1.1   Inoculum preparation 
The inoculum of each V. cholerae isolate was prepared by taking the fresh overnight (12-
16 hrs) growth of V. cholerae from a non-selective medium (Nutrient Agar). The freshly 
grown cells were suspended in phosphate buffer saline (PBS) and the turbidity of the 
suspension was adjusted by comparing it with 0.5 McFarland Standard.  
2.16.1.2  Bacterial lawn preparation on MH Agar 
The cotton swabs dipped in the well suspended inoculum tubes were spread on the dried 
Mueller-Hinton (MH) agar (Oxoid, Hampshire – UK) plates to prepare the lawns of V. 
cholerae O1 isolates. Then the plates were kept for 5 minutes in the biological safety 
cabinet level-2 (BSL-2). After this the antibiotic discs were dispensed by disc dispenser.  
2.16.1.3  Incubation and Results Interpretation 
The plates were incubated at 37˚C for 16-20 hours for antimicrobial susceptibility testing 
and the results were interpreted according to guidelines of the clinical laboratory 
standards institute (CLSI) (CLSI, 2009). In case when the antimicrobial susceptibility for 
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certain antibiotics had not been defined for V. cholerae by CLSI, the criterion for 
Enterobacteriaceae was used for V. cholerae.  
2.17  Genotypic characterization of antimicrobial resistance 
2.17.1   Detection of integrative and conjugative element (ICE) SXT 
The SXT is a type of integrative and conjugative element (ICE) ubiquitously present in V. 
cholerae O1 El Tor around the world. In 1996, SXT element was discovered in V. 
cholerae O139 (MO10) isolate form Madras - India and it was found to confer resistance 
to different antibiotics such as streptomycin, chloramphenicol, trimethoprim and 
sulfamethoxazole. Thereafter, it was found in O1 El Tor isolates from Bangladesh and 
spread to other countries. The primers used for the detection of SXT element are listed in 
the Table 2.4. See section 2.9 for PCR conditions. 
2.17.2  Detection of integrons 
Integrons are the gene cassette transferring mobile elements which play an important role 
in the transfer of antimicrobial resistance in the bacterial populations (Mazel, 2006). 
Integrons of class 1, 2 and 3 were detected by using HEP35/HEP36 primers which 
amplified the consensus regions of the integrases of three classes of integrons (White et 
al., 2000). The PCR fragments were restriction digested with Hinf1. Integrons were 
identified on the basis of fragments generated after digestion with Hinf1. These included: 
class 1 (491 bp), class 2 (300 and 191 bp) and class 3 (119 and 372 bp).  
2.17.3  Genotypic characterization of sulphonamide resistance 
The sul genes mostly sul1, sul2 and sul3 are responsible for resistance to sulphonamides 
in V. cholerae. The prevalence of above mentioned sul genes was studied by PCR as 
described earlier (Kerrn et al., 2002; Perreten and Boerlin, 2003). 
2.17.4  Detection of genes encoding resistance to streptomycin 
Resistance to streptomycin was genetically characterized by detecting strA and strB by 
PCR using previously designed primer sets (Hochhut et al., 2001; Ramachandran et al., 
2007). 
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2.17.5  Detection of genes encoding resistance to trimethoprim 
Dehydrofolate reductases involved in the metabolism of folic acid play important role in 
encoding trimethoprim resistance. PCR was performed to detect the dehydrofolate 
reductases (dfrA1 and dfrA18) which are common in V. cholerae (Chuanchuen et al., 
2008; Hochhut et al., 2001). 
2.17.6  Quinolones resistance 
Quinolone resistance encoding gene cassettes (usually horizontally transferable) which 
included qnrA, qnrB and qnrS were detected by PCR as described previously (Cattoir et 
al., 2007b).  
2.17.7  Detection of florR 
When the SXT element was first discovered in O139 it carried chloramphenicol 
resistance encoding element (florR). But after the period, the O1 serogroup carried the 
SXT element but chloramphenicol resistance was missing in those O1 El Tor isolates. 
PCR was performed to detect the florR as described earlier (Hochhut et al., 2001). 
2.17.8   Characterization of resistance to tetracycline 
Tetracycline was recommended as adjunct treatment therapy of cholera besides fluids 
replacement. Tetracycline resistance encoding gene was detected by PCR targeting tetR.  
2.17.9  Detection of mutations in gyrA and parC  
The mutations in quinolone resistance determining region (QRDRs) of gyrase A (gyrA), 
gyrase B (gyrB), and DNA topoisomerase IV (parC) were associated with quinolones 
resistance in the bacterial populations (Strahilevitz et al., 2009). A transversion of ATC 
in the codon 83 of gyrA resulting substitution of serine to isoleucine was determined. 
Similarly, a mutation in the parC by transversion (underlined) of C to T in codon 
85(TCG) substituting leucine for serine was also checked. The sequences of the gyrA and 
parC were aligned by using MEGA6 (Tamura et al., 2013). 
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Table 2.4 Oligonucleotides used for genotypic characterization of antibiotic resistance. 
Gene Oligonucleotides (5’-3’) Annealing 
Temp. (˚C) 
PCR amplicon 
(bp) 
Reference 
Int* HEP35 TGCGGGTYAARGATBTKGATTT 
HEP36 CARCACATGCGTRTARAT 
55 491 (White et al., 2000) 
qnrA1-A6 Forward AGAGGATTTCTCACGCCAGG 
Reverse TGCCAGGCACAGATCTTGAC 
55 580 (Cattoir et al., 2007a) 
qnrB1-B6 Forward GGMATHGAAATTCGCCACTG 
Reverse TTTGCYGYYCGCCAGTCGAA 
 
55 264 (Cattoir et al., 2007b) 
qnrS1-S2 Forward GCAAGTTCATTGAACAGGGT 
Reverse TCTAAACCGTCGAGTTCGGCG 
 
55 428 (Cattoir et al., 2007a) 
SXT Forward ATGGCGTTATCAGTTAGCTGGC 
Reverse GCGAAGATCATGCATAGACC 
 
60 1035 (Bhanumathi et al., 2003) 
Sul1 Forward CGGCGTGGGCTACCTGAACG 
Reverse GCCGATCGCGTGAAGTTCCG 
 
65 428 (Kerrn et al., 2002) 
sul2 Forward GCGCTCAAGGCAGATGGCATT 
Reverse GCGTTTGATACCGGCACCCGT 
 
65 285 (Kerrn et al., 2002) 
sul3 Forward GAGCAAGATTTTTGGAATCG 
Reverse CTAACCTAGGGCTTTGGA 
 
61 787 (Perreten and Boerlin, 
2003) 
drfA1 Forward CAATGGCTGTTGGTTGGAC 
Reverse CCGGCTCGATGTCTATTGT 
 
60 253 (Chuanchuen et al., 2008) 
dfrA18 Forward TGGGTAAGACACTAGTCATGGG 
Reverse ACTGCCGTTTTCGATAATGTGG 
 
60  (Hochhut et al., 2001) 
strA Forward TTGATGTGGTGTCCCGCAATGC 
Reverse CCAATCGCAGATAGAAGGCAA 
 
60 384 (Hochhut et al., 2001) 
strB Forward CCGCGATAGCTAGATCGCGTT 
Reverse CGACTACCAGGCGACCGAAAT 
 
60 515 (Ramachandran et al., 
2007) 
florR Forward TTATCTCCCTGTCGTTCCAGCG 
Reverse TCGTCGAACTCTGCCAAATG 
 
67 915 (Hochhut et al., 2001) 
TetR 
 
Forward CGGCTTTACAGGGCAATTCT 
Reverse CGTTGCTGGAATTTGCCCTA  
60 
 
235 
 
This study 
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2.18 Multilocus variable number of tandem repeats (VNTRs) analysis 
(MLVA) 
For genotyping of the V. cholerae O1 El Tor isolates multilocus variable number of 
tandem repeats analysis (MLVA) was performed. In this case, five loci were selected 
containing variable number of tandem repeats as described previously (Choi et al., 2010; 
Ghosh et al., 2008). Among these, three loci were on chromosome 1 and two on 
chromosome 2. These included VC0147, VC0436-7 (intergenic), VC1650, VCA0171 and 
VCA0283. MLVA of 98 V. cholerae O1 El Tor isolates was performed which included 
all isolates collected in 2010 and 2011 whereas four representative isolates of 2009 which 
included BH11, BH20, BHA and BHJ. The oligonucleotides used in the analysis are 
listed in table 2.5.  
2.18.1  PCR  
Briefly, the sequences of these five loci for MLVA were retrieved from the whole 
genome data of the V. cholerae O1 El Tor isolates of Pakistan by in-silico PCR by using 
the fastPCR software (Kalendar et al., 2011). The numbers of repeats in the sequences of 
different loci were found by using the tandem repeat finder (Benson, 1999).   
The number of repeats at a locus was used as allele type. The allele number of different 
loci was given by mentioning the number of repeats at that locus. The VNTR profile of 
each V. cholerae O1 El Tor was obtained by combining the number of repeats of five 
VNTR loci such as VC0147, VC0436-7, VC1650, VCA0171 and VCA0283, in a string. 
For example, 8,3,6,14,13.  
2.18.2 Clonality analysis 
The VNTR profiles of the isolates were analysed to find the relationship among the El 
Tor isolates collected during the three years study by JAVA softwares, eBURST and 
Phyloviz respectively (Feil et al., 2004; Francisco et al., 2012). In MLVA, a unique 
VNTR profile described a sequence type (ST) whereas the clonal complex (CC) 
comprised of a group of STs having a common ancestor. The CCs were generated by 
eBURST algorithm (Feil et al., 2004) which were retrieved as a set of STs differing at a 
single locus or single locus variants. Hence, it was composed of STs which differed in  
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Table 2.5 Oligonucleotides used for amplification of VNTR loci. 
Chromosome locus Oligonucleotides (5’ – 3’) Motif References 
1 VC0147 Forward CCAAACCACTGCAACGGATA 
Reverse GCTGCTCGACCTGAGAGAGA 
 
AACAGA (Choi et al., 2010) 
VC0436-7 Forward CGTGGTACTAAGTTCCACGC 
Reverse CGTTTTTACCACGCTCCGCTTC 
 
GACCTA (Stine et al., 2008) 
VC1650 Forward CTACCAAGCGGCGGTTAAGCTG 
Reverse TGGGCAACCTGCTGGTAGC 
 
GATAATCCA (Ghosh et al., 2008) 
2 VCA0171 Forward GCATCATCCACAGCGTTTGG 
Reverse GCTGAAGCCTTTCGCGATCC 
 
TGCTGT (Ghosh et al., 2008) 
VCA0283 Forward CTTCATCGGCAAACAAGACA 
Reverse TTGCGCACAATTCTCTTTGA 
 
ACCAGA (Choi et al., 2010) 
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one of the five loci. Each CC had a founder ST with which other STs were related, the 
founder ST was the one having maximum single locus variants within a CC. The 
credibility of the founder was calculated by 1000 bootstrap replicates. Phyloviz is a 
platform independent software which uses the geoBurst algorithm to determine the 
founder organism in the epidemiological studies by generating allele profiles and 
displaying the epidemiological data. Phyloviz shows results as annotated graphs and 
overlay of database queries is also possible to represent the relationship between the 
organisms of population and STs which differ from others by one locus. A minimum 
spanning tree (MST) which displays the organisms and their relationship with the 
founder was constructed by using Phyloviz. 
2.19  Genome sequencing 
98 genomes of V. cholerae O1 El Tor isolates of clinical origin, which included all 
isolates of 2010 and 2011 whereas only four representatives O1 El Tor isolates 
(BH11, BH20, BHA and BHJ) retrieved during 2009, were sequenced by Illumina 
Hiseq platform (Illumina, San Diego, California – USA). Initially, multiplex 
sequencing libraries each with insertion capacity of 250 bp were created and loaded 
on the sequencing platform cell to get paired end reads of 72-bases sequencing of 96 
libraries. Each library was labelled with a unique index tag. Then the tag information 
was used to assign reads to individual samples. An average coverage of 200X was 
achieved for all the samples in the SNPs calling regions. All the sequence data was 
submitted to the European Nucleotide Archive with the accession codes.  
2.19.1   Whole-Genome alignment and SNPs detection in the core genome 
The 72-base paired end read data of all the isolates were mapped to genome of V. 
cholerae O1 El Tor strain N16961 (Genbank accession no. AE003852 and 
AE003853) by using SMALT software and whole genome alignment of all the 
isolates was obtained (www.sanger.ac.uk/resoruces/software/smalt). The SNPs in the 
core genome was called according to the methods described before (Harris et al., 
2010b). All those reads were rejected either which were not mapped to the reference 
N16961 or absent in the reference genome and these were not considered for SNPs 
detection. The SNPs were filtered in order to get the good quality SNPs, for these 
sites having SNP quality score <30 as well as SNPs absent in 75% of the reads at any 
heterogeneous mapped sites were also excluded. Only high density SNP clusters or 
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the possible recombination sites were excluded as described earlier (Croucher et al., 
2011). 
2.19.2  Phylogenetic analysis, comparative genomics, and linear gegression 
analysis 
Phylogenetic trees were estimated based on all the SNPs called from the genome as 
explained earlier by RAxML version 0.7.4 (Stamatakis, 2006) default settings.  
PAML (Yang, 2007) was used to reconstruct all polymorphic events on the tree for 
calculating the number of SNPs on branches. M66, a pre-seventh pandemic strain 
(accession nos. CP001233 and CP001234), was used as an outgroup to root the 
phylogenetic tree (Mutreja et al., 2011). Figtree 
(http://tree.bio.ed.ac.uk/software/figtree/) software for reading phylogenetic tree was 
used to visualize and order the tree. To assemble the paired end reads a de novo 
genome assembly program Velvet version 0.7.03 (Zerbino and Birney, 2008), was 
used to generate multicontig draft genome of each sample. Appropriate parameters 
were set to give the best k-mer size and at least 20× k-mer coverage. Since, the V. 
cholerae of the current seventh pandemic are highly similar at the core genome level, 
N16961 El Tor strain was used as reference to order the contigs by Abacas software 
(Assefa et al., 2009). Annotation was transferred from the reference strain to all the 
ordered draft genomes. All the genomes were compared with the reference 
N16961strain and files were generated by using TBLASTX (Altschul et al., 1990) 
against N16961 FASTA sequence serving a base which is used to manually compare 
the genomes by Artemis Comparison Tool  (Carver et al., 2008). Path-O-Gen version 
1.3 (http://tree.bio.ed.ac.uk/software/pathogen), was used to open the final 
phylogenetic tree, and the root-to-tip distance data for each strain were exported to 
Excel (Microsoft, Richmond, WA, USA). Linear regression curve against the strain’s 
isolation date were plotted on the basis of these data. The R2 correlation, slope, and p 
values were determined by using the inbuilt regression package of R statistical 
environment (www.r-project.org).  
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3 Results 
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3.1 Isolation of Vibrio cholerae 
During the current study, 2009-2011, a total of 1114 samples were collected from 
different sources including clinical (969) and environmental (145) i.e, water, waste water 
and fish (Table 3.1). In August 2010, Pakistan experienced the worst floods in its 63-year 
history which caused huge loss of civic infrastructure contaminating the drinking water 
sources (Figure 3.1) by flood water and an unprecedented increase in cholera affecting 
thousands of people in flood affected areas (Figure 3.2).  All the samples were processed 
and subjected to various standard biochemical tests and further confirmation was made 
by performing the V. cholerae species-specific PCR targeting ompW and rtxA genes 
respectively (Figure 3.3). Overall 120 V. cholerae were identified which included 113 
(94%) from clinical samples whereas only eight (6%) belonged to environmental sources.  
3.2 Percentage of V. cholerae among different sources in Pakistan 
The overall prevalence of V. cholerae was 10.7%. In sewage samples the prevalence of V. 
cholerae was the highest (15%), however the sample size was small in this case as only 
20 samples were collected,  followed by clinical and fish samples with 11.7% and 6 % 
respectively, whereas it was the lowest in drinking water samples (2.1%) (Figure 3.4). In 
the clinical samples, yearwise prevalence of V. cholerae was the highest (13.5%) in 2010 
when the country was affected by the worst floods of its history. V. cholerae was isolated 
both from flood affected and non-flood affected areas of country whereas the prevalence 
was 11.4% in 2011 and the lowest in 2009 with 8%. In 2010, V. cholerae isolation was 
high in the flood affected cities of Jamshoro, Hyderabad and D I Khan with 50%, 42% 
and 18% respectively, whereas the coastal city Karachi also had high prevalence of 36% 
(Table 3.2). In 2011, the highest prevalence (27%) was in Nowshera followed by 
Charsada, Murree and Larkana with 20%, 18% and 17% respectively (Table. 3.3). 
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Table 3.1 Isolation of V. cholerae from different sources in Pakistan during 2009-
2011. 
Year  Source Total Samples 
collected 
Vibrio cholerae 
isolation 
Prevalence (%) 
2009 Clinical 150 13 8 
2010 Clinical 319 42 13.5 
 Water 50 0 0 
 Fish 20 0 0 
2011 Clinical 500 57 11.4 
 Fish 30 3 10 
 Water 25 2 8 
 Waste water 20 3 15 
  Total: 1114 Total: 120  
 
 
 
 
Figure 3.1 Destruction by 2010 floods in Pakistan. 
The devastating floods in 2010 not only destroyed the infrastructure including homes, but 
the raised level of flood water also resulted in mixing of flood water with the water 
sources including wells, streams, underground water storages.  
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Figure 3.2: Cholera patient with severe dehydration in D I Khan in 2010. 
A child affected with cholera showing signs of severe dehydration in 2010 during floods in D I 
Khan – Khyber Pakhtunkhwa. 
 
Figure 3.3 Identification, serogroup and biotype determination of Vibrio cholerae by PCR. 
Lane 1, 100 bp DNA ladder; Lane 2, rtxA amplification from plasmid carrying rtxA gene 
used as positive control; Lane 3 and 4, identification by detection of rtxA and ompW 
genes respectively; Lane 5; ctxA gene amplification; Lane 6, serotyping by multiplex 
PCR (m-PCR) detecting serogroup O1 and O139 specific wb and Lane 7, biotyping by 
m-PCR detecting tcpA of classical and El Tor type (All 98 V. cholerae O1 El Tor isolates 
have results like this figure except one isolate, CS15 (V. cholerae O1 El Tor ) which  
lacked ctxA gene, however as an O1 El Tor isolate it also had wbO1 and tcpA 
El Tor
.
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Figure 3.4 Prevalence of V. cholerae in different sources from Pakistan during 2009 - 2011. 
The prevalence of V. cholerae was highest in the waste water samples, although the 
sample size was small, followed by clinical, fish and drinking water sources. 
 
Table 3.2 Isolation of V. cholerae O1 El Tor from flood affected and unaffected cities 
of Pakistan during 2010. 
Province, District Flood Status Total acute diarrhoea 
samples collected  
V. cholerae O1 El Tor 
isolates, no. (%) 
Khyber Pakhtunkhwa    
 Dera Ismail Khan Affected 55 7 (13) 
 Nowshera Affected 20 1 (5) 
 Charsada Affected 40 0 
 Peshawar Unaffected 50 4 (8) 
Sindh    
 Khairpur Affected 36 1 (3) 
 Jamshoro Affected 10 5 (50) 
 Sukkur Affected 6 0 
 Shikarpur Affected 6 0 
 Karachi Unaffected 25 8 (32) 
 Hyderabad Affected 19 8 (42) 
Punjab    
 Dera Gazi Khan Affected 2 0 
 Muzaffargarh Affected 25 0 
 Rawalpindi Unaffected 25 4 (16) 
Total, N=319 Affected 219 (68) 22 (10) 
 Unaffected 100 (32) 16 (16) 
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Table 3.3 Isolation of V. cholerae O1 El Tor from Pakistan during 2011.  
Province, District Total acute diarrhoea sample 
collected 
V. cholerae O1 El Tor 
isolates, no. (%) 
Khyber Pakhtunkhwa   
 Peshawar 35 04 (11) 
 Nowshera 30 08 (27) 
 Charsada 20 05 (20) 
 Swabi 12 01 (8) 
Sindh   
 Larkana 18 03 (17) 
 Badin 19 01 (5) 
 Dadu 07 01 (14) 
 Saanghar 09 01 (11) 
 Sukkur 22 01 (4) 
Baluchistan   
 Zoab 17 01 (6) 
 Chaman 16 01 (6) 
Punjab   
 Murree 50 9 (18) 
 Rawalpindi 33 04 (12) 
 Islamabad 30 02 (7) 
 Attock 10 01 (10) 
 Rahimyar Khan 14 01 (7) 
 Bahawalnagar 06 01 (17) 
 Chakwal 10 01 (10) 
 Qasor 08 01 (12) 
 Chiniot 09 01 (11) 
 Sialkot 15 01 (7) 
 Multan 14 02 (14) 
 Okara 11 01 (9) 
 Kamalia 20 01 (5) 
 Muzaffargarh 11 01 (9) 
Gilgit Baltistan   
 Gilgit 40 01 (3) 
Azad Jammu & Kashmir   
 Muzaffarabad 14 01 (7) 
 Total, N=500 56 (11) 
69 
 
3.3 Serogroup, serotype and biotype 
Vibrio cholerae has above 200 serogroups, but mainly two serogroups O1 and O139 were 
associated with pathogenic V. cholerae and were responsible for cholera epidemics and 
outbreaks in the past. The serogroup of V. cholerae isolates was determined by 
agglutination with polyvalent Inaba and Ogawa antisera. Among the total 120 V. cholerae 
isolates, 108 (89.2%) isolates were of serogroup O1. 96% (108/113) of clinical isolates 
have O1 serogroup while none of the isolate from environmental sources had O1 
serogroup. Serogroup of the V. cholerae was also confirmed by multiplex PCR targeting 
the serogroup O1 and O139 specific regions of the rfb gene. O139 serogroup that evolved 
in the early 1990’s was associated with epidemics in last decade of twentieth century was 
not detected in any of V. cholerae isolate from Pakistan during the current study (Figure 
3.5). However, non-O1/non-O139 V. cholerae were also isolated from the clinical 
samples and overall 13 non-O1/non-O139 isolated were retrieved from clinical and 
environmental sources. Non-O1/non-O139 isolates had 4.5% (5 isolates) share in clinical 
samples and year wise prevalence of these non-O1/non-O139 serogroups was 9.5% in 
2010, 1.7% in 2011 whereas in 2009 non-O1/non-O139 were not isolated. Among the 
five non-O1/non-O139 isolates in clinical samples, three, one and one were isolated from 
D I Khan, Karachi and Murree respectively. All the eight V. cholerae isolates from 
environmental sources such as water, waste water and fish belonged to non-O1/non-O139 
serogroups as they did not agglutinate with the polyvalent Inaba and Ogawa antisera. 
Among the three serotypes, Inaba, Ogawa and Hikojima, of V. cholerae O1, in Pakistan 
all the O1 isolates have Ogawa serotype and Inaba serotype was not found in Pakistan 
during the current study. Similarly, all the serogroup O1 isolates have El Tor biotype 
which was determined by traditional methods involving chicken cell agglutination, 
Voges-Proskauer (VP) test and sheep blood agar haemolysis as well as by PCR based on 
the amplification of the classical and El Tor biotype specific regions of toxin co-regulated 
pilus A (tcpA) (Figure 3.3). The El Tor biotypes is the cause of current seventh cholera 
pandemic while the classical biotype was not detected in any isolate of serogroup O1 
investigated during the current study, which caused the first six cholera pandemics. 
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Figure 3.5 Prevalence of O1 and non-O1/non-O139 serogroups of V. cholerae among 
different sources in Pakistan. 
The figure shows that serogroup O1 was only prevalent in clinical samples whereas non-
O1/non-O139 serogroups are present in all sources like fish, water and waste water as 
well as in clinical samples. 
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3.4 Virulence factors 
The V. cholerae O1 El Tor isolates were characterized for the presence of virulence genes 
such as hlyA, int, toxT, aldA and tagA by PCR. The results categorized all V. cholerae O1 
El Tor isolates in two virulence profiles (VPs) on the basis of presence of these genes. 
Virulence profile-1 (VP-1) contained hlyA, int, toxT, aldA and tagA whereas virulence 
profile-2 (VP-2) contained only hlyA, int and toxT. Overall, VP-1 consisted of 37 (38%) 
O1 isolates whereas VP-2 represented 61 (62%) O1 El Tor isolates. V. cholerae 
haemolysin (hlyA) was present in all V. cholerae O1 El Tor isolates of VP-1 and VP-2 
(Figure 3.6). Similarly, all O1 El Tor isolates (VP-1 and VP-2) carried the toxR and int 
genes which are part of the Vibrio pathogenicity island-1, VPI-1 (Figure 3.7 and 3.8). It 
is clear that in VP-1, VPI-1 is intact, however in VP-2 VPI-1 has deletion of aldA and 
tagA (Figure 3.9 and 3.10). During the study, prevalence of VP-1 and VP-2 varied 
(Figure 3.11). The prevalence of VP-1 ranged from 100%, 81% and 3.5% during 2009, 
2010 and 2011 respectively. In 2010, 6/7 isolates of VP-2 belonged to the coastal city of 
Karachi and only one isolate (HH18) from its neighbouring city of Hyderabad. However 
in 2011, VP-2 was dominant with prevalence of 96% present across all five provinces of 
Pakistan and only two isolates (NP5 and NP6) from Nowshera, Khyber Pakhtunkhwa 
belonged to VP-1. 
3.5 CTX prophage analysis 
In V. cholerae O1 El Tor RS1 element is located adjacent to CTX prophage. The genetic 
structure of RS1 is similar to RS2 of CTX prophage. The genetic array and location of 
RS1 and CTX prophage were determined by PCR using different primers sets. Cholera 
toxin (ctxA and ctxB),  which is the major virulence factor and responsible for severe 
secretory diarrhoea was detected in 97 out of 98 V. cholerae O1 El Tor isolates analysed 
(Figure 3.12 and 3.18).  The only isolate (CS15) which lacked cholera toxin and the 
further study showed that both CTX prophage and RS1 were also absent. This particular 
O1 El Tor isolate (CS15) belonged to Charsada in Khyber Pakhtunkhwa and was isolated 
in 2011. Similarly, other CTX genes like zonula occludens toxin (zot), accessory cholera 
enterotoxin (ace) and core encoded pilin (cep) were also present in 97 out of 98 isolates 
(Figure 3.15 and 3.19). Similarly, RS1 presence was confirmed in 97/98 V. cholerae O1  
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Figure 3.6 Detection of hlyA in V. cholerae O1 El Tor isolates. 
M, DNA ladder; PC, V. cholerae O1 El Tor N16961 and NC is PCR control. V. cholerae 
haemolysin A (hlyA) which causes haemolysis as well as other cytopathic effects in host cells was 
detected in all V. cholerae O1 El Tor. However as example only few isolates are shown. 
 
 
Figure 3.7 Detection of int of VPI-1 in V. cholerae O1 El Tor. 
M, DNA ladder; PC, V. cholerae O1 El Tor N16961 and NC is PCR control. This shows that int 
is present in all V. cholerae O1 El Tor isolates as only few results are shown in the gel. 
 
 
Figure 3.8 Detection of toxT in V. cholerae O1 El Tor from Pakistan. 
M, DNA ladder; PC, V. cholerae O1 El Tor N16961 and NC is PCR control. This shows that toxT 
is present in all V. cholerae O1 El Tor isolates as only few results are shown in the gel. 
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Figure 3.9: Detection of tagA in V. cholerae O1 El Tor isolates. 
M, DNA ladder; PC, V. cholerae O1 El Tor N16961 and NC is PCR control. This shows that 
tagA is not present in all V. cholerae O1 El Tor isolates as only few results are shown in the gel. 
 
Figure 3.10: Detection of aldA in V. cholerae O1 El Tor isolates. 
M, DNA ladder; PC, V. cholerae O1 El Tor N16961 and NC is PCR control. The PCR shows that 
aldA has not been uniformly present in V. cholerae O1 El Tor isolates from Pakistan during 2009-
2011. Only few results are shown.  
 
Figure 3.11 Prevalence of virulence profiles (VP-1 and VP-2) of V. cholerae O1 El Tor 
during 2009-2011. 
The figure shows change in the prevalence of VP-1 and VP-2 as VP-2 which was less prevalent 
in 2010 became dominant in 2011.
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El Tor isolates by detecting rstC (Figure 3.13). The results showed that only one El Tor 
strain (CS15) lacked RS1 and CTX prophage. However, rstR of El Tor (rstR
ET
) biotype 
was present in the RS2 of all CTX prophage carrying isolates, (Figure 3.14), whereas 
other rstR types, classical, Calcutta, and environmental were not detected in any of the V. 
cholerae isolates investigated during this period. 
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Figure 3.12 ctxA amplification in V. cholerae O1 El Tor.  
M, 100 bp DNA ladder; PC, V. cholerae O1 El Tor N16961 and NC is PCR control. Other lanes 
consisting of representative V. cholerae O1 El Tor collected during this study, 2009-11 showed 
that cholera toxin is present in all El Tor isolates except CS15. 
 
Figure 3.13  rstC of RS1 detection in V. cholerae O1 El Tor.  
M, 200 bp DNA ladder; PC, V. cholerae O1 El Tor N16961 and NC is PCR control. Other lanes 
showing representative V. cholerae O1 El Tor collected during this study, 2009-11. Isolate CS15 
lacked rstC showing that RS1 is absent.  
 
Figure 3.14 Detection of rstR and its type determination 
M, 200 bp DNA ladder; PC, V. cholerae O1 El Tor N16961 and NC is PCR control. Other lanes 
showing representative isolates of V. cholerae O1 El Tor collected during this study, 2009-11, 
that rstR
ET
 is present in all V. cholerae O1 El Tor from Pakistan except CS-15. 
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3.5.1 CTX and RS1 array structure  
RS1 was present at the start on chromosome 1 and TLC was also present because primer 
set ch1F/rstAR amplified the region between chromosome 1 and RS1 as ch1F primer was 
taken from TLC region (Figure 3.16). However, CTX was present at the end of array on 
chromosome 1 because primers set ctxBF/ch1R amplified sequence between ctxB and 
chromosome 1 (Figure 3.18).  To determine the order of CTX and RS1 on chromosome 
1, there were two possibilities (RS1-CTX or CTX-RS1) for this purpose, two primers sets 
used which included rstCF/cepR and ctxBF/rstCR for RS1-CTX and CTX-RS1 
respectively, primers rstCF/cepR gave amplified fragments indicating that CTX and RS1 
are arranged in RS1-CTX order on chromosome 1 whereas primers set ctxBF/rstCR gave 
no fragments (Figure 3.19). To determine the tandem repeats of CTX and RS1 by primer 
sets ctxBF/cepR and rstCF4/rstCR4 respectively, no DNA fragments were amplified 
showing that tandem repeats of both CTX and RS1 were absent (results not shown). Both 
CTX and RS1 were absent on chromosome 2 because by using primers set ch2F/ch2R 
integration site of CTX and RS1 on chromosome 2 was amplified in case of presence of 
CTX or RS1 a large PCR product (>1 kb ) would have been amplified (Figure 3.17). The 
detailed results of CTX prophage analysis are summarized in the figure 3.20). 
3.5.2 ctxB type 
The translated ctxB sequences of 98 V. cholerae O1 El Tor isolates was aligned against 
the ctxB of N16961 (El Tor reference) and O395 (classical reference) which showed that 
ctxB of these isolates was of classical type. The deduced amino acid sequences showed 
that CtxB of Pakistan isolates was 100% identical to CtxB of V. cholerae O395 having 
substitutions of histidine and threonine at 38 and 68 positions respectively (Figure 3.21). 
Such El Tor strains are referred as El Tor variants.   
Out of the 98 V. cholerae O1 El Tor isolates, only six isolates had six ToxR binding 
repeats (TTTTGAT) between ctxA and zot in the ctxAB promoter region whereas all other 
isolates had five repeats in this region. Yearwise and geographic data of these isolates 
showed that four out of six isolates having six repeats belonged to Sindh which were 
collected in 2010 and 2011, whereas the remaining two were collected from Murree and 
Muzaffarabad during 2011 (data not shown). 
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Figure 3.15 Detection of zot in CTX prophage of V. cholerae O1 El Tor. 
M, DNA ladder; PC, V. cholerae O1 El Tor N16961 and NC is PCR control. Zot virulence factor 
was present in all V. cholerae O1 El Tor except CS15 which lacked zot as well as other genes of 
CTX prophage.  
 
Figure 3.16 Determination of RS1 position on the chromosome 1. 
M, 200 bp DNA ladder and NC is PCR control. Other lanes showing representative V. cholerae 
O1 El Tor isolates collected during this study, 2009-11 that RS1 is located on the chromosome 1 
as well as showing that TLC is present because ch1F primer has been taken from TLC. 
 
Figure 3.17 Absence of CTX prophage and RS1 on the chromosome 2 of V. cholerae O1 El 
Tor.  
M, 200 bp DNA ladder; PC, V. cholerae O1 El Tor N16961; and NC is PCR control. Other lanes 
showing representative V. cholerae O1 El Tor isolates. The amplification of intact gene at the 
integration site of CTX prophage and RS1 shows that CTX and RS1 of these are absent in the 
chromosome 2, otherwsie product of large size (many kbs) would have been amplified. 
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Figure 3.18 Determination of CTX position on chromosome 1 of V. cholerae O1 El Tor.  
M, 200 bp DNA ladder and NC is PCR control. Other lanes showing representative V. cholerae 
O1 El Tor isolates collected during this study, 2009-11. This amplification product consists of 
some sequences of ctxB and core region of chromosome 1 showed that ctxB of CTXΦ is located 
adjacent to the chromosome 1, hence CTX prophage is located at the end of RS1-CTXΦ array on 
chromosome 1. (see also figure 3.19). 
 
 
 
Figure 3.19  RS1-CTX prophage array determination in V. cholerae O1 El Tor. 
M, 1 kb DNA marker and NC is PCR control. Other lanes showing representative V. cholerae O1 
El Tor isolates collected during the current study, 2009-11, that amplification of the segment, 
starting from rstC (RS1) to cep (CTX prophage) proving that the array is RS1-CTX in all the 
isolates as well as that cep is also present. Only one O1 El Tor isolate (CS15) lacked both RS1 
and CTX prophage. 
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Figure 3.20 Organization and position of CTX prophage and RS1 in V. cholerae O1 El Tor 
from Pakistan. 
Arrows show the transcription direction of the genes. The figure shows presence of toxin linked 
cryptic element (TLC), RS1 and a single copy of CTX prophage integrated on the chromosome 1 
whereas the chromosome 2 does not carry any of these. No tandem repeats of CTX or RS1 are 
present. rstR
ET
: rstR of El Tor type, ctxB
cla
: ctxB of classical type. 
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Figure 3.21 Amino acid sequence alignment of B sub-unit of cholera toxin by using MEGA6. 
The amino acid sequence alignment of CtxB of V. cholerae O1 El Tor from Pakistan during 2009 to 2011 with V. cholerae O1 El Tor (N16961) 
and V. cholerae O1 classical (O395). Identical amino acids are represented by dots. 
81 
 
3.6 Antimicrobial susceptibility testing 
The response of V. cholerae O1 to various antimicrobials was categorized in three 
categories: resistant, intermediate and sensitive (Table 3.4). The results showed that all 
97 O1 El Tor isolates were resistant to nalidixic acid, streptomycin, sulfamethoxazole and 
trimethoprim (Table 3.5). However, the resistance to other antimicrobials was not 
uniformly distributed among the isolates studied.  
Resistance to tetracycline was very high as overall 63% isolates were tetracycline 
resistant. Year wise tetracycline resistance data showed that tetracycline resistance 
increased from zero to 96.5% during the three year period. In 2009 all three isolates 
(BH11, BH20 and BHJ) tested for antimicrobial susceptibility were sensitive to 
tetracycline. However, during 2010 and 2011, tetracycline effectivity was reduced as 
18.4% and   96.5% isolates were tetracycline resistant respectively. The only two 
tetracycline sensitive isolates, (NP5 and NP6) in 2011 were isolated from district 
Nowshera of Khyber Pakhtunkhwa (Table 3.5). Geographic data of the isolates suggested 
that in 2010, tetracycline resistance was confined to coastal zone of province Sindh as   
7/8 tetracycline resistant isolates belonged to Karachi and only one to Hyderabad. In the 
following year, 2011, almost 97% of the isolates from all over the country were resistant 
to tetracycline.  
Ampicillin was less effective against V. cholerae O1 El Tor during this period. Overall 
19.5% isolates were ampicillin resistant. However, during the study period, a trend of 
increased resistance to ampicillin was observed as the ampicillin resistant O1 El Tor 
constituted 0%, 7.45% and 28% of the O1 El Tor collected during 2009, 2010 and 2011 
respectively (Table 3.5).  
Chloramphenicol resistance in V. cholerae O1 El Tor was low as overall 63% isolates 
were sensitive to chloramphenicol while  only 6.1% isolates showed resistance, most of 
the chloramphenicol resistant isolates belonged to 2009 and 2010 (Table 3.5).  
In fluoroquinolones, susceptibility to ciprofloxacin and ofloxacin was tested. The results 
of this experiment showed 97% of the V. cholerae isolates were susceptible to ofloxacin 
whereas 3% were categorized as intermediate and none of the isolate showed resistance 
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Table 3.4 Antimicrobial susceptibility profiles of V. cholerae O1 El Tor from Pakistan by disc diffusion. 
 
 
Sr. 
 
City  Isolation Date 
(dd/mm/yy) 
Isolate 
ID TE E CAZ C SXT NA CIP AMP S OFX CTX W 
1 Rawalpindi September/2009 BH-11 S I S R R R S I R S S R 
2 Rawalpindi September/2009 BH-20 S I S R R R I I R S S R 
3 Rawalpindi September/2009 BH-J S I S I R R S S R S S R 
4 Peshawar 10/08/2010 P-9 I I S I R R I S R S I R 
5 Peshawar 12/08/2010 P-57 I I I I R R I S R S I R 
6 Peshawar 12/08/2010 P-76 I I I I R R I I R S S R 
7 Peshawar 12/08/2010 P-83 S I S I R R I S R S I R 
8 D I Khan 25/08/2010 D-1 S I I I R R S I R S S R 
9 D I Khan 25/08/2010 D-4 S I I I R R S I R I S R 
10 D I Khan 25/08/2010 D-25 S I I I R R S I R S S R 
11 D I Khan 25/08/2010 D-30 S I S I R R I I R S I R 
12 D I Khan 25/08/2010 D-38 S I S I R R S I R S S R 
13 D I Khan 25/08/2010 D-48 I I S I R R S I R S S R 
14 D I Khan 25/08/2010 D-59 S I S I R R S I R S S R 
15 Nowshera 01/10/2010 DN-4 S I I I R R S I R S S R 
16 Rawalpindi 16/18/2010 RG-6 S I I I R R S I R S S R 
17 Rawalpindi 16/18/2010 RG-11 S I S S R R S I R S I R 
18 Rawalpindi 16/09/2010 R-22 S I S I R R S I R S S R 
19 Rawalpindi 16/09/2010 R-24 S I I I R R S I R S S R 
20 Khairpur 18/10/2010 KPD-3 I I S I R R I S R S I R 
21 Karachi 25/10/2010 KCH-7 R I R S R R I I R S S R 
22 Karachi 25/10/2010 KCH-9 R I R S R R I R R S I R 
23 Karachi 25/10/2010 KCH-10 R I R S R R I I R S I R 
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Sr. 
 
City  Isolation Date 
(dd/mm/yy) 
Isolate 
ID TE E CAZ C SXT NA CIP AMP S OFX CTX W 
24 Karachi 26/10/2010 KCH-15 I I I I R R I I R S S R 
25 Karachi 26/10/2010 KCH-16 R I I S R R I I R S I R 
26 Karachi 26/10/2010 KCH-17 R I I S R R I I R S S R 
27 Karachi 26/10/2010 KCH-18 I I R I R R I I R S I R 
28 Karachi 27/10/2010 KCH-20 R I R S R R I R R S I R 
29 Jamshoro 29/10/2010 KTH-2 I I S R R R I I R S I R 
30 Jamshoro 29/10/2010 KTH-3 I I S I R R I S R S I R 
31 Jamshoro 29/10/2010 KTH-4 I I S I R R I I R S I R 
32 Jamshoro 29/10/2010 KTH-6 S I S I R R I I R S S R 
33 Jamshoro 29/10/2010 KTH-7 I I S I R R I S R S I R 
34 Hyderabad 29/10/2010 HH-1 S I S I R R I I R S I R 
35 Hyderabad 29/10/2010 HH-3 I I S I R R R I R S I R 
36 Hyderabad 29/10/2010 HH-4 I I R I R R I I R S I R 
37 Hyderabad 29/10/2010 HH-5 I I I I R R I I R I R R 
38 Hyderabad 29/10/2010 HH-14 I I R I R R I I R S I R 
39 Hyderabad 29/10/2010 HH-15 I I S I R R I I R S I R 
40 Hyderabad 29/10/2010 HH-17 S I I R R R I R R S I R 
41 Hyderabad 29/10/2010 HH-18 R I S I R R I I R S I R 
42 Charsada 09/08/2011 CS-1 R I S S R R I R R S S R 
43 Charsada 09/08/2011 CS-12 R I S S R R S I R S S R 
44 Charsada 09/08/2011 CS-15 R I S S R R S S R S S R 
45 Charsada 09/08/2011 CS-16 R I S S R R S I R S S R 
46 Charsada 09/08/2011 CS-18 R I S S R R I  R R S S R 
47 Peshawar 11/08/2011 PS-7 R I S S R R S I R S S R 
48 Peshawar 11/08/2011 PS-18 R R S S R R I I R S S R 
49 Peshawar 11/08/2011 PS-25 R I S S R R I I R S S R 
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Sr. 
 
City  Isolation Date 
(dd/mm/yy) 
Isolate 
ID TE E CAZ C SXT NA CIP AMP S OFX CTX W 
50 Peshawar August/2011 769 R I S S R R S R R S S R 
51 Nowshera 13/08/2011 N-5 R I S S R R I I R S S R 
52 Nowshera 13/08/2011 N-7 R I S S R R I I R S S R 
53 Nowshera 13/08/2011 N-10 R I S S R R I I R S S R 
54 Nowshera 13/08/2011 NP-3 R I S S R R S R R S S R 
55 Nowshera 13/08/2011 NP-5 S I S R R R S I R S S R 
56 Nowshera 13/08/2011 NP-6 S I S R R R S S R S S R 
57 Nowshera 13/08/2011 NP-7 R I S S R R S I R S S R 
58 Nowshera 13/08/2011 NP-14 R I S S R R S R R S S R 
59 Swabi August/2011 770 R I S S R R S R R S S R 
60 Larkana August2011 751 R I S S R R I I R S S R 
61 Larkana August/2011 759 R I S S R R S I R S S R 
62 Larkana August/2011 760 R I S S R R S I R S S R 
63 Badin August/2011 754 R I S S R R S S R S S R 
64 Dadu August/2011 756 R I S S R R I R R S I R 
65 Sanghar August/2011 758 R I S S R R S S R S S R 
66 Sukkur August/2011 763 R R S S R R I R R S I R 
67 Zoab August/2011 753 R I S S R R S I R S S R 
68 Chamman August/2011 750 R I S S R R S R R I I R 
69 Murree 19/07/2011 703 R I S S R R S R R S S R 
70 Murree 19/07/2011 709 R I S S R R S I R S S R 
71 Murree 19/07/2011 719 R I S S R R I R R S S R 
72 Murree 20/07/2011 722 R I S S R R I I R S S R 
73 Murree 20/07/2011 729 R I S S R R I I R S S R 
74 Murree 20/07/2011 732 R I S S R R S S R S S R 
75 Murree 21/07/2011 736 R I S S R R S I R S S R 
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Sr. 
 
City  Isolation Date 
(dd/mm/yy) 
Isolate 
ID TE E CAZ C SXT NA CIP AMP S OFX CTX W 
76 Murree 21/07/2011 739 R I S S R R S R R S S R 
77 Murree 21/07/2011 742 R I S S R R I R R S S R 
78 Rawalpindi 08/08/2011 F-5 R I S S R R I I R S S R 
79 Rawalpindi 08/08/2011 F-6 R I S S R R S I R S S R 
80 Rawalpindi August/2011 764 R I S S R R I I R S S R 
81 Rawalpindi August/2011 767 R I S S R R I I R S S R 
82 Attock 31/07/2011 A-4 R I S S R R S I R S S R 
83 Rahimyar Khan August/2011 755 R I S S R R S I R S S R 
84 Bahawalnagar August/2011 757 R I S S R R S I R S S R 
85 Chakwal August/2011 765 R I S S R R S I R S S R 
86 Qasoor August/2011 761 R I S S R R I R R S S R 
87 Chiniot August/2011 BW-5 R I S S R R I I R S S R 
88 Sialkot August/2011 773 R I I S R R S I R S S R 
89 Multan August/2011 771 R I S S R R I I R S S R 
90 Multan August/2011 772 R I S S R R S I R S S R 
91 Okara August/2011 776 R I S S R R S I R S S R 
92 Kamalia August/2011 775 R I S S R R S S R S S R 
93 Islamabad August/2011 768 R I S S R R I I R S S R 
94 Islamabad August/2011 774 R I S S R R S I R S S R 
95 Gilgit Baltistan 01/08/2011 GB-39 R I S S R R S I R S S R 
96 Muzaffargarh August/2011     752 R I S S R R S R R S S R 
97 Muzaffarabad August/2011     762 R R S S R R I R R S I R 
AMP: ampicillin (10 µg), C: chloramphenicol (30 µg), CIP: ciprofloxacin (5 µg), CTX: cefotaxime (30 µg),CAZ: ceftazidime (30 µg),E: 
erythromycin (15 µg),NA: nalidixic acid (30 µg),OFX: ofloxacin (5 µg), S: streptomycin (10 µg), SXT: sulfamethoxazole / trimethoprim 
(23.71/1.25 µg),W: trimethoprim (25 µg),TE: tetracycline (30 µg). 
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Table 3.5 Year-wise response of V. cholerae O1 El Tor to different antibiotics. 
Antibiotic 2009 (n=3) 2010 (n=38) 2011 (n=56) Overall (n=97) 
R I S R I S R I S R I S 
Tetracycline 0      0 100 18.4 42.1 39.4 96.4 0 3.6 63 17 20 
Erythromycin 0 100 0 0 100 0 3.6 96.4 0 2 42 56 
Ceftazidime 0 0 100 18.4 34.2 47.3 0 1.8 98.2 7.2 14.4 78.3 
Chloramphenicol 66.6 33.3 0 5.2 76.3 18.4 3.6 0 96.4 6 31 63 
Trimethoprim 100 0 0 100 0 0 100 0 0 100 0 0 
Ciprofloxacin 0 33.3 66.6 2.6 68.4 28.9 0 39.2 60.7 1 50.5 48.4 
Sulfamethozol-T 100 0 0 100 0 0 100 0 0 100 0 0 
Streptomycin 100 0 0 100 0 0 100 0 0 100 0 0 
Ofloxacin 0 0 100 0 5.2 94.7 0 108 98.2 0 3 97 
Nalidixic acic 100 0 0 100 0 0 100 0 0 100 0 0 
Cefotaxime 0 0 100 2.6 57.9 39.5 0 7.14 92.8 1 27 72 
Ampicillin 0 66.6 33.3 7.9 76.3 15.8 28.6 60.7 10.7 19.5 67 13.4 
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to ofloxacin. In case of ciprofloxacin which is one of the antibiotics used in for cholera 
treatment, one percent isolates were resistant while those having intermediate resistance 
and susceptible were 50.5% and 48.4% respectively (Table 3.5).  
7.1% of V. cholerae O1 El Tor isolates were resistant to ceftazidime while the 
intermediate and sensitive isolates were 14.4% and 78.3% respectively. All the 
ceftazidime resistant isolates were collected during 2010 from different parts of Pakistan 
whereas most of the sensitive isolates were collected during 2009 and 2011. Only 1% 
isolates were resistant to cefotaxime while 72% and 27% were sensitive and intermediate 
resistant to the drug respectively. The only cefotaxime resistant isolate (HH4) was 
collected from Hyderabad, Sindh during 2010. Year wise susceptibility profile of 
cefotaxime showed that in 2009 and 2011 almost all O1 El Tor were sensitive while in 
2010 the sensitive isolates constituted 39.4% of the isolates. (Table 3.5).  
Erythromycin which is also prescribed to treat cholera, the majority of the V. cholerae O1 
El Tor i.e, 98% were categorized as intermediately resistant whereas 2% isolates were 
characterized as resistant. The resistant erythromycin resistant isolates (NP5 and NP6) 
were retrieved from cholera patients in Nowshera, Khyber Pakhtunkhwa during 2011 
(Table 3.5).  
3.7 Genotypic characterization of antimicrobial resistance 
The genetic basis of antibiotic resistance in V. cholerae O1 El Tor isolates was explored 
by different PCRs. The integrative and conjugative element (ICE) SXT which carries 
genes to encode resistance to certain antibiotics was detected by amplifying the integrase 
(SXTint), it was uniformly present in all O1 El Tor isolates from Pakistan (Figure 3.22).  
The resistance to sulphonamides was found to be due to the presence of sul2 gene in all 
V. cholerae O1 El Tor while sul1 and sul3 were not detected in any of the El Tor isolate 
from Pakistan (Figure 3.23).  
dfrA1 (encoding trimethoprim resistance) was present in all El Tor isolates while dfrA18 
was absent in the isolates investigated during the current study. strA and strB which 
encode resistance to streptomycin were detected in all the isolates (Figure 3.24) (Table 
3.4).  
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 florR conferring chloramphenicol resistance was detected in only 10 isolates. In 2011, it 
was detected only in four isolates, whereas in 2010 and 2009 floR was detected in higher 
proportions (results not shown). However, the phenotypic antimicrobial susceptibility 
testing revealed very low resistance to chloramphenicol (Table 3.4 and 3.6).  
Tetracycline resistance encoding gene tetR was detected in vast majority of the isolates 
(Table 3.6) and its presence was in agreement with the phenotypic results of tetracycline 
resistance as we also observed the same pattern (results not shown).  
3.7.1 Absence of integrons 
For identification and detection of the class 1, class 2 and class 3 integron, PCR was 
performed which could not amplify the consensus sequence of the integrases of all the 
three classes of integrons, thereby, showing that integrons were absent in all V. cholerae 
O1 El Tor isolates from Pakistan (Table 3.6).  
3.7.2 Absence of quinolones resistance genes 
PCR was performed to detect quinolones resistance encoding genes qnrA, qnrB and qnrS 
which resulted in negative outcome for the presence of the quinolones resistance 
encoding elements in any of the V. cholerae O1 El Tor isolates (Table 3.6). 
3.7.3 Resistance mutations in gyrA and parC 
The sequence of the gyrA and parC were taken from WGS data of the isolates, which 
showed that all the 97 V. cholerae O1 El Tor isolates collected during 2009 to 2011 have 
point mutations in the respective quinolone resistance determining regions (QRDRs) of 
gyrA and parC. In gyrA a transversion (underlined) of G to T in codon 83 (AGT) 
substituted isoleucine for serine whereas in parC a transversion (underlined) of C to T in 
codon 85 (TCG) substituted leucine for serine (Figure 3.25 and Figure 3.26).  
On the basis of antibiotic resistance encoding elements, two genotypic profiles were 
observed in the V. cholerae O1 El Tor from Pakistan collected during 2009 to 2011 
(Table 3.6).  
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Figure 3.22 SXTint detection in V. cholerae O1 El Tor isolates. 
M, 100 bp DNA ladder and NC is PCR control. Other lanes showing amplification of SXTint in 
the representative V. cholerae O1 El Tor isolates collected during this study, 2009-11.  
 
 
Figure 3.23 Detection of sul2 in V. cholerae O1 El Tor isolates from Pakistan. 
M, 100 bp DNA ladder and NC is PCR control. Other lanes showing that representative V. 
cholerae O1 El Tor isolates collected during this study, 2009-11, carry sul2 to encode 
sulfamethoxazole resistance (sul1 and sul3 results not shown). 
 
 
Figure 3.24 Amplification of strB in V. cholerae O1 El Tor isolates from Pakistan. 
M, 100 bp DNA ladder and NC is PCR control. Other lanes showing the presence of strB 
encoding streptomycin resistance in V. cholerae O1 El Tor isolates collected during the current 
study, 2009-11 (strA resuls not shown). 
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Figure 3.25 Amino acid sequence alignment of gyrase A of V. cholerae O1 El Tor from Pakistan by using MEGA 6.0. 
The amino acid sequence alignment of GyrA of V. cholerae O1 El Tor from Pakistan isolated during 2009 to 2011 with V. cholerae 
O1 El Tor N16961 showing substitution of serine (S) by isoleucine (I) at 83 amino acid position. Identical amino acids are 
 represented by dots. 
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Figure 3.26 Amino acid sequence alignment of ParC of V. cholerae O1 El Tor from Pakistan. 
The amino acid sequence alignment of ParC of V. cholerae O1 El Tor from Pakistan isolated during 2009 to 2011 with V. cholerae O1 El Tor 
N16961 by MEGA 6.0 showing substitution of serine (S) by Leucine (L) at 85 amino acid position. Identical amino acids are represented by dots. 
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 Table  3.6  Genotypic characterization of antibiotic resistance in V. cholerae O1 El Tor. 
a= 2009; b= 2010; c= 2011 
Genotypic 
Resistance Profile 
(GRP) 
No. Vibrio 
cholerae O1 El 
Tor 
Antimicrobial 
resistance encoding 
genes present 
Antimicrobial 
resistane encoding 
elements not detected 
gyrA mutation parC mutation 
GRP-1 4
a
, 31
b
, 2
c
 SXT, sul2, drfA1, strA, 
strB, florR 
intI, int2, int3, qnrA, 
qnrB, qnrS, sul1, sul3, 
dfrA18, tetA, tetR 
+ + 
GRP-2 7
b
, 54
c
 SXT, sul2, dfrA1, strA, 
strB, tetA, tetR 
int1, int2, int3, qnrA, 
qnrB, qnrS, sul1, sul3, 
dfrA18, florR 
+ + 
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3.8 MLVA 
For multilocus variable number of tandem repeats (VNTRs) analysis (MLVA), five loci 
VC0147, VC0436-7, VC1650, VCA0171 and VCA0283 were amplified by PCR. The 
first four loci were amplified in all isolates whereas locus VCA0283 of chromosome 2 
was not present in four isolates (739, F6, 764 and 765) from Murree, Rawalpindi and 
Chakwal in Punjab province isolated during 2011. The PCR amplicons for these loci 
varied in size as expected, generally depending on the number of the repeats.  
The alleles to different loci were given depending on the number of repeats at a locus. 
The alleles of different loci observed in the isolates are mentioned in the Table 3.7. 
Overall 39 alleles were found for these five loci. The number of alleles ranged from 4 to 
13. The lowest number of allelic forms were observed in VC0147, VC0436-7 and 
VC1650 loci located on the large chromosome whereas the loci on the small chromosome 
VCA0171 and VCA0283 generated much diversity having 10 and 13 alleles respectively 
(Table 3.8).  
Total 44 sequence types (STs) were found to represent the VNTR analysis of the V. 
cholerae O1 El Tor isolates from Pakistan. Each ST represented a unique combination of 
all the alleles of five loci present in an isolate. The smallest sequence type (ST) 
comprised of only one isolate while the largest sequence type, ST27 comprised of 19 
isolates (Table 3.9). From the year wise analysis, it was found that the VNTR diversity 
was high during the year 2010 while it was less in 2011 (Table 3.10).  
The clonal relationship among the V. cholerae O1 El Tor isolates collected during 2009 -
11 was determined by MLVA protocol using eBURST and Phyloviz softwares (Feil et 
al., 2004; Francisco et al., 2012). A clonal complex was defined as a cluster of sequence 
types which differ from each other by a single allele change at one locus only. By this 
approach, a total of six clonal complexes (CCs) and three singletons were generated by 
eBURST and Phyloviz using geoBURST algorithm (Figure 3.27 and 3.28A). These 
included four large CCs containing 22, 7, 4, and 4 STs  respectively, while two smaller 
groups consisting two STs each and three singletons consisting of a single ST which were 
not related to any of the clonal complexes. Generally, the El Tor isolates of 2011 (year) 
had higher number of repeats than 2010 (year) isolates in all three loci of chromosome 1.   
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      Table 3.7 Alleles of different VNTR loci in V. cholerae O1 El Tor. 
Chromosome  Loci VNTR repeat Alleles 
1 VC0147 AACAGA 7 
 VC0436-7 GACCCTA 5  
 VC1650 GATAATCCCA 04 
2 VCA0171 TGCTGT 11 
 VCA0283 ACCAGA 14 
 
 
 
           Table 3.8 Clonal complexes of V. cholerae O1 El Tor based on sequence types.  
Clonal Group Sequences Types  
(STs) 
No. of V. cholerae O1 
El Tor 
1 22 58 
2 7 21 
3 4 6 
4 4 4 
5 2 3 
6 2 2 
03 Singletons 3 4 
 Total: 44 Total: 98 
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Table 3.9 Variable number of tandem repeats profile of V. cholerae O1 El Tor isolates from Pakistan.  
Province City  Isolation 
Date 
Isolate ID VC0147 VC0436-7 VC1650 VCA0171 VCA0483 Sequence 
Type (ST) 
Clonal 
Complex 
Punjab Rawalpindi 2009 BH11 8 3 6 14 13 ST1 V 
Punjab Rawalpindi 2009 BH20 11 3 6 14 12 ST2 I 
Punjab Rawalpindi 2009 BHJ 8 3 6 13 12 ST3 I 
Punjab Rawalpindi 2009 BHA 11 3 6 13 12 ST4 I 
Punjab Rawalpindi 2010 RG6 5 3 4 6 5 ST5 II 
Punjab Rawalpindi 2010 RG11 5 3 4 6 5 ST5 II 
KPK Peshawar 2010 P9 8 3 6 10 16 ST6 IV 
KPK Peshawar 2010 P57 7 3 6 9 15 ST7 Singleton 
KPK Peshawar 2010 P76 7 3 6 11 10 ST8 III 
KPK Peshawar 2010 P83 7 3 6 11 18 ST9 III 
KPK DI Khan 2010 D1 7 3 6 11 10 ST8 III 
KPK DI Khan 2010 D4 8 3 6 9 8 ST10 IV 
KPK DI Khan 2010 D25 8 3 6 10 8 ST11 IV 
KPK DI Khan 2010 D30 5 3 4 7 5 ST12 II 
KPK DI Khan 2010 D38 5 3 4 6 5 ST5 II 
KPK DI Khan 2010 D48 5 3 4 7 5 ST12 II 
KPK DI Khan 2010 D59 5 3 4 7 5 ST12 II 
Punjab Rawalpindi 2010 R22 5 3 4 6 5 ST5 II 
Punjab Rawalpindi 2010 R24 5 3 4 7 6 ST13 II 
KPK Nowshera 2010 DN4 5 3 4 6 5 ST5 II 
Sindh Khairpur 2010 KPD3 5 3 4 7 6 ST13 II 
Sindh Karachi 2010 KCH7 5 4 4 6 5 ST14 II 
Sindh Karachi 2010 KCH9 9 7 7 12 10 ST15 VI 
Sindh Karachi 2010 KCH10 9 7 7 12 10 ST15 VI 
Sindh Karachi 2010 KCH15 6 3 5 8 7 ST16 Singleton 
Sindh Karachi 2010 KCH16 5 5 4 7 5 ST17 II 
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Province City  Isolation 
Date 
Isolate ID VC0147 VC0436-7 VC1650 VCA0171 VCA0483 Sequence 
Type (ST) 
Clonal 
Complex 
Sindh Karachi 2010 KCH17 9 7 7 11 10 ST18 VI 
Sindh Karachi 2010 KCH18 5 3 4 7 5 ST12 II 
Sindh Karachi 2010 KCH20 8 7 6 9 8 ST19 IV 
Sindh Jamshoro 2010 KTH2 7 3 6 11 9 ST20 III 
Sindh Jamshoro 2010 KTH3 5 3 4 7 5 ST12 II 
Sindh Jamshoro 2010 KTH4 6 3 5 8 7 ST16 Singleton 
Sindh Jamshoro 2010 KTH6 5 3 4 7 5 ST12 II 
Sindh Jamshoro 2010 KTH7 5 3 4 7 5 ST12 II 
Sindh Hyderabad 2010 HH1 5 3 4 6 6 ST21 II 
Sindh Hyderabad 2010 HH3 7 3 5 9 7 ST22 Singleton 
Sindh Hyderabad 2010 HH4 5 3 4 6 5 ST5 II 
Sindh Hyderabad 2010 HH5 5 3 4 7 5 ST12 II 
Sindh Hyderabad 2010 HH14 7 3 6 11 10 ST5 III 
Sindh Hyderabad 2010 HH15 6 3 6 11 10 ST23 III 
Sindh Hyderabad 2010 HH17 5 3 4 7 5 ST12 II 
Sindh Hyderabad 2010 HH18 5 4 4 7 5 ST24 II 
KPK Peshawar 2011 PS7 11 7 7 14 13 ST25 I 
KPK Peshawar 2011 PS18 11 6 7 14 12 ST26 I 
KPK Peshawar 2011 PS25 11 7 7 13 12 ST27 I 
KPK Peshawar 2011 769 11 7 7 14 10 ST28 I 
KPK Nowshera 2011 N5 11 7 7 14 12 ST29 I 
KPK Nowshera 2011 N7 11 7 7 13 12 ST27 I 
KPK Nowshera 2011 N10 11 7 7 13 12 ST27 I 
KPK Nowshera 2011 NP3 11 7 7 15 13 ST30 I 
KPK Nowshera 2011 NP5 11 7 6 15 13 ST31 I 
KPK Nowshera 2011 NP6 7 3 6 14 13 ST32 V 
KPK Nowshera 2011 NP7 5 7 7 15 13 ST33 I 
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Province City  Isolation 
Date 
Isolate ID VC0147 VC0436-7 VC1650 VCA0171 VCA0483 Sequence 
Type (ST) 
Clonal 
Complex 
KPK Nowshera 2011 NP14 10 7 7 13 12 ST34 I 
KPK Charsada 2011 CS1 11 6 7 15 13 ST35 I 
KPK Charsada 2011 CS12 11 6 7 14 12 ST26 I 
KPK Charsada 2011 CS15 11 7 7 14 12 ST29 I 
KPK Charsada 2011 CS16 11 7 7 13 12 ST27 I 
KPK Charsada 2011 CS18 11 7 7 13 12 ST27 I 
KPK Swabi 2011 770 11 7 6 13 11 ST36 I 
Sindh Larkana 2011 751 11 7 7 14 13 ST25 I 
Sindh Larkana 2011 759 11 7 7 13 12 ST27 I 
Sindh Larkana 2011 760 11 7 7 15 13 ST30 I 
Sindh Badin  2011 754 11 7 7 13 12 ST27 I 
Sindh Dadu 2011 756 11 7 7 14 12 ST29 I 
Sindh Sanghar 2011 758 11 7 7 14 13 ST25 I 
Sindh Sukkur 2011 763 11 7 7 13 12 ST27 I 
Baluchistan Zoab 2011 753 11 7 7 13 12 ST27 I 
Baluchistan Chamman 2011 750 11 7 7 15 13 ST30 I 
Punjab Murree 2011 703 11 7 7 15 11 ST37 I 
Punjab Murree 2011 709 11 7 7 14 13 ST25 I 
Punjab Murree 2011 719 11 7 7 13 12 ST27 I 
Punjab Murree 2011 722 11 7 7 12 11 ST38 I 
Punjab Murree 2011 729 11 7 7 14 13 ST25 I 
Punjab Murree 2011 732 11 7 7 13 12 ST27 I 
Punjab Murree 2011 736 10 7 7 14 13 ST39 I 
Punjab Murree 2011 739 11 7 7 14 X ST40 I 
Punjab Murree 2011 742 11 7 7 14 13 ST25 I 
Punjab Rawalpindi 2011 F5 11 7 7 13 12 ST27 I 
Punjab Rawalpindi 2011 F6 11 7 7 14 X ST27 I 
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Province City  Isolation 
Date 
Isolate ID VC0147 VC0436-7 VC1650 VCA0171 VCA0483 Sequence 
Type (ST) 
Clonal 
Complex 
Punjab Rawalpindi 2011 764 11 7 7 14 X ST27 I 
Punjab Rawalpindi 2011 767 11 7 7 13 12 ST40 I 
Federal 
Capital 
Islamabad 2011 768 11 7 7 13 12 ST40 I 
Federal 
Capital 
Islamabad 2011 774 11 7 7 14 13 ST25 I 
Punjab Attock 2011 A4 11 7 7 14 12 ST29 I 
Punjab Rahimyar 
Khan   
2011 755 11 7 7 15 14 ST41 I 
Punjab Bahawalnagar 2011 757 11 7 7 13 12 ST27 I 
Punjab Chakwal 2011 765 11 7 7 14 X ST40 I 
Punjab Qasoor 2011 761 11 7 7 14 13 ST25 I 
Punjab Chiniot 2011 BW5 11 7 7 13 11 ST42 I 
Punjab Sialkot 2011 773 11 7 7 14 11 ST43 I 
Punjab Multan 2011 771 11 7 7 13 12 ST27 I 
Punjab Multan 2011 772 11 7 7 14 13 ST25 I 
Punjab Okara 2011 776 11 7 6 13 12 ST44 I 
Punjab Kamalia 2011 775 11 7 7 15 13 ST30 I 
AJK Muzaffarabad 2011 762 11 7 7 13 12 ST27 I 
Galgit 
Baltistan 
Galgit 2011 GB39 11 7 7 14 12 ST29 I 
Punjab Muzaffargarh 2011 752 11 7 7 13 12 ST27 I 
99 
 
 
3.8.1 Clonal complex 1  
 The first group was the biggest group which contained 22 STs comprising 58 (59%) 
isolates analysed. The CC1 also contained the ST40 which included all four isolates 
which lacked VC0283 locus, the allele profile of this ST was 11,7,7,14,X. Most of the 
genotypes in this group were isolated during 2011 from different part of Pakistan (Figure 
3.28A). This group contained 22 STs among them the major STs consisted of 18, 9 and 5 
isolates respectively while many single isolate STs were also present in this group. CC1, 
ST40 V. cholerae isolated in 2011 belonged to this group, and 3 out of 4 isolates of 2009 
and none of isolates of 2010 period was present in clonal complex 1.  
3.8.2 Clonal complex 2   
This group consisted of 21 out of 38 isolates of 2010 as this exclusively represented the 
STs of both flood affected and non-flood affected cities in 2010 (Figure 3.28A ). CC2 
comprised of seven STs among them two major STs, ST12 and ST5, represented 12 and 
05 isolates respectively. Group 2 was characterized by its distinct MLVA profiles, 5,3,4, 
X,X; 5,4,4,X,X and  5,5,4,X,X, as well as by lower number of repeats in all the five loci 
particularly in VCA0171 and VCA0283 which usually have more diversity with higher 
number of tandem repeats.  
3.8.3 Clonal complexes 3 and 4  
Both these CCs represented four STs each, however CC3 overall related six isolates 
whereas CC4 had four isolates. Similarly like CC2, CC3 and CC4 also represented the 
O1 El Tor V. cholerae isolates of 2010 (Figure 3.27 and 3.28A). However, the number of 
repeats among the members of CC3 and CC4 at different loci was more than those in 
CC2. The major allele profiles for CC3 and CC4 were 8,3,6,X,X and 9,7,7,X,X 
respectively. 
3.8.4 Singletons 
All three singletons belonged to 2010 El Tor isolates from Jamshoro, Hyderabad and 
Karachi in Sindh, highlighting the diversity of El Tor isolates in the respective year.  
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Minimum spanning tree was constructed by using Phyloviz software which linked all the 
clonal complexes and singletons (figure 3.28B). Signature gene deletions (tagA and aldA) 
in VPI-1 as well characteristic antibiotic resistance pattern divided all O1 El Tor isolates 
from Pakistan in two groups (Table 3.6) and (Figure 3.27). However, in MLVA analysis, 
the clonal complexes did not reflect such divide (Figure 3.28A and B).  
 
Multi locus variable number of tandem repeat analysis (MLVA) and virulence and 
genotypic resistance profiles: 
In MLVA, the clonal complexes to some extent related the V. cholerae O1 El Tor isolates 
collected from different cities of Pakistan during 2009 – 2011. However, all the 98 O1 El 
Tor isolates were categorized in two virulence profiles (VP-1 and VP-2) and genotypic 
resistance profiles (GRP-1 and GRP-2) on the basis of virulence and drug resistance 
characterization tests respectively. The composition of CCs was independent of this 
grouping. CC-2 and 4 exclusively represented the VP-1 and GRP-1 isolates while clonal 
complex 5 (CC5) also consisted 3/4 O1 El Tor isolates of VP-1 and GRP-1 collected 
during 2010 (Figure 3.28A). CC-1 mostly related the El Tor isolates of 2011 belonging to 
VP-2 and GRP-2.  
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Table 3.10 Distribution of STs during 2009-2011. 
Year  STs Isolates 
2009 4 4 
2010 20 38 
2011 20 56 
  Total: 98 
 
 
 
 
Figure 3.27 Clonal complexes of V. cholerae O1 El Tor by using eBURST.  
Six clonal complexes and 03 singletons relating 98 clinical V. cholerae O1 El Tor isolates from 
Pakistan during 2009-11.  Red, yellow and black nodes are representing group founder, sub-group 
founder and other STs in a clonal complex. The size of the node is proportional to the number of 
isolates a ST is representing whereas solid lines are representing single locus variants. 
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Figure 3.28 Clonal Complexes and minimum spanning tree of V. cholerae O1 El Tor by 
using geoBURST algorithm. 
A. Six clonal complexes and three singletons based on single locus variant representing O1El Tor 
isolated from cholera patients in Pakistan during 2009-2011. B. Minimum spanning tree based on 
MLVA analysis of V. cholerae O1 El Tor.  The circle represents the virulence profile (VP), 
genotypic resistance profile (GRP) and year of isolation of the isolates and size of depends on the 
size of the ST. 
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3.9 Whole genome sequencing 
Vibrio cholerae O1 El Tor isolates obtained during 2009–2011 were sequenced by 
Illumina sequencing platform. Based on the genome wide single nucleotide 
polymorphisms (SNPs), the phylogeny was studied by high-resolution maximum 
likelihood phylogenetic tree comparing about 146 genomes of V. cholerae around the 
world collected during the last 80 years. The sequences of the isolates were mapped to 
the reference genome of V. cholerae O1 El Tor strain N16961 (isolated from Bangladesh, 
1975, accession number AE003852-3). 
The phylogenetic tree of the V. cholerae from Pakistan and other global and temporal 
representative El Tor strain revealed that the Pakistan cholera isolates formed two 
contemporary sub-clades (PSC-1 and PSC-2) which had originated from different points 
in the third wave of the current seventh pandemic category of cholera (Figure 3.29). 
Overall 37 (38%) isolates belonged to PSC-2 while 61 (62%) isolates represented PSC-1. 
Yearwise prevalence of the PSCs showed that in 2009 and 2010, PSC-2 was the 
dominant of the two sub-clades as it contained 100% and 82% El Tor isolates in the two 
years respectively whereas PSC-1 dominated in 2011 (Figure 3.30). PSC-1 which 
consisted only 18% (07/38) isolates in 2010 belonging to the coastal city of Karachi (6/7) 
and its neighbouring city, Hyderabad (1/7) (Figure 3.31), however in 2011, this PSC-1 
became the most prevalent as it represented 54/56 (96.4%) isolates from all over Pakistan 
whereas PSC-2 included only 2/56 (3.6%) isolates (Figure 3.30 and Figure 32). 
Geographic distribution of the sub-clades showed that PSC-2 was existing in 2009 and 
2010 from flood affected and non-flood affected areas of Pakistan while PSC-1 which 
appeared in 2010 and almost replaced PSC-2 in the following year, 2011 (Figure 3.30). 
After removing genomic recombination site, 1,826 variable sites in genome defined 
diversity in the El Tor global phylogeny. Based on the basis of this site, both PSCs were 
distinguished from their ancestors in the third wave of cholera transmission by only 12 
(PSC-1) and 22 (PSC-2) SNPs respectively. Among the sub-clades the isolates were 
closely related, with only four and 76 SNPs within PSC-1 and PSC-2 respectively.  
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Figure 3.29 SNP based maximum –liklihood phylogeny of V. cholerae O1 El Tor from 
Pakistan. 
SNP-based-maximum likelihood phylogeny position categorizing O1 El Tor isolates from 
Pakistan into two sub-clades (PSC-1 and PSC-2) of  the third wave of the current seventh cholera  
pandemic relative to a global collection of 146 V. cholerae isolates from  Asia, Africa, South 
America, and Germany (Shah et al., 2014).  
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Figure 3.30 Prevalence of PSC-1 and PSC-2 in Pakistan during 2009-2011. 
The figure shows that prevalence of PSC-1 increased from 2010-2011, however PSC-2 
showed a decreasing trend of prevalence during 2009-2011 in Pakistan.  
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Figure 3.31 Geographic distribution of PSC-1 and PSC-2 in Pakistan during 2009-2010. 
The figure shows that in 2009 and 2010, PSC-2 was present in majority of the cities in 
Pakistan whereas PSC-1 appeared only in Karachi and Hyderabad. 
 
Figure 3.32 Dominance of PSC-1 over PSC-2 in Pakistan during 2011. 
The North oriented map of Pakistan shows that during 2011 PSC-1 was dominant and 
geographically distributed in all the provinces of Pakistan whereas PSC-2 existing only in 
Nowshera.
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In an earlier study, the genomic variations in the seventh pandemic V. cholerae O1 El Tor 
were determined to follow a clock-wise rate (Mutreja et al., 2011). Thus, we also 
analysed the PSC-1 and PSC-2 isolates by regression analysis to calculate the SNP 
accumulation rate based on date of isolation and geographic location and the root-to-tip 
distances. The results showed a strong and statistically significant relationship when the 
root to tip distances of the PSCs isolates were plotted against the isolation date and 
geographic position. The observed phylogeographic correlation between mutation rate 
and isolation date, confirmed that isolates of both PSCs isolated earlier were close to the 
root of PSCs whereas those isolated after them were away from the root (R
2
=0.27, p < 
0.001) (Figure 3.33). The monthly and annual SNP accumulation rate of the Pakistan V. 
cholerae isolates were 0.288 SNPs and 3.45 SNPs respectively were in agreement with 
the 3.3 SNPs/year of the global collection of seventh pandemic cholera strains calculated 
earlier (Mutreja et al., 2011).  
The analysis V. cholerae O1 El Tor isolated during 2010 showed that the PSC-2 isolates 
collected in the late July and August had shorter root-to-tip distances from the nearby 
locations of the Indus River in Peshawar, Nowshera, D I Khan and Rawalpindi in the 
north of Pakistan.  
While the V. cholerae O1 collected from Khairpur, Jamshoro, Hyderabad and Karachi 
from the southern Pakistan. The root to tip phylogenetic tree distance plot of the PSC-2 
sub-clade from the source of the river Indus confirmed this relationship (R
2
=0.35, p < 
0.001) (Figure 3.34). The observed pattern was consistent with the origins and 
progression of the 2010 floods, which started in the end of July and progressed through 
the Indus river southwest passing through Nowshera, D I Khan, Jamshoro and Hyderabad 
in August.  
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Figure 3.33 A scatter plot of root-to-tip distance vs. isolation date for PSC-1 and PSC-2 
combined during 2010 (Shah et al., 2014). 
 
 
 
Figure 3.34 A scatter plot of root-to-tip distance vs. distance from the Indus river source for 
PSC-2 during 2010 (Shah et al., 2014) 
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3.9.1 Sub-clade signature genomic deletions: 
The whole genome sequence (WGS) analysis of the Pakistan cholerae isolates showed 
that both Pakistan sub-clades (PSCs) were distinguished from each other by sub-clade 
specific deletions particularly in the Vibrio pathogenicity island-1 (VPI-1) and Vibrio 
seventh pandemic-2 (VSP-2) which may have role in the relative virulence and 
transmission of the sub-clades. 
All the PSC-1 isolates had a unique three-gene deletion (VC0810-0821) in the Vibrio 
pathogenicity island-1 (VPI-1). These deleted genes encoded for aldehyde dehydrogenase 
(aldA), ToxR regulated gene A (tagA) and a hypothetical protein (Figure 3.35). The other 
sub-clade specific deletion included four genes (VC0495-0498) of VSP-2 (Figure 3.36). 
This four gene deletion in VSP-2 was also reported among Bangladesh cholera outbreak 
strains in 2004 (Pang et al., 2007).  
In contrast, all PSC-2 isolates had intact Vibrio pathogenicity island-1 (VPI-1), however, 
they had a frame shift mutation in the acfC, accessory colonizing factor (VC0841). The 
VSP-2 in PSC-2 was characterized by a large 18 gene deletion (VC0495-0512) which has 
also been reported from strains causing epidemic in Haiti and other parts (Figure 3.3).  
3.9.2 Sub-clade specific antimicrobial resistance  
The antimicrobial microbial resistance patterns of Pakistan V. cholerae O1 El Tor isolates 
possessed sub-clade signature antibiotic resistance. As all the PSC-1 isolates showed 
tetracycline resistance by disc diffusion while all PSC-2 were sensitive to tetracycline. 
Further, this sub-clade specific tetracycline resistance was confirmed at genomic level as 
all PSC-1 carried tetA and tetR which play role as efflux pump to help in tetracycline 
resistance while all the PSC-2 isolates did not carry the genes encoding tetracycline 
resistance.  
Similarly , in the V. cholerae O1 El Tor collection, all six chloramphenicol resistant 
isolates belonged to PSC-2 , however all the PSC-2 isolates carried florR gene to encode 
for chloramphenicol resistance. florR was not detected in the PSC-1 isolates.  
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Figure 3.35 Signature deletion in VPI-1 of PSC-1 isolates. 
Alignment of VPI-1 of PSC-1 isolate and V. cholerae O1 El Tor N16961 by using Artemis Comparative Tool (ACT) showing a unique three gene 
deletion (VC0819-VC0821) in  a representative PSC-1 isolate. 
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Figure 3.36 A four gene deletion in VSP-2 of PSC-1 isolates. 
Alignment of VSP-1 of PSC-1 isolate and V. cholerae O1 El Tor N16961 by using Artemis Comparative Tool (ACT) showing four gene 
(VC0495-VC0498) deletion in a representative PSC-1 isolate. 
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Figure 3.37 A 18 gene deletion in VSP-2 of PSC-2 isolates. 
Alignment of VSP-1 of PSC-2 isolate and V. cholerae O1 El Tor N16961 by using Artemis Comparative Tool (ACT) showing a large 18 gene 
(VC0495-VC0512) deletion in a representative PSC-2 isolate. 
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3.9.3 Pakistan sub-clades (PSCs) in 2013 and future 
From the WGS analysis of the O1 El Tor isolates of 2009-2011, both the PSCs were 
distinguished by signature deletion in VP1-1. Although the V. cholerae O1 El Tor 
isolated in 2013 were not analysed by whole genome sequencing (WGS), however 
based on these PSCs signature, the 2013 El Tor isolates were predicted to be from 
PSC-1 because these also lacked the three genes (VC0819-0821) of VPI-1, which was 
confirmed by performing PCR. Additionally, the tetracycline resistance among the 
2013 O1 El Tor isolates also strengthened this hypothesis.  
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4 Discussion 
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In this study to characterize V. cholerae samples from various sources including 
clinical, drinking water, sewage and fish were collected from different provinces of 
Pakistan during 2009-2011. Prevalence of V. cholerae in different sources including 
clinical, drinking water, fish and sewage was also investigated. The clinical isolates 
were further characterized by phenotypic and genotypic approaches for antimicrobial 
resistance, CTX prophage analysis, multilocus variable number of tandem repeats 
analysis (MLVA), whole genome sequence (WGS) analysis and phylogeny based on 
single nucleotide polymorphisms (SNPs) comparing Pakistan V. cholerae O1 El Tor 
isolates with a collection of 146 El Tor isolates representing temporal and global 
origins.  
Cholera, a severe acute watery diarrhoeal disease, has been responsible for huge loss 
of life in the past and it has affected mankind in different continents. The work of 
Snow and others depicted the association of the disease with contaminated water 
sources, which emphasized the need of clean and safe drinking water (Snow, 1849). 
With the improvement in the sanitary conditions and availability of microbiologically 
safe drinking water to its population by developed countries, cholera has been 
eradicated or very few cases are encountered. However, the disease is still a scourge 
for the under developed and poor countries due to unavailability of clean water and 
hygienic conditions. With these socio-economic conditions, the environmental factors 
or calamities like floods, hurricanes, earthquakes, droughts also affect the incidence or 
in some cases are responsible for cholera epidemics because of disrupted civic 
supplies and mixing of the sewage with water reservoirs of local populations (Hasan 
et al., 2012; Hendriksen et al., 2011; Shah et al., 2014).  
In the last two centuries, seven cholerae pandemics have been reported and most of 
these originated from the Bay of Bengal. The first six pandemics were caused by V. 
cholerae O1 Classical biotype while the current seventh pandemic has been caused by 
El Tor biotype (Barua and Greenough, 1992).  
120 V. cholerae O1 El Tor were isolated from different sources including clinical 
samples, drinking water, sewage and fish. The highest prevalence was from the acute 
watery diarrhoea patients. Looking at the year wise data, the prevalence was highest 
in 2010 when the country was affected by the worst floods in its history and cholera 
was officially reported (WHO, 2011). Under such emergency situation or natural 
disasters the frequency of waterborne diseases increases, the same situation was faced 
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by Haiti when the 2010 earthquake disrupted civic supplies which resulted in about 
half million cholera cases and thousands of deaths (Barzilay et al., 2013). Likewise 
the climatic conditions also affect these waterborne diseases as seen in the 
subcontinent after monsoon, in summer the risk of cholera is increased due to 
favourable survival conditions in the environment (Emch et al., 2008; Lipp et al., 
2002). In 2010, the isolation of V. cholerae was high in flood affected areas as 
compared to sporadic cases from other parts of the country. In 2011, all V. cholerae 
isolates collected were from non-flood affected areas, however some local outbreaks 
in Murree, Nowshera and Charsada were also studied where the isolation rate of V. 
cholerae was higher than other cities. 
V. cholerae isolation from drinking water and fish was less. Only 7.5% samples 
obtained from fish were positive for V. cholerae in contrast to previous reports where 
high prevalence of upto 70% was observed in fish (Senderovich et al., 2010). This 
may be due to the source of the fish because in our case, the fish samples were taken 
from local fish farms. On the other hand, this may be due to the existence of viable 
but non culturable (VBNC) V. cholerae in the environment due to nutrient shortage or 
metabolic activity but cannot be revived on standard laboratory media (Grimes et al., 
1986; Novitsky and Morita, 1977; Xu et al., 1982). The highest prevalence in oceanic 
fish is understandable due to the ubiquitous nature of V. cholerae in the marine 
environment where it has other hosts like crabs, copepods, corals, etc. (Huq et al., 
1983; Perez-Rosas and Hazen, 1988) causing many outbreaks in the past affecting 
different countries (Blake et al., 1980; Lin et al., 1986; Pavia et al., 1987).  
Other environmental sources, like poultry were also examined for V. cholerae to 
understand the mechanism behind cholera spread in the human populations. However, 
none of the poultry sample collected from different cities was found positive for V. 
cholerae in contrast to a study in Bangladesh which showed its significant prevalence 
in the poultry carcass (Akond et al., 2008) as well as previous studies showed survival 
of V. cholerae in poultry products (Kolvin and Roberts, 1982).  
Since, cholera is predominantly a waterborne disease, water samples from various 
hostels in Rawalpindi and community water supplies in different areas were screened 
but still the isolation rate was very low in these samples. Although the previous work 
showed increased prevalence of V. cholerae in the tube wells and local supplies 
(http://www.jpathology.com/Issues/Previous%20Articles/10(8).html). However, in a 
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similar study to monitor water quality in earthquake affected areas the prevalence of 
V. cholerae was also low as compared to other genera such as Stapylococcus, 
Streptococcus, Enterobacter and Pseudomonas (Rasheed et al., 2009). Only three V. 
cholerae strains were isolated from city drain, effluent of slaughter house and sewage 
of local population and overall prevalence was low.  
V. cholerae has more than 200 serogroups but only O1 and O139 are associated with  
severe disease because they are equipped with potent virulence factors like cholera 
toxin and toxin co-regulated pili, TCP (Kaper et al., 1995; Taylor et al., 1987). 
Among the clinical sources, prevalence of O1 serogroup was very high (95%), 
however the non-O1/non-O139 serogroups have prevalence of 5%. The high 
prevalence of the O1 can be explained by virtue of cholera toxin which leads to severe 
acute diarrhoea accompanying rapid fluid loss and patients rush to the clinic or health 
facilities for treatment, whereas non-O1/non-O139 or non-toxigenic groups usually 
cause mild diarrhoea which might be a reason for not visiting the hospital for 
treatment (Lencer and Tsai, 2003). The non-O1/non-O139 V. cholerae may or may 
not possess cholera toxin, however recently some elements or genes like haemolysin 
(hlyA), type three secretion system (TTSS) and type six secretion system (TSSS) have 
role in severe diarrhoea (Dziejman et al., 2005; Figueroa-Arredondo et al., 2001; 
MacIntyre et al., 2010). The highest prevalence of non-O1/non-O139 was found to be 
in DI Khan which was affected by floods in 2010. Local outbreaks of non-O1/non-
O139 serogroups were reported in India, Bangladesh and Thailand (Ghosh-Banerjee 
et al., 2010; Na-Ubol et al., 2011; Son et al., 2011). Recently the extensively studied 
2010 Haiti cholera outbreak showed that a significantly high number of cholera cases 
were caused by V. cholerae isolates other than O1 (Piarroux et al., 2011). Serogroup 
O139 was not isolated from any sample of clinical or environmental origin during the 
current study. The O139 serogroup was initially thought to replace the O1 El Tor in 
the 1990s and starting the eighth cholera pandemic (Nair et al., 1994). However, 
O139 prevalence has been reduced in recent times. In Pakistan, previous reports also 
identified O139 as the cause of cholera in the last decade of 20
th
 century and first few 
years of 21
st
 century (Jabeen and Hasan, 2003; Siddiqui et al., 2006). However, 
during the last five years O139 was not reported. Local “gastro” outbreaks reported 
from Mirpur Khas and Karachi in Sindh analysed in the recent years were caused by 
O1 serogroup (Hannan et al., 2008; Jabeen et al., 2008). This study has shown that in 
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Pakistan like other regions in the world serogroup O1 has regained its position as the 
major serogroup causing cholera and that the seventh pandemic is not over. 
From the environmental sources, all V. cholerae isolates belonged to the non-O1/non-
O139 serogroups. Other groups from different countries isolated serogroup O1 and 
O139 from the environmental sources as well (Bagchi et al., 1993; Chatterjee et al., 
2009). However, with more systematic and extensive sampling, the actual 
contribution of environment in disease burden can be assessed with more accuracy. 
Generally, cholera infections peak up in the summer season but the organisms still 
persists throughout the year in different environments such as oceans, animal hosts, in 
the form of biofilms, but the colony forming units (CFUs) are generally reduced in 
such extreme conditions (Colwell, 1996; Rivera et al., 2001). The existence of less 
virulent non-O1/non-O139 serogroups in the environments may be regarded as good 
as the toxigenic serogroups are not existing which are far more virulent and cause 
epidemics if they are introduced into the communal water supplies, etc. On the other 
hand, these non-O1/non-O139 isolates while surviving in different environments are 
being equipped with virulence factors like toxins, mobile genetic elements and drug 
resistance cassettes, which they may exchange with O1 V. cholerae and hence their 
infections may become difficult to treat in the future. 
All the serogroup O1 V. cholerae have Ogawa serotype while Inaba was not found in 
any O1 isolate during the current study. Generally Ogawa serotype dominated in 
Pakistan during 1990s and until 2003, however in 2008 Inaba serotypes was more 
prevalent than Ogawa in Karachi (Hannan et al., 2008; Jabeen et al., 2008; Sheikh et 
al., 1997). Similarly on regional and global level including India, Haiti, Bangladesh, 
Malaysia, Mozambique Vietnam and  Thailand, Ogawa serotype has dominated over 
the Inaba (Ang et al., 2010; Goel et al., 2011; Lee et al., 2006; Rashed et al., 2014; 
Talkington et al., 2011; Tapchaisri et al., 2008; Tran et al., 2012). The Ogawa 
serotype may be associated with the fitness and survival of the O1 serogroup in the 
present circumstances.  
Classical biotype caused the first six cholera pandemics while the El Tor biotype was 
responsible for the current seventh cholera pandemic. All the Pakistan O1 cholera 
isolates had El Tor biotype which was confirmed by biochemical tests as well as by 
detection of biotype specific tcpA by PCR. This El Tor biotype is causing cholera all 
over the world and has been found globally in the recent past (Ghosh-Banerjee et al., 
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2010; Goel et al., 2011; Hendriksen et al., 2011; Safa et al., 2008; Shah et al., 2014) 
however, the classical biotype has rare incidence. 
Toxin co-regulated pili (TCP) is one of the major virulence factors of V. cholerae 
along with the cholera toxin and helps in anchoring the bacterium to the cell surfaces 
of the host (Kirn et al., 2000). TCP (homopolymers of TcpA subunits) are encoded on 
Vibrio pathogenicity island-1 (VP1-1) which also encodes the ToxT regulator for 
cholera toxin and TCP. VPI-1 is a 40 kb genetic element encoding tcpA and other 
virulence factors including ToxT, aldA, ToxR, acfC, etc. (Karaolis et al., 1998). 
Analysis of VPI-1 showed that although ToxT and int were present consistently in all 
the O1 El Tor isolates, however the prevalence of aldehyde dehydrogenase A (aldA) 
and ToxR activated gene A (tagA) was not uniform in O1 El Tor isolates investigated 
during this study. This deletion of aldA and tagA was unique to Pakistan isolates as it 
was not observed in contemporary El Tor isolates from other parts of the world (Chin 
et al., 2011; Mutreja et al., 2011; Reimer et al., 2011). In this study, for the first time, 
V. cholerae O1 El Tor lacking aldA and tagA were isolated in 2010 (Shah et al., 
2014). However, the increased prevalence or dominance of such strains in the 2011 
suggested that in Pakistan two types of VPI-1 are existent (intact VPI-1 and VPI-1 
with three gene deletion). Both genes, aldA and tagA, have role in the virulence, as 
aldA increases the survival in certain environment by ensuring the availability of 
certain nutrients while tagA has a role of mucinase which helps in V. cholerae 
transmission by modifying the host cell surfaces (Szabady et al., 2011). These two 
forms of VPI-1 (intact VPI-1 and VPI-1 lacking aldA and tagA) suggest that cholera 
in Pakistan is caused by two different types of Ol El Tor strains implying two 
different sources of cholera spread in 2010 and 2011. In 2011 the aldA and tagA 
negative isolates constituted 96% of the isolated O1 El Tor whereas aldA and tagA 
positive only constituted only 4 % of O1 El Tor isolates, and in 2009 all the isolates 
were positive for aldA and tagA. It can be suggested that aldA and tagA negative O1 
El Tor type is becoming dominant in Pakistan, hence these strains may have some 
other factors which enhance their fitness and ensure better survival relative to the 
strains which possess intact VPI-1. 
Antibiotic resistance is an ancient phenomenon (D'Costa et al., 2011) and with 
exposure to these formerly called wonder drugs, the resistance has started to emerge 
soon after the discovery (Barber and Rozwadowska-Dowzenko, 1948; Levy, 1982). In 
120 
 
Vibrio cholerae drug resistance is mediated by mutations at certain loci such as parC, 
gyrA, etc. as well as by exchange of genetic material through plasmids and 
transposons, mobile genetic elements like  Integrons, and integrative and conjugative 
elements (ICEs) carrying resistance encoding genes disseminate resistance genes 
across different species very rapidly (Kitaoka et al., 2011). In the early 1970’s 
resistance to different antibiotics was mediated by conjugative plasmids which carry 
antibiotic resistance genes (Glass et al., 1983). Then with the passage of time the 
integrons were found to transfer antimicrobial resistance in Vibrio cholerae in 
different countries (Ahmed et al., 2006; Dalsgaard et al., 2000a; Dalsgaard et al., 
2001; Dalsgaard et al., 2000b; Hall and Collis, 1995). In 1996, an ICE named SXT 
was discovered in a V. cholerae O139 strain from Madras, India. It encoded resistance 
to trimethoprim/sulfamethoxazole, streptomycin and chloramphenicol (Waldor et al., 
1996; Ceccarelli et al., 2006). In the later years, O1 strains resistant to these 
antibiotics were isolated from India and as well as from other countries such as South 
Africa and Bangladesh (Amita et al., 2003; Dalsgaard et al., 2001; Hochhut et al., 
2001). Recently, this SXT/ICE has spread globally and majority of the O1 isolates are 
resistant to these drugs (Burrus et al., 2006; Ehara et al., 2004; Mutreja et al., 2011; 
Shah et al., 2014).  
The clinical isolates (97 V. cholerae O1) we investigated during in this study (2009 to 
2011) were all multiple antibiotics resistant. All the isolates were resistant to nalidixic 
acid, trimethoprim/sulfamethoxazole and streptomycin. In past, V. cholerae O1 El Tor 
isolates associated with sporadic and epidemic cholera in Karachi during 1990-2008 
were also sulfamethoxazole resistant (Hannan et al., 2008; Jabeen et al., 2008; Sheikh 
et al., 1997).  However, resistance to nalidixic acid was not previously observed in 
Pakistan as a seven year study (1990-1997) on V. cholerae O1 and O139 in Karachi 
showed almost 100% sensitivity to nalidixic acid (Sheikh et al., 1997). This specific 
resistance pattern is now observed in cholera isolates around the world (Ang et al., 
2010; Kiiru et al., 2013; Kutar et al., 2013). Since cholera is a severe diarrhoeal 
disease, if it is not properly treated then the case fatality may rise upto 50% as is 
evident from history of the disease where it caused thousands of deaths in the 
epidemic areas (Barua and Greenough, 1992). With the introduction of the oral 
rehydration therapy millions of lives were saved. But in severe cases, besides the oral 
rehydration treatment there is requirement to reduce the fluids loss as early as 
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possible, so with the dawn of antibiotic era, the antibiotics used to treat cholera 
resulted in the reduced fluid requirement, fluid loss and vibrio secretion in stool 
(Wallace et al., 1968). However, with the use of antibiotics for prophylaxis and 
cholera treatment many resistant strains emerged and the problem of antibiotic 
resistance further aggravated with the emergence of the multiple antibiotic resistant V. 
cholerae strains in different parts of the world . 
A trend of increase in tetracycline resistance in V. cholerae was observed during the 
current study period (2009-11). It is interesting to note that after 2009 tetracycline 
resistance increased in V. cholerae. In 2010, 8/38 isolates were resistant to 
tetracycline and in 2011 almost all the strains were resistant to tetracycline except two 
from Nowshera. Previous studies in Pakistan showed that till 1992 V. cholerae in 
Pakistan were sensitive to tetracycline, however tetracycline resistance suddenly 
emerged in 1993 and then reduced to almost zero in 2000 and in 2008 majority of O1 
strains were sensitive to tetracycline (Hannan et al., 2008; Jabeen and Hasan, 2003; 
Jabeen et al., 2008; Sheikh et al., 1997). 
Tetracycline has been used for cholera treatment for long time. In the 1960s, 
tetracycline was used for the treatment of cholera in different parts (Islam, 1987) 
where after regular use tetracycline resistant cholera strains emerged. In 1980, 
tetracycline resistance was observed following prescription for cholera treatment for 8 
months, the resistance appeared in V. cholerae isolates. In Zambia, in 1995 
tetracycline resistance was about 95% and after its limited use/use of erythromycin as 
alternate for treatment of cholera, the tetracycline resistance decreased in the next 
decade (Mwansa et al., 2007). Tetracycline resistance has also been observed in many 
other countries in South Asia, India and Bangladesh (Bhattacharya et al., 2011; 
Faruque et al., 2007a) while in Haiti and Kenya tetracycline resistance is not common 
and still it is effective (Hendriksen et al., 2011; Kiiru et al., 2013). Tetracycline 
resistance which is also used to predict resistance pattern to doxycycline shows that 
doxycycline, which is used as first line of drug for cholera treatment, has not been 
effective in Pakistan in the present circumstances. 
Majority of the isolates exhibited intermediate level of resistance to erythromycin 
during the three year period which highlights the looming threat of resistance to this 
antibiotic which is part of the current antimicrobial regimen to treat cholera especially 
in children and pregnant women (Kabir et al., 1996). However, in Malaysia 100% 
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erythromycin resistant V. cholerae O1 El Tor caused epidemics in 2009 (Ang et al., 
2010). Ciprofloxacin resistance was very low in V. cholerae O1 El Tor isolates which 
may provide an alternate for treatment in severely dehydrated cases as well as only 
single or few doses are enough in contrast to multiple dose regimen of tetracycline or 
erythromycin for infection treatment (Saha et al., 2005). All the V. cholerae O1 El 
Tor collected during this study were sensitive to ofloxacin,  previous studies on O1 
isolates from Pakistan conducted in different periods also exhibited this pattern 
(Hannan et al., 2008; Jabeen et al., 2008). 
Resistance to chloramphenicol was very low as almost 98% isolates were sensitive. 
Retrospective drug resistance analysis in V. cholerae O1 in Pakistan also 
demonstrated sensitivity to chloramphenicol in Pakistan (Jabeen et al., 2008; Sheikh 
et al., 1997). In this study, ampicillin resistance in V. cholerae O1 gradually increased 
during 2009-2011 in Pakistan. In past for the first time in 2008, 100% ampicillin 
resistant V. cholerae were isolated from cholera outbreak in Mirpur Khas – Sindh, 
whereas ampicillin sensitive V. cholerae O1 El Tor were associated with cholera 
outbreaks in Karachi during 1990-2005 (Hannan et al., 2008; Jabeen et al., 2008). V. 
cholerae genome is highly dynamic and within the last few decades many changes 
have been observed in the genome of this current seventh pandemic pathogen related 
to increased virulence and survival fitness by offering resistance to antibiotics. Vibrio 
cholerae drug resistance is mediated by mutations in the certain loci such as parC, 
gyrA, etc. as well as by exchange of genetic material through plasmids and 
transposons,  mobile genetic elements like Integrons, and integrative and conjugative 
elements (ICEs) carrying resistance encoding genes disseminate resistance genes 
across different species very rapidly (Kitaoka et al., 2011; Yoshida et al., 1990). The 
ICE, SXT element was present in all the V. cholerae isolates. After its discovery, the 
SXT elements has now become a regular feature of the genome content of the V. 
cholerae O1 El Tor in different parts of the world (Taviani et al., 2012). SXT encoded 
resistance to many antibiotics including sulfamethoxazole, trimethoprim, 
streptomycin and chloramphenicol in the beginning (Dalsgaard et al., 2001; Hochhut 
et al., 2001). However, with the passage of time in El Tor isolates, the 
chloramphenicol resistance was not encoded on SXT. In this study, two types of 
genotypic profiles were found, one encoding resistance to sulfamethoxazole, dfrA1, 
tetA and strAB whereas the other contained sul2, dfrA1, strAB and floR. The 
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phenotypic resistance was consistent with the presence of sul2, dfrA1 and strAB while 
in 38 isolates having floR, only 6 showed resistances to chloramphenicol at 
phenotypic level. It is suggested that the sensitivity to chloramphenicol may be due to 
lower expression of florR or other factors which need to be analysed. All the 98 
tetracycline resistant were positive for the presence of TetA which exhibit a new type 
of SXT incorporating TetA. 
All the V. cholerae O1 El Tor isolates have gyrA and parC mutations responsible for 
quinolones resistance at the respective loci. Such mutations are not present in the V. 
cholerae O1 El Tor N16961 strain but now recently these mutations are observed in 
isolates from India, Bangladesh, Haiti, Nigeria and Cameron which have been shown 
to increase resistance to quinolones such as ciprofloxacin (Baranwal et al., 2002; 
Hasan et al., 2012; Islam et al., 2009; Kim et al., 2010; Quilici et al., 2010). Before 
this study we had limited data about the current antimicrobial resistance pattern in V. 
cholerae from Pakistan. This study highlighted emergence of nalidixic resistance after 
1996 and tetracycline resistance re-emergence in Pakistan after 2008 in V. cholerae 
O1 El Tor isolates in the context of past studies (Hannan et al., 2008; Jabeen et al., 
2008).  
Cholera toxin is the main virulence factor of V. cholerae encoded on the CTX 
prophage. The CTX prophage has undergone evolutionary changes with the time. It is 
also related with the disease conditions because different copies or tandem repeats of 
CTX prophage cause the severe diseases and isolates carrying such phages in the 
epidemic situations become extremely virulent and the fatality rate may rise (Waldor 
and Mekalanos, 1996). Characterization of CTX prophage may be useful to track 
outbreak source and is valuable in determining the evolutionary aspect of cholera 
phage because different distinct phage types have been associated with outbreaks in 
Mozambique (Faruque et al., 2007b; Hasan et al., 2012). The O1 V. cholerae of 
Pakistan have the CTX prophage which is recently prevalent in South Asia and 
Southeast Asia (Goel et al., 2011; Nguyen et al., 2009). The isolates investigated 
during the current study have ctxB of classical type whereas rstR of El Tor type.  
 This ctxB type was present in El Tor isolates of US Gulf Coast and caused sporadic 
infections (Olsvik et al., 1993). A retrospective study in India showed ctxB
Classical
 
presence in Kolkata during 1989 and then showed its dominance over the ctxB
ET
 in 
the 1990s (Raychoudhuri et al., 2009). Now this ctxB
Classical
 is dominant over ctxB 
El 
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Tor
 genotype in India (Kumar and Thomas, 2011). In Bangladesh this particular ctxB 
type caused outbreaks in 2004 (Nair et al., 2002) and from Mozambique ctxB
Classical
 
was reported in cholera outbreak strains (Ansaruzzaman et al., 2004). In the last 
decade, El Tor variants caused outbreaks in Hong Kong, Sri Lanka, Japan, China and 
Malaysia (Ang et al., 2010; Safa et al., 2008). However in 2012 and 2013 few V. 
cholerae O1 El Tor and O139 isolated after a decade from cholera patients and 
surface waters in Bangladesh possessed ctxB
El Tor 
which is characteristic O1 El Tor 
isolates as well as present in V. cholerae O1 El Tor N16961 reference (Rashed et al., 
2013). We did not have any prior information about ctxB
Classical
 status in Pakistan, 
however in 2010 V. cholerae O1 El Tor isolates from Pakistan were analysed 
extensively which found ctxB
Classical
 (Shah et al., 2014) in the El Tor isolates and this 
ctxB genotype is still associated with cholera outbreaks and sporadic infections in 
Pakistan.  
An unusually higher frequency of the ToxR binding repeat (TTTTGAT) between ctxA 
and zot in the ctxAB promoter region was found in CTX of V. cholerae El Tor isolates 
from Pakistan with average five to six repeats. V. cholerae O1 classical isolate (O395) 
has 7 repeats of this heptad sequence whereas the O1 El Tor has 4. In the isolates of 
Bangladesh and India its frequency is three or four. In 2011, the Haiti cholera 
outbreak isolates have five repeats (Hasan et al., 2012; Nair et al., 2006; Son et al., 
2011). The higher repeat frequency is usually related to strong binding of important 
virulence gene regulator ToxR often associated with more production of the cholera 
toxin and hence increased virulence (Pfau and Taylor, 1996) as experienced in case of 
Haiti cholera outbreak. So, the CTX prophage in Pakistan has this unique feature in 
contrast to other CTX prophages in the region.  
Genotyping of the isolates has importance for determining clonal relationship among 
isolates of different outbreaks. In contrast to the conventional methods of genotyping, 
PCR based methods are becoming popular for advantage of reproducibility and results 
can be shared easily between laboratories across the world.  
All the O1 El Tor isolates were analysed for epidemiological purpose by MLVA 
because such robust, economic, reproducible and reliable methods are an important 
tool in epidemiological studies. MLVA has been successfully used for transmission 
analysis of many bacterial pathogens (Jureen et al., 2003). 
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Poleg in 2007 identified 17 loci for VNTR analysis of V. cholerae (Danin-Poleg et al., 
2007) which comprised of simple sequence repeats (SSR) loci to efficiently 
discriminate V. cholerae isolates of O1, O139 and non-O1/non-O139 serogroups. 
Later on MLVA based on repeats in five loci was introduced which differentiated V. 
cholerae of O1 and O139 serogroups as well as of environmental isolates (Stine et al., 
2008). The relatedness among V. cholerae isolated from cholera patients and their 
households was determined by MLVA, however the MLVA profiles showed less 
stability than MLST (Kendall et al., 2010). MLVA has been extensively applied for 
genotyping clinical and environmental isolates from different geographical areas for 
retrospective and epidemiological studies (Ghosh et al., 2008; Lam et al., 2012). 
Similarly, MLVA analysis related the clonal complex with distinct outbreaks and 
geographical spread in Thailand (Okada et al., 2012). Non-O1/non-O139 Vibrio 
cholerae isolates from cholera patients in Haiti were also analysed by MLVA for 
clonal relatedness (Hasan et al., 2012). MLVA analysis for temporal changes in V. 
cholerae O1 strains in Pakistan and geographical spread during 2009-2011 divided 
the isolates in six clonal complexes and 3 singletons.  
The genotyping of the V. cholerae isolates from Pakistan, by MLVA generated 44 
sequence types (STs) arranged in six clonal complexes and three singletons on the 
basis of single locus variants. Clonal complexes contained, STs consisting the isolates 
of a particular year. For example, largest clonal group included majority of the 
isolates from 2011, similarly the second and third clonal groups included the isolates 
belonging to 2010. 
In MLVA, the three loci on the large chromosome (VC0147, VC0436-7 and VC1650) 
showed less variation whereas both loci on the small chromosome (VCA0171 and 
VCA0283) showed higher variability as has already been reported (Kendall et al., 
2010) which may be due to the nature of the small chromosome which contains higher 
proportion of the hypothetical genes as compared to the large chromosome 
(Heidelberg et al., 2000). Generally, the repeat frequency for two loci (VC0147 and 
VC0436-7) during 2010 was less in all the cities whereas in Karachi the repeat 
frequency for the above mentioned loci was higher with exceptions. Such lower 
number of repeats was also observed in MLVA analysis of V. cholerae O1 and O139 
serogroups from seasonal cholera outbreak strains in Bangladesh (Stine et al., 2008). 
The loci on chromosome 2 (VCA0171 and VCA0283) are hypervariable. In a recent 
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study, MLVA based on three hypervariable loci (VC0147, VCA0171 and VCA0283) 
was found suitable for epidemiological analysis due to few loci and discriminatory 
ability (Zhou et al., 2013). However, in contrary to their findings many STs 
representing many isolates (STs comprising higher number of isolates) were also 
found and the diversity in STs was also observed in the isolates. MLVA discriminated 
2010 isolates more than the 2011 isolates as this may be due to floods when a large 
population were infected from V. cholerae from many diverse sources due to 
contaminated water and high population density due to displacements during flood. 
However, in 2011  the scale of flood was much less than 2010, so the isolates have 
less diversity due to a particular pattern of spread established by any of the factors, 
either mass migration or contaminated water, food ,etc.  
In 2011, one unique MLVA profile, 11, 7, 7,14,0 was also generated which related all 
the PSC-1 O1 El Tor isolates from cities of Punjab during 2011.  In 2011, the MLVA 
profiles were distinct from the 2010 by having a higher number of repeats in three loci 
(VC0147, VC0436-7, and VC1650) higher repeat frequencies in these loci were also 
reported in V. cholerae isolates from the sub-continent. However, the exact ST of 
these isolates was different (Choi et al., 2010). Among the four isolates of 2009 
isolated from Rawalpindi, two have lower repeat frequency in the three loci on the 
large chromosome whereas two have higher repeat numbers in these loci. 
MLVA clonal complexes did not relate the isolates on the bases of the antibiotic 
resistance pattern as mostly the antibiotic resistance genes are acquired by horizontal 
gene transfer, however in the previous studies it related the V. cholerae strains from 
Mozambique and Bangladesh on the basis of the CTX prophage (Choi et al., 2010).  
Now a days the revolutionary progress in all spheres of life, brought blessings for 
human beings in travelling, healthcare, communication and technology, etc. The quick 
mobility resulted in rapid spread of infectious diseases from one region to other 
region in extremely short span of time (Brzuszkiewicz et al., 2011; Jenson and Szabo, 
2011; Mutreja, 2012). As a result of this global village like phenomenon, it has 
become essential for the healthcare authorities in order to control infectious diseases 
like cholera to be aware of its global structure and changes occurring in the pathogen 
to avoid future epidemics or to effectively control the disease. In order to control  
infectious disease epidemics and prevent their  spread by source tracking the origin of 
epidemic pathogen, different standard approaches such as amplified fragment length 
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polymorphism (AFLP), Pulse field gel electrophoresis (PFGE), multilocus sequence  
typing (MLST), multilocus variable number of tandem repeats analysis (MLVA) are 
frequently used (Foley et al., 2009). These approaches provide higher resolution about 
the strains prevalent in different regions of the world and their clonal relationships.  
 In1995, PFGE was applied to determine relationship of newly emerged toxigenic V. 
cholerae O139 and it also differentiated the O139 isolates from O1 isolates. But the 
complete genome sequence of Vibrio cholerae O1 El Tor NCTC 16961 (Heidelberg et 
al., 2000) opened new avenues to explore this organism and to understand the basis 
for its pathogenesis and virulence. Then based on the published sequence of V. 
cholerae N16961, in 2002 a microarray was developed for a comparative genomic 
study between pre-seventh pandemic, post pandemic, O1 classical non-toxigenic and 
O139 strains to track the changes in the genome of V. cholerae that had been taken 
place from 1940 to 1992 (Dziejman et al., 2002).  In the last five years, advances in 
the genome sequencing technology made it possible to sequence microbial genomes 
rapidly in cost effective manner. Genotyping or genome characteristics of epidemic 
pathogens is important to source track the diseases and to take efficient measures to 
control the disease such as characterization and source tracking of  the V. cholerae 
and E. coli epidemic strains in Haiti  (Hendriksen et al., 2011) and Germany 
(Brzuszkiewicz et al., 2011) respectively.  
To this effect, in the last few years a large number of genomes of V. cholerae O1 El 
Tor around the world have been sequenced (Reimer et al., 2011). Whole genome 
sequence typing (WGST) was applied to answer very critical questions: track the 
source of cholera outbreak strain in Haiti (Hendriksen et al., 2011) and to know about 
the changes in this pathogen during the last 80 years or so (Mutreja et al., 2011). The 
later study focused on the temporal changes the pathogen has under gone since 1961 
(the start of the current seventh pandemic) as well by comparing some strains from 
the pre-pandemic and also some belonging to the early 20
th
 century. The study by 
Mutreja et al., 2011 revealed that V. cholerae El Tor causing current epidemic are 
highly similar and show little SNP variations compared to those belonging to the pre-
seventh pandemic and from previous six pandemics. The seventh pandemics V. 
cholerae O1 El Tor were classified in three waves originating from the Bay of 
Bengal. Therefore, it is important to have the genome sequence of V. cholerae O1 El 
Tor from all the major cholera endemic regions which will be very useful for source 
128 
 
tracking to prevent global spread. Pakistan like many other countries also faces the 
challenge of cholera but to a lesser extent than other countries in the region like India 
and Bangladesh. However, very few reports about V. cholerae have been published 
from Pakistan and the epidemic strains in Pakistan have never been analysed in a 
comprehensive manner, except some responsible for travel associated cholera cases in 
USA (Reimer et al., 2011). To fill this gap in knowledge about V. cholerae in 
Pakistan, O1 El Tor strains from flood and non-flood areas of Pakistan have been 
sequenced and SNP based phylogeny was studied.  
Whole genome sequence analysis and phylogenetic relationship based on SNPs 
grouped the V. cholerae isolates from Pakistan during the study into two distinct sub-
clades named as Pakistan sub-clade 1 (PSC-1) and Pakistan sub-clade 2 (PSC-2). 
Both the PSCs belonged to the third transmission wave of the current seventh 
pandemic (Figure 3.29). The phylogenetic relationship of PSCs also compared them 
with 146 V. cholerae isolates representing a global collection of V. cholerae 
originated from different regions, including the isolates responsible for the 2010 Haiti 
cholera outbreak (Hendriksen et al., 2011). This phylogenetic relationship linked 
PSCs with the cholera isolates from sub-continent and those of Haiti. The 
phylogenetic analysis of 2010 cholera isolates of Pakistan showed that both PSCs 
exhibit distinct signature genome features as well as geographic distribution. The 
PSCs distribution revealed that PSC-1 was restricted in and around the non-flood 
affected city of Karachi and only one of seven PSC-1 isolates belonged to the 
neighbouring city of Hyderabad. However, PSC-2 has wide distribution in both flood-
affected and non-flood affected cities in the country. 
The root-to-tip distances of Pakistan sub-clade 2 (PSC-2) were analysed which related 
the direction of river Indus flow to the spread of cholera and it can be inferred that 
during 2010 floods in Pakistan cholera spread possibly by three routes (Figure 4.1).  
The most cautious explanation of PSC-2 spread in Pakistan may be through the course 
of river Indus flow during floods whereas PSC-2 seems to be originated in the coastal 
city of Karachi, but could not penetrate the rest of the country. The other route of 
cholera spread in Pakistan in 2010 in non-flood affected areas may be due to the 
transmission of cholera from flood affected to non-flood areas by human travel or 
other routes such as transporters, travellers and caused sporadic cases.  
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Figure 4.1 Cholera spread in Pakistan during 2010 floods. 
A. Map of Pakistan showing isolation V. cholerae O1 El Tor from Pakistan during 2010. The 
locations are represented by circles whereas circles with red outer shade represent the flood 
affected areas. The hypothetical spread of sub-clades is indicated by white arrows. B. 
Cumulative root-to-tip distances of Pakistan sub-clades. Each V. cholerae O1 El Tor is 
represented by a circle whereas the circle colour and shade correspond to the location and 
month of isolation respectively. August, light grey; September, medium grey; October, dark 
grey (Shah et al., 2014). 
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The whole genome sequencing and comparative genomics of PSCs, revealed sub-
clade specific signature deletions in Vibrio pathogenicity island 1 (VPI-1) and Vibrio 
seventh pandemic island 2 (VSP-2). VPI-1 of PSC-1 had a unique three gene deletion   
(VC0819-VC0921), and a result lack aldehyde dehydrogenase (aldA), ToxR regulated 
gene A (tagA) and the coding sequence of a hypothetical protein. aldA gene has a 
metabolic role probably in the utilization of certain carbon sources for energy 
purposes whereas tagA is a mucinase, which modifies the host cell surface during V. 
cholerae infection (Szabady et al., 2011), as a result the V. cholerae strains are 
secreted from the host into the environment. In our findings, this novel three gene 
deletion in VPI-1 has not been found in V. cholerae around the world, although 
deletion of entire VPI-1 in a V. cholerae O1 El Tor strain was reported which had 
been carried to US from Pakistan during travel (Reimer et al., 2011). PSC-1 had a 
deletion in VSP-2 (VC0495-VC0498). This four-gene deletion was also found in V. 
cholerae isolates from Bangladesh in 2008 (Chin et al., 2011). In contrast to PSC-1, 
VPI-1 in PSC-2 was intact, however accessory colonization factor C (acfC) in this 
sub-clade had been interrupted by frame shift mutations. 
VSP-2 of PSC-2 had a large 18-gene deletion (VC0495-VC0512) which was similar 
to other contemporary isolates from Haiti in 2010 and China in 2005 (Chin et al., 
2011; Pang et al., 2007). Hence, PSC-2 was closer to Haiti V. cholerae O1 El Tor 
isolates in the phylogenetic map (Figure 3.29). 
A putative type IV pilin (VC0502) was also part of this deletion, which may affect the 
colonizing and virulence ability of the PSC-2.  The above mentioned deletions in 
VSP-2 of PSC-2 are in consistence with the phylogenetic grouping of the isolates. 
Further studies should be designed to evaluate the role of these deletions in the 
survival and maintenance of the sub-clade both within and outside the host.  The 
genetic composition of the SXT element was similar in both sub-clades and it was 
present in all the isolates of both PSCs. 
The three genes group, VC1577 (almG), VC1578 (almF) and VC1579 (almE), was 
intact in both subclades and has been shown recently to be responsible for the 
resistance to polymixinB/nalidixic acid which is a feature of the El Tor biotype 
(Hankins et al., 2012).  
In addition to signature deletions in VPI-1 and VSP-2, both PSCs had characteristic 
antibiotic resistance profiles. All PSC-1 isolates were resistant to tetracycline whereas 
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all PSC-2 isolates were sensitive to tetracycline. Furthermore, the genetic basis of 
tetracycline in PSC-1 involves tetA and tetR which were absent in PSC-2.  Likewise, 
all the PSC-2 isolates had floR in the genome whereas florR was absent in PSC-1. 
However, phenotypically only few PSC-2 strains were resistant to chloramphenicol.  
The phylogenetic position of PSC-1 and PSC-2 on the phylogenetic tree of a global V. 
cholerae collection showed that PSC-1 was close to V. cholerae O1 El Tor isolates 
from India and Bangladesh responsible for cholera in 2006 and 2007 whereas V. 
cholerae from Bangladesh India in 2004-5 were related to PSC-2 (Mutreja et al., 
2011).  
The whole genome sequence analysis and SNPs based phylogenetic study shows 
higher resolution, therefore it is one of the best approaches employed in the 
epidemiological and phylogenetic studies. The two PSCs identified based on this 
approach showed excellent results as both the genotypic as well as drug resistance 
features were in agreement with each other. In case of MLVA which was performed 
earlier could not relate the drug resistance patterns and genomic features to clonal 
complexes (CCs) because it was based only on variations in five loci which could not 
reflect the complete genomic picture.  
The whole genome analysis and phylogenomics of 2009-2011 V. cholerae O1 El To 
isolates greatly helped us in understanding the evolutionary and epidemiological 
dynamics of O1 El Tor in Pakistan. Since, all the four O1 El Tor isolates in 2009 
belonged toPSC-2 and in 2010, 82% of the O1 El Tor isolates were grouped in PSC-2 
whereas PSC-1 consisted of only 18% O1 El Tor isolates during 2010. In 2011, 96% 
of El Tor isolates all over Pakistan belonged to PSC-1 whereas PSC-2 represented 
only 4% isolates. Hence, it can be speculated that PSC-2 had already existed in 
Pakistan, whereas in 2010 PSC-1 originated or appeared in Karachi by some unknown 
routes or more likely from the marine ecosystem because marine ecosystem being the 
natural habitat of V. cholerae plays an important role in transmission, evolution and 
spread of the cholera pathogen to other regions. PSC-1 dominated in 2011 all over the 
country, however it is still an important question that how PSC-1 was transmitted 
from Karachi to far off areas in North such as Gilgit Baltistan close to the mountain 
range from where the river Indus starts and spread throughout Pakistan whereas PSC-
2 was confined only to Nowshera in Khyber-Pakhtunkhwa.  
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The evolutionary trends of PSCs suggest that PSC-1 has become the dominant V. 
cholerae O1 El Tor sub-clade causing cholera in Pakistan. The PSCs unique genomic 
characteristics and antibiotic resistance patterns have shown that in contrast to other 
countries, in Pakistan a new sub-clade (PSC-1) has evolved. The existence of PSC-2 
in 2009 in a central city, Rawalpindi, supports that PSC-2 had already existed in 
Pakistan, however the ongoing study in the group showed that this sub-clade is being 
replaced by a new sub-clade, PSC-1. These powerful genetic markers derived from 
this data can be used to design PCR based assays which will facilitate the surveillance 
and tracking of PSC-1 and PSC-2 in Pakistan. In addition, the sub-clade specific drug 
profile may suggest the effective antibiotic treatment of cholera. 
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5   Conclusions 
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Characterization Vibrio cholerae from Pakistan during 2009-2011 was very helpful in 
answering some important questions about prevalence of V. cholerae in different 
sources, prevalent serogroups and biotypes, associated antibiotic resistance pattern 
and CTX  prophage structure. Furthermore, the whole genome sequencing and SNPs 
based phylogenetics filled the gap in knowledge about prevalent V. cholerae in 
Pakistan and gave an understanding about the genetic makeup of V. cholerae O1 El 
Tor isolates from Pakistan. 
In the clinical cases, the prevalence of V. cholerae O1 was very high as compared to 
non-O1/non-O139 serogroups. However, serogroup O139 seemed to be eliminated as 
shown during the current study. El Tor biotype of V. cholerae O1 which caused the 
current seventh pandemic is still prevalent around the world including Pakistan 
whereas the classical biotype was not detected. 
CTX prophage encoding cholera toxin was present in all El Tor isolates analysed 
except one isolated from Charsada. The ctxB of classical biotype was present whereas 
higher frequency of heptanucleotide (TTTTGAT) between ctxA and zot suggested that 
these isolates may have the increased virulence potential. 
All the V. cholerae O1 El Tor isolates investigated from Pakistan were multiple 
antibiotics resistant. The antimicrobial resistance increased during the study as we 
observed shift from tetracycline sensitive to tetracycline resistance V. cholerae O1 El 
Tor isolates in Pakistan during 2009 to 2011. Resistance to other antibiotics like 
ampicillin also showed an increase in resistance trend with 0%, 7.9% and 28% 
isolates exhibiting resistance to ampicillin in 2009, 2010 and 2011 respectively. 
However, resistance to other antibiotics has not been a cause of concern in the current 
scenario. 
Integrative and conjugative element SXT was discovered in V. cholerae in 1996 and 
since then it has spread to different parts of the world and lead to an increase in 
antibiotic resistance to sulfamethoxazole, trimethoprim and streptomycin. This SXT 
element was present in all O1 El Tor isolates from Pakistan.  
Two distinct sub-clades of V. cholerae O1 El Tor (PSC-1 and PSC-2) caused the 
epidemic and sporadic cholera infections in Pakistan during 2009-2011. PSC-1 has a 
signature three gene deletion in VPI-1. The Pakistan sub-clade 2 (PSC-2) was 
observed in 2009 and 2010 from all over Pakistan except Karachi whereas PSC-1 was 
mainly seen in 2011. It appears that one of the sub-clades i.e, PSC-2, is replaced in the 
135 
 
following years by PSC-1 as PSC-2 was only found in Charsada (Khyber 
Pakhtunkhwa) during 2011. Based on the whole genome sequence data and canonical 
SNPs, rapid sub-clade specific detection assay can be designed which will be useful in 
source tracking and transmission of cholera both at local as well as at the global level. 
Moreover, fluoroquinolones such as ciprofloxacin is the drug of choice associated 
with the prevalent PSC-1 in Pakistan.   
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Annexure: 
COMSATS Institute of Information Technology 
Department of Biosciences 
Park Road, Islamabad- Pakistan 
 
Patient history form for sample collection from diarrhoea patients 
 
Sample ID:  Date: 
Patient Name: Age: Sex: 
Area/City: Hospital:  
Sample collected 
Stool: Rectal swab: 
 
Clinical history: 
Watery diarrhoea 
Bloody diarrhoea 
Any other: 
On set of diarrhoea ………………  days. 
 
Associated Symptoms: 
Temperature: Y/N 
Vomitting: Y/N 
Abdominal pain: 
Dehydration Status:   
No dehydration Mild  
 
Severe 
Treatment Status: Y/N, if yes 
Days: 
Antibiotics: 
Others: 
Outcome of the therapy: 
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Drinking water source: 
Possible cause of diarrhoea: 
Other associated diseases: 
Hospital ID: 
Contact: 
 
        Patient/Guardian consent 
 
